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ABSTRACT OF THE DISSERTATION
CONFORMATIONAL DYNAMICS AND STABILITY ASSOCIATED WITH
MAGNESIUM OR CALCIUM BINDING TO DREAM IN THE REGULATION OF
INTERACTIONS BETWEEN DREAM AND DNA OR PRESENILINS
by
Khoa Ngoc Pham
Florida International University, 2016
Miami, Florida
Professor Jaroslava Miksovska, Major Professor
Downstream regulatory element antagonist modulator (DREAM) is involved in
various interactions with targets both inside and outside of the nucleus. In the cytoplasm,
DREAM interacts with the C-terminal fragments of presenilins to facilitate the production
of β-amyloid plaques in Alzheimer’s disease. In the nucleus, Ca2+ free DREAM directly
binds to specific downstream regulatory elements of prodynorphin/c-fos gene to repress
the gene transcription in pain modulation. These interactions are regulated by Ca2+ and/or
Mg2+ association at the EF-hands in DREAM. Therefore, understanding the
conformational dynamics and stability associated with Ca2+ and/or Mg2+ binding to
DREAM is crucial for elucidating the mechanisms of interactions of DREAM with DNA
or presenilins. The critical barrier for envisioning the mechanisms of these interactions lies
in the lack of NMR/crystal structures of Apo and Mg2+DREAM.
Using a combination of fluorescence spectroscopy, circular dichroism, isothermal
titration calorimetry, photothermal spectroscopy, and computational approaches, I showed
that Mg2+ association at the EF-hand 2 structurally stabilizes the N-terminal alpha-helices

vii

1, 2, and 5, facilitating the interaction with DNA. Binding of Ca2+ at the EF-hand 3 induces
significant structural changes in DREAM, mediated by several hydrophobic residues in
both the N- and C-domains. These findings illustrate the critical role of EF-hand 3 for Ca2+
signal transduction from the C- to N-terminus in DREAM. The Ca2+ association at the EFhand 4 stabilizes the C-terminus by forming a cluster consisting of several hydrophobic
residues in C-terminal domain. I also demonstrated that association of presenilin-1
carboxyl peptide with DREAM is Ca2+ dependent and the complex is stabilized by aromatic
residues F462 and F465 from presenilin-1 and F252 from DREAM. Stabilization is also
provided by residues R200 and R207 in the loop connecting 7 and 8 in DREAM and
the residues D450 and D458 in presenilin-1.
These findings provide a structural basis for the development of new drugs for chronic
pain and Alzheimer’s disease treatments.

viii

TABLE OF CONTENTS
CHAPTER

PAGE

PREFACE ........................................................................................................................... 1
1.

INTRODUCTION ....................................................................................................... 2
1.1
Calcium and intracellular Ca2+ signaling network ...................................... 2
1.2
Intracellular calcium binding proteins ........................................................ 4
1.3
Neuronal calcium sensor (NCS) proteins and the biological
functions of Ca2+ binding to NCS proteins ................................................. 5
1.3.1 Class A: Neuronal calcium sensor 1 ......................................................... 12
1.3.2 Class B: Visinin-like proteins, hippocalcin, and neurocalcin ................... 13
1.3.3 Class C: Recoverin .................................................................................... 14
1.3.4 Class D: Guanylyl cyclase activating proteins......................................... 16
1.3.5 Class E: Potassium channel interacting proteins ...................................... 17
1.3.5.1 KChIP3/DREAM/calsenilin ..................................................................... 19
1.3.5.2 Structural insight from DREAM ............................................................... 20
1.3.5.3 The Ca2+ and Mg2+ binding properties in DREAM ......................................24

2.

OBJECTIVES ............................................................................................................ 26
2.1
Objective 1 ................................................................................................ 27
2.2
Objective 2 ................................................................................................ 28
2.3
Objective 3 ................................................................................................ 28
2.4
Objective 4 ................................................................................................ 29

3.

MATERIAL AND METHODS ................................................................................. 32
3.1
Materials ................................................................................................... 32
3.2
Methods..................................................................................................... 33
3.3
Methods used in chapter 4 ........................................................................ 70
3.4
Methods used in chapter 5 ........................................................................ 74
3.5
Methods used in chapter 6 ........................................................................ 77
3.6
Methods used in chapter 7 ........................................................................ 81
3.7
Materials and methods used in chapter 8 .................................................. 88

4.

CALCIUM AND MAGNESIUM MODULATE CONFORMATIONAL
DYNAMICS AND STABILITY OF DOWNSTREAM REGULATORY
ELEMENT ANTAGONIST MODULATOR ........................................................... 91
4.1
Background and significance .................................................................... 91
4.2
Results ....................................................................................................... 95
4.3
Discussion ............................................................................................... 106
4.4
Summary ................................................................................................. 113

ix

5.

CALCIUM AND MAGNESIUM BINDING TO THE C-TERMINAL
DOMAIN MODULATES DREAM STRUCTURE, DYNAMICS, AND
STABILITY ............................................................................................................. 115
5.1
Background and significance .................................................................. 115
5.2
Results ..................................................................................................... 117
5.3
Discussion ............................................................................................... 127
5.4
Summary ................................................................................................. 131

6.

MOLECULAR INSIGHTS INTO DREAM AND PRESENILIN 1 CTERMINAL FRAGMENT INTERACTIONS ........................................................ 133
6.1
Background and significance .................................................................. 133
6.2
Results ..................................................................................................... 135
6.3
Discussion ............................................................................................... 151
6.4
Summary ................................................................................................. 155

7.

THE ROLE OF INDIVIDUAL EF-HANDS IN MODULATING DREAM
CONFORMATIONAL DYNAMICS AND INTERACTION WITH DNA ........... 156
7.1
Background and significance .................................................................. 156
7.2
Results ..................................................................................................... 158
7.3
Discussion ............................................................................................... 196
7.4
Summary ................................................................................................. 202

8.

CHARACTERIZE KINETICS AND THERMODYNAMICS ASSOCIATED
WITH CARBON MONOXIDE BINDING OR RELEASING FROM HORSE
HEART MYOGLOBIN AND MICROPEROXIDASE-11 IN SODIUM BIS(2-ETHYLHEXYL) SULFOSUCCINATE ENCAPSULATION: A MODEL
SYSTEM TO STUDY CONFORMATIONAL DYNAMICS OF DREAM
FULL LENGTH IN MEMBRANE ANCHORED STATE. ................................... 203
8.1 Background and significance ........................................................................... 203
8.2 Results.............................................................................................................. 205
8.3 Summary and Outlook ..................................................................................... 210

9.

CONCLUSIONS ..................................................................................................... 212

LIST OF REFERENCES ................................................................................................ 215
VITA ............................................................................................................................... 236

x

LIST OF TABLES
TABLE

PAGE

Table 3.1 Chemical components for electrophoresis running buffer .............................. 35
Table 3.2 Chemical components for sample treatment buffer ........................................ 36
Table 3.3 DREAM protein extinction coefficient at 280 nm ..........................................36
Table 3.4 List of extinction coefficients (nm), emission maximum wavelength
(Em.max) of fluorophores used ..................................................................... 59
Table 3.5 Volumes and concentrations of protein and chemicals used to prepare
CD samples of Apo, Mg2+,Ca2+, and Ca2+Mg2+ bound DREAM at
identical concentration of DREAM protein .................................................... 65
Table 4.1 Stern-Volmer constant (Ksv) and bimolecular quenching constant (kq)
of DREAM protein ......................................................................................... 98
Table 4.2 Emission decay parameters for DREAM using a continuous Gaussian
distribution and a discrete component .......................................................... 100
Table 4.3 Thermodynamic parameters for GuHCl induced denaturation of
DREAM in the absence/presence of Ca2+ and Mg2+..................................... 103
Table 5.1 Thermodynamic parameters for Ca2+ and Mg2+ binding to DREAM-C ....... 119
Table 5.2 The Stern-Volmer constants (Ksv) for acrylamide quenching of
DREAM-C .................................................................................................... 122
Table 5.3 Fluorescence decay parameters for DREAM-C intrinsic tryptophan
residue. Data were analyzed using a Gaussian-discrete model..................... 124
Table 5.4 Fluorescence decay parameters for nile red:DREAM-C. The
experimental data were analyzed using a discrete component and
continuous Gaussian distribution model ....................................................... 125
Table 5.5 Thermodynamic parameters for DREAM-C unfolding ................................ 127
Table 6.1 Dissociation constant (Kd) of DREAM binding to HLβ and HL9 in PS1CTF ............................................................................................................... 137
Table 6.2 Dissociation constant (Kd) of DREAM-C binding to HL9 in PS1-CTF ....... 139

xi

Table 6.3 Dissociation constant (Kd) for HL9 binding to DREAM EF-hand
mutants .......................................................................................................... 142
Table 6.4 Kinetic parameters for HL9 association with Ca2+DREAM......................... 144
Table 7.1 Emission decay parameters of W169 in DREAM EF-hand mutants
using a continuous Gaussian distribution and a discrete component ............ 167
Table 7.2 Decay parameters for 1,8-ANS and DREAM EF-hand mutant
complexes ..................................................................................................... 170
Table 7.3 ITC parameters recovered for DNA binding to DREAM and DREAM
EF-hand mutants using a two sets of sites model ......................................... 173
Table 7.4 Time-resolved anisotropy decay parameters of DREAM and DNA
interaction ..................................................................................................... 181
Table 8.1 The position of the Soret band and Q bands for Mb, and MP-11
encapsulated within the AOT reverse micelles, wo = 40. The numbers is
parenthesis corresponds to the max for Mb and MP-11 in aqueous
solutions, pH 7.0 ........................................................................................... 206

xii

LIST OF FIGURES
FIGURE

PAGE

Figure 1.1 Scheme illustrating a common intracellular Ca2+ signaling network.
Adapted from (Berridge et al., 2000)................................................................3
Figure 1.2 A single EF-hand 2 of recoverin (PDB code: 4YI8). The EF-hand
consists of an entering α-helix, a Ca2+ binding loop, and an exiting αhelix. The Ca2+ atom (green sphere) is coordinated by a canonical
Ca2+ binding loop illustrating the pentagonal bipyramidal
coordination of the Ca2+ ion (purple lines) and the hydrogen bonding
found in the loop (black lines). The side chain oxygen atoms are in
red and the coordinating oxygen atoms from water are shown as red
spheres. .............................................................................................................7
Figure 1.3 The sequence of a canonical Ca2+ binding loop. The Ca2+ ligands are
indicated by their positions in the loop. The ninth Ca2+ ligand (-X
coordinate) is typically provided by a water molecule. Adapted from
reference (Gifford et al., 2007). ........................................................................8
Figure 1.4 N-terminal domain of recoverin contains a pair of EF-hands (PDB
code: 4YI8, residues: 1-94). Alpha helices, denoted by α, 1 to 5 are
respectively labeled. EF-hand 1 is composed of α2 and α3; likewise,
EF-hand 2 contains α4 and α5. Ca2+ is shown as a green sphere. ....................9
Figure 1.5 Representation of phylogenetic relationships in NCS proteins.
Adapted from (Burgoyne et al., 2001). ...........................................................10
Figure 1.6 Sequence alignment of NCS proteins from classes A to E. Conserved
residues are represented by a star, whereas asterisks indicate identical
residues, colons indicate very similar residues, and periods are for
weakly similar residues...................................................................................11
Figure 1.7 Top: Schematic diagram of EF-hands in NCS1 protein. Bottom left:
structure of myristoylated ApoNCS1 (PDB code: 2L2E). Bottom
right: structure of three Ca2+ bound at EF-hand 2, 3, and 4 of nonmyristoylated NCS-1 (PDB code: 2LCP). The EF-hands 1, 2, 3, and
4 of NCS1 are colored in cyan, green, yellow, and red, respectively.
The Ca2+ ions are the yellow spheres and the myristoyl group is
colored in pink.. ..............................................................................................12
Figure 1.8 The crystal structure of Ca2+ bound non-myristoylated neurocalcin
(PDB: 1BJF (Vijay-Kumar, 1999)). The EF-hands 1-4 are labeled
accordingly as EF-1, EF-2, EF-3, and EF-4. The Ca2+ ion (yellow

xiii

sphere) is bound at EF-2, EF-3, and EF-4. The EF-1 is disabled from
binding of Ca2+/Mg2+ due to a Cys-Pro sequence in its Ca2+ binding
loop .................................................................................................................13
Figure 1.9 Top: Schematic diagram of EF-hands in recoverin. Bottom: (a)
structure of myristoylated ApoRecoverin (PDB code: 1IKU), (b) 1
Ca2+ ion bound at EF-3 (PDB code: 1OMR), and (c) Ca2+ ion is bound
at EF-hands 2 and 3 (PDB code: 1JSA). The structure of two Ca2+
bound non-myristoylated recoverin is shown in light blue in (c) (PDB
code: 4YI8). EF-hands 1, 2, 3, and 4 in recoverin are colored in cyan,
green, yellow, and red, respectively. The Ca2+ ions (yellow spheres)
are bound at EF-hand 2 and 3. The myristoyl group is shown as pink
spheres and the N-terminal eight-residue-flexible loop is highlighted
in yellow.. .......................................................................................................15
Figure 1.10 Top: Schematic diagram of EF-hands in GCAPs. Bottom: (left)
structure of Mg2+bound at EF-hand 2 of myristoylated GCAP 1
mutant V77E (Mg2+ is not shown, PDB code: 2NA0) and (right)
structure of Ca2+ bound at EF-hands 2, 3, and 4 in GCAP 1 (PDB
code: 2R2I). EF-hands 1 to 4 are highlighted in cyan, green, yellow,
and red, respectively. The Ca2+ ions are shown as yellow spheres.. ...............17
Figure 1.11 KChIPs and splice variants in class E. Some KChIP isoforms have
myristoylation or palmitoylation sites, assisting membrane
association and localization. The GenBank accession number for
human KChIP1 isoforms 1.1, 1.2, 1.3 DQ148478, DQ148477, and
DQ148476. The GenBank accession number for human KChIP2
isoforms 2.1, 2.2, 2.3, 2.4, and 2.5 are NM-01491, DQ148480,
DQ148481, DQ148482, and DQ148483. The GenBank accession
number for human KChIP3 isoforms 3.1 and 3.2 are DQ148485 and
DQ148486. The GenBank accession number for human KChIP4
isoforms are DQ148487, DQ148488, DQ148491, DQ148489,
DQ148490, and DQ148492, respectively. Adapted from (Burgoyne,
2007).. .............................................................................................................18
Figure 1.12 The amino acid sequence of mouse DREAM (Gene code: Q9QXT8).
The Ca2+ and/or Mg2+ binding loops of EF-hands 1, 2, 3, and 4 are
underlined. The negatively charged amino acids involved in
Ca2+/Mg2+coordination are shown in red. The conserved sequence
CPxG (in brown) in the first EF-hand eliminates binding of
Ca2+/Mg2+ at this site. The flexible loop connecting α7 from EFhands 3 and α8 from EF-hand 4 is shown in light green and
underlined, while the positively residues R200 and R207 in the loop
are shown in blue. The leucine residues (155LxxLL159, and L251)
at Ca2+DREAM dimeric interface are highlighted in purple. .........................21

xiv

Figure 1.13 Three dimensional cartoon structure of Ca2+DREAM (PBS: 2JUL,
residues 76 – 256) (Lusin et al., 2008). The structure DREAM
consists of 10 α-helices (43% secondary structure content) connected
by random coils, turns, and a few beta sheets (2%). From left to right,
the positively charged residues postulated to facilitate DNA binding
(K87, K90, K91, R98, K101, R160) are shown in licorice. The EFhands 1, 2, 3, and 4 are shown in cyan, green, yellow, and orange,
respectively. The N-terminal α-helix (α1) and the C-terminal alpha
helix (α10) are labeled in blue and red, respectively. The single
intrinsic tryptophan residue (W169) is shown in yellow licorice. The
long flexible loop connecting α7 and α8 is shown in blue. The Ca2+
ion (yellow sphere) is bound to EF-hands 3 and 4. ........................................22
Figure 1.14 The central hydrophobic cluster (shown in stick) connecting the Nand the C-terminal domains of DREAM (PDB: 2JUL) (Lusin et al.,
2008). ..............................................................................................................23
Figure 1.15 The C-terminal hydrophobic cluster (as shown in stick) of DREAM
(Lusin et al., 2008). .........................................................................................24
Figure 3.1 The Perrin-Jablonski diagram. The arrows represent the transition of
a quantum change. The transitions begin at the lowest vibrational
levels of each electronic state (S0, S1, and S2) for both absorption
(blue arrows) and de-excitation (green arrows). The transition from
the excited state to the ground state always happens from the first
lowest level of S1. The non-emissive de-excitation transitions are
internal conversion (ic), intersystem crossing (isc), excited state
reaction, quenching, photolysis, and FRET. The excited molecule
passes from the singlet (S1) to the triplet (T1) state via isc. The
emission from T1 is phosphorescence (red arrow). The other deexcitation transitions from T1 are similar to that of the S1. Adapted
from (Lakowicz 2006; Periasamy and Clegg 2010).. .....................................38
Figure 3.2 Relative phase shift () and modulation of the excitation (subscript
E) and emission light (subscript F) in FD fluorescence spectroscopy.
AC and DC indicate the amplitude and offset of the respective waves.
Adapted from (Ross and Jameson, 2008).. .....................................................42
Figure 3.3 Schematic diagram for measurement of fluorescence anisotropy.
Adapted from (Lakowicz, 2006). ...................................................................49
Figure 3.4 Schematic diagram illustrating emission intensities for a single
fluorophore in a coordinate system. Adapted from (Lakowicz, 2006) ...........50

xv

Figure 3.5 Schematic diagram for measurement of anisotropy decays with
frequency-domain. Adapted from (Lakowicz, 2002). ....................................54
Figure 3.6 Schematic diagram of a stopped-flow mixer. Reaction A and B are
driven into the mixer through valves A and B. The previous content
of the tube and cuvette are flushed out the stopping syringe via valve
S that is open during flow. When the plunger of the stopping syringe
hits a block, the valve S is closed and the contents of the cuvette can
be probed during reaction mixture. Adapted from (Hargrove, 2005). ............57
Figure 3.7 Scheme representing linearly polarized light that is converted using a
linear polarizer and the circularly polarized light that is created using
a quarter-wave (/4) plate. Adapted from (Berova et al., 2000). ...................60
Figure 3.8 A: when circularly polarized light passes through achiral samples, its
EL and ER components of are constant. B: when circularly polarized
light passes through chiral samples, EL (blue) and ER (green)
components are absorbed in distinctly, resulting in elliptical polarized
light (red). Adapted from (Kelly et al., 2005).................................................61
Figure 3.9 Far UV CD spectra associated with various types of secondary
structure of proteins. Adapted from (Berova et al., 2000). .............................63
Figure 3.10 Near UV CD spectrum for various aromatic side chains of proteins.
Adapted from (Kelly, Jess et al. 2005). ..........................................................64
Figure 3.11 Schematic representation of an ITC instrument. The sample cell and
the reference cell are kept at the same temperature. The reference cell
is always kept at the experimental temperature. The ligand
component of the interaction is placed in the syringe and the other in
the cell. Upon the first titration (injection), the change in heat
associated with binding (endothermic or exothermic) results in a
change in temperature in the sample cell. A change in power (heat/s)
is required to return the cells to identical temperatures (T) (ΔT = 0).
This change in power is recorded during injections. The binding
isotherm and the integrated thermogram are shown in the top right.
Adapted from (Ladbury and Chowdhry, 1996; Ladbury, 2004). ...................68
Figure 3.12 A schematic diagram illustrating isothermal parameters being
generated from an isotherm fitting curve........................................................69
Figure 4.1 The aromatic clusters identified in DREAM C-terminus (grey solid
surface) and N-terminus (blue solid surface). EF-hand 1 in DREAM
is shown in cyan, EF-hand 2 in green, EF-hand 3 in yellow, EF-hand

xvi

4 in orange, W169 in wireframe surface, and calcium ions shown as
yellow spheres ................................................................................................94
Figure 4.2 Fluorescence emission spectra of Apo, Mg2+, Ca2+, and
Ca2+Mg2+DREAM upon excitation at 295 nm. Note that the emission
spectrum of ApoDREAM and Mg2+DREAM are almost identical,
and likewise for Ca2+DREAM and Ca2+Mg2+DREAM.. ................................96
Figure 4.3 Stern-Volmer plot for acrylamide quenching of DREAM in the
absence/presence of Ca2+ and Mg2+. Error bar represents standard
deviations of three independent measurements.. ............................................97
Figure 4.4 Frequency-domain intensity decay of 40 µM ApoDREAM (open
squares), Mg2+DREAM (open circles), Ca2+DREAM (closed
squares), and Mg2+Ca2+DREAM (closed circles). The solid lines
represent the data fitting using a Gaussian distribution model and
single exponential decay model. Note that the experimental data for
ApoDREAM and Mg2+DREAM are nearly identical, and likewise for
the data for Ca2+DREAM and Ca2+Mg2+DREAM. ........................................99
Figure 4.5 Fluorescence lifetime rotational distribution of Mg2+DREAM and
Ca2+Mg2+DREAM using a continuous Gaussian distribution and a
discrete single exponential decay component. To simplify, the
lifetime rotational distribution curves of ApoDREAM and
Ca2+DREAM are not shown. ..........................................................................99
Figure 4.6 CD spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ DREAM in the farUV region. The concentration of the protein was 40 μM in 10 mM
Tris buffer (pH 7.4), 1 mM DTT, and 10 mM LDAO. Spectra were
corrected for the baseline of the buffer. ........................................................101
Figure 4.7 (a): CD spectra of 40 µM ApoDREAM in the presence of 0, 1, 2, 3,
4, 5, 6, 7, and 7.4 M GuHCl. (b): Representative equilibrium
unfolding traces of DREAM as determined by the CD signal change
at 220 nm. Solid black lines are fitting curves of experimental data
using equation 3.60 in section 3.2.3.4. The thermodynamic
parameters are reported in Table 4.3 ............................................................102
Figure 4.8 Root-mean-square fluctuations (RMSF) of the C backbone in
ApoDREAM and Ca2+DREAM. ..................................................................105
Figure 4.9 Top: Overlaid MD simulations structures of ApoDREAM (in red)
and Ca2+ bound DREAM (in yellow). Alpha-helices 1 – 10 in
DREAM are labeled by α1 – α10, respectively. EF-hand 1 is
composed of α2 and α3, EF-hand 2 composed of α4 and α5, EF-hand

xvii

3 composed of α6 and α7, EF-hand 4 composed of α8 and α9. The
position of the W169 residue is shown with sticks. Bottom: Ca2+
triggered reorganization of the EF-hand 3 (left) and EF-hand 4 (right).
......................................................................................................................106
Figure 4.10 Top: charged and polar amino acid residues surrounding W169 in the
structure of DREAM (PBD entry 2JUL, shown in blue) and Cterminal domain of DREAM (PBD entry 2E6W, shown in green).
Bottom: Left: SASA of W169 in DREAM during 270 ns of the MD
trajectory. Right: Partially buried (in blue) and solvent exposed (in
green) orientation of W169 side chain in DREAM structure. ......................109
Figure 5.1 Binding isotherm for Ca2+ association to DREAM-C in the absence
of Mg2+. Top panel represents for a raw power titration curve, bottom
panel shows integration data, and the solid line presents the two sets
of sites fitting curve. .....................................................................................118
Figure 5.2 The CD spectra of DREAM-C in the presence/absence of Ca2+ and/or
Mg2+ ..............................................................................................................120
Figure 5.3 The fluorescence steady-state emission spectra of intrinsic W169
residue (A) and the CD spectra (B) of DREAM-C.......................................121
Figure 5.4 Stern-Volmer plot for acrylamide quenching of DREAM-C in the
absence/presence of Ca2+ and Mg2+ ..............................................................122
Figure 5.5 Frequency-domain intensity decays for W169 in the
presence/absence of Ca2+ and/or Mg2+. Phase delays are solid
symbols, modulation ratios are empty symbols, and the solid lines
represent the calculated fitting curves. .........................................................123
Figure 5.6 Fluorescence steady-state emission spectra of nile red (A) and 1,8
ANS (B) bind to DREAM-C in the presence/absence of Ca2+ and/or
Mg2+. .............................................................................................................125
Figure 5.7 GuHCl-induced unfolding DREAM-C in the presence/absence of
Ca2+ and/or Mg2+. Unfolding parameters were recovered using a twostate model. ...................................................................................................126
Figure 6.1 Left: Protein-protein docking complex of Ca2+DREAM (PDB: 2JUL,
molecule 1) and PS1-CTF (PDB: 2KR6, molecule 1). DREAM
(residues 76-256) contains 10 α-helices respectively labeled α1 - α10,
and four EF-hands: EF-1, EF-2, EF-3, and EF-4. Two Ca2+ ions
(yellow sphere) are bound at EF-3 and EF-4 loops in DREAM. PS1CTF comprises two trans-membrane helices: HL7 and HL8, a solvent

xviii

exposed helix HLβ, and an intramembranous HL9 which is divided
into two perpendicular helices. Right: Detailed presentation of the
binding interfaces between Ca2+DREAM and PS1-CTF. Amino acid
residues from DREAM and PS1 are colored in green and red,
respectively. Yellow dot lines represent for hydrogen bond
interactions. ...................................................................................................136
Figure 6.2 Titration curves for DREAM binding to HL9 (a) and HLβ (b) of PS1CTF. Solid lines correspond to the best fit using equation 3.63 in
Method section 3.5.2.....................................................................................138
Figure 6.3 Titration curves for DREAM-C binding to HL9 of PS1-CTF in the
presence and absence of Ca2+. Solid lines correspond to the best fit
using equation 3.63 in Method section 3.5.2. ...............................................139
Figure 6.4 Sequence alignment of 66 amino acid residues in the carboxylterminus of mouse DREAM with various members of KChIPs
subfamily and NCS1 protein using Clustal Omega program. The
conserved hydrophobic residues at the binding interface with HL9 are
highlighted in green. The conserved basic residues at positions 200
and 207 in the flexible loop of various members in KChIP subfamily
are highlighted in blue. The neutral residue and the acidic residue of
NCS1 corresponding to positions 200 and 207 in flexible loop are
highlighted in grey and red, respectively. Aromatic residues
corresponding to π- π stacking interaction with PS1 are in orange. .............140
Figure 6.5 Titration curves for HL9 binding to Ca2+DREAM-NCS1 (a) and
Ca2+DREAM-KChIP1 (b). Solid lines correspond to the best fit using
equation 3.63 in Method section 3.5.2. .........................................................140
Figure 6.6 Titration curves for HL9 binding to Ca2+DREAM-E234Q (a) and
Ca2+DREAM-E186Q (b). Solid lines correspond to the best fit using
equation 3.63 in Method section 3.5.2. .........................................................141
Figure 6.7 Panel (a) is time-resolved anisotropy of HL9 in buffer solution
(circles) and HL9 bound Ca2+DREAM (square). Differential phase
angle and modulation ratio are shown as solid and empty symbols,
respectively. Panel (b) is a Job plot curve represents a 1:1
stoichiometry for molecular association of HL9 with Ca2+DREAM. ..........143
Figure 6.8 Titration curves for HL9 binding to Ca2+DREAM by monitoring
FITC fluorescence emission change at 520 nm (inset figure). Solid
lines correspond to the best fit using equation 3.63 in section 3.5.2.
The dissociation constant was determined to be 0.6 μM. .............................144

xix

Figure 6.9 Kinetics trace for association of HL9 to Ca2+DREAM (a) and
dissociation of HL9 from ApoDREAM (b) monitored by change in
the fluorescence intensity at 520 nm. The solid line represents single
exponential fitting curve. ..............................................................................145
Figure 6.10 The Arrhenius plot of HL9 association with Ca2+DREAM. Ea and
experimental error were determined from the mean and standard
deviations of three independent measurements, respectively... ....................146
Figure 6.11 Apparent association rate constants (kon(obs)) were plotted against
Ca2+DREAM concentrations. The association rate constant (kon) and
the dissociation rate constant (koff) were determined to be is about 0.6
x 106 M-1s-1 and 1.0 s-1, respectively.............................................................147
Figure 6.12 The bar plot represents titrations of 20 μM of Ca2+DREAM,
ApoDREAM, Ca2+DREAM-F252A, and ApoDREAM-F252A into
0.5μM PS1-HL9............................................................................................148
Figure 6.13 Titration curves for HL9 binding to Ca2+DREAM in the presence of
0.3 M NaCl. The Solid line corresponds to the best fit using equation
3.63 in section 3.5.2. .....................................................................................149
Figure 6.14 Titration of NS5806 into the Ca2+DREAM-HL9 complex. The
dissociation constant was determined by fitting the data using a single
binding site displacement equation 3.64 in section 3.5.2. ............................150
Figure 6.15 Left: Superposed structures of Ca2+DREAM (PDB code: 2JUL,
molecule 1, cyan) and molecular dynamics simulation structure of
ApoDREAM (yellow). Alpha helices 1 – 10 in DREAM are labeled
by α1 – α10, respectively. The movement of α10 away from α7 is
indicated by black arrows. Right: aromatic ring of F252 in
ApoDREAM rotates ~90 degrees with respect to aromatic ring of
F252 in Ca2+ bound DREAM. The guanidinium group of R200 in
ApoDREAM points 180 degrees away with respect to that of
Ca2+DREAM.................................................................................................153
Figure 7.1 Tryptophan (W169) emission spectra of Apo, Mg2+, Ca2+, and
Ca2+Mg2+ bound DREAM-D150N (left panel) and DREAM-E186Q
(right panel) upon excitation at 295 nm. Conditions: 40 µM DREAM
in 20 mM Tris pH 7.4, 10 mM LDAO, and 1 mM DTT.. ............................159
Figure 7.2 W169 emission spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ bound
DREAM-E234Q. Conditions: 40 µM DREAM in 20 mM Tris pH
7.4, 10 mM LDAO, and 1 mM DTT. ...........................................................161

xx

Figure 7.3 Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS
(right panel) bound to DREAM-D150N (40 µM). The excitation
wavelength was 350 nm and 319 nm for 1,8-ANS and 2,6-ANS,
respectively. ..................................................................................................162
Figure 7.4 Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS
(right panel) bound to DREAM-E186Q (40 µM). The excitation
wavelength was 350 nm and 319 nm for 1,8-ANS and 2,6-ANS,
respectively.. .................................................................................................163
Figure 7.5 Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS
(right panel) bound to DREAM-E234Q (40 µM). The excitation
wavelength was 350 nm and 319 nm for 1,8-ANS and 2,6-ANS,
respectively.. .................................................................................................164
Figure 7.6 Frequency-domain W169 intensity decay of Apo, Mg2+, Ca2+, and
Ca2+Mg2+ bound DREAM-D150N (left panel) and DREAM-E186
(right panel). The solid lines represent the data fitting using a
combination of Gaussian distribution and discrete exponential decay
model. The recovered parameters are shown Table 2. .................................165
Figure 7.7 Frequency-domain intensity decay of Apo, Mg2+, Ca2+, and Ca2+Mg2+
bound DREAM-E234Q (40 μM). The solid lines represent the data
fitting using a combination of Gaussian distribution and discrete
exponential decay model ..............................................................................166
Figure 7.8 Frequency domain intensity decay of 1,8-ANS bound to DREAMD150N. Phase delay and modulation ratio are shown as solid symbols
and empty symbols, respectively. Recovered intensity decay
parameters are shown Table 7.2. ..................................................................168
Figure 7.9 Frequency domain intensity decay of 1,8-ANS bound to DREAME186Q (left) and DREAM-E234Q (right). Phase delay and
modulation ratio are shown as solid symbols and empty symbols,
respectively. Recovered intensity decay parameters are shown Table
7.2. ................................................................................................................169
Figure 7.10 Circular dichroism spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+
DREAM-D150N (left panel) and DREAM-E186Q (right panel).
Conditions: 40 μM DREAM in 20 mM Tris pH 7.4, 10 mM LDAO,
and 1 mM DTT. ............................................................................................171
Figure 7.11 Circular dichroism spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+
DREAM-E234Q. Conditions: 40 μM DREAM-E234Q in 20 mM
Tris pH 7.4, 10 mM LDAO, and 1 mM DTT. ..............................................172

xxi

Figure 7.12 ITC isotherms for ApoDREAM (A) and Mg2+DREAM (B) binding
to DNA. The upper panels of each profile reflects the thermal power
expressed in units of µcal/s. The lower panel shows integrated
reaction heats (ΔH) expressed in units of kcal/mol. The solid lines
present the best fitting curve using a two-set of sites model with
deletion of the first titration point. The experiment was carried out by
titration of 500 μM of DREAM protein (in syringe) into 15 μM DNA
(in sample chamber) at 25 ˚C........................................................................175
Figure 7.13 ITC isotherms for ApoDREAM-D150N (A) and ApoDREAME186Q (B), and ApoDREAM-E234Q binding to DNA. The upper
panels of each profile reflects the thermal power expressed in units
of µcal/s. The lower panel shows integrated reaction heats (ΔH)
expressed in units of kcal/mol. The solid lines present the best fitting
curve using a two-set of sites model with deletion of the first titration
point. The recovered isothermal parameters are shown in Table 7.3. ..........177
Figure 7.14 ITC isotherms for Ca2+DREAM (A), Ca2+DREAM-D150N (B),
Ca2+DREAM-E186Q (C), and Ca2+DREAM-E234Q (D) binding to
DNA. The upper panels of each profile reflects the thermal power
expressed in units of µcal/s. The lower panel shows integrated
reaction heats (ΔH) expressed in units of kcal/mol. The solid lines
present the best fitting curve using a sequential binding sites model
with deletion of the first titration point. The recovered isothermal
parameters are shown in Table 7.3. ..............................................................178
Figure 7.15 A: Time-resolved anisotropy of DNA in buffer solution (triangle),
Ca2+DREAM-DNA complex (square), and ApoDREAM-DNA
complex (circle). B: Time-resolved anisotropy of DNA in buffer
solution containing 100 μM MgCl2 (pentagon) and Mg2+DREAMDNA complex (hexagon). Differential phase angle and modulation
ratio are shown as solid and empty symbols, respectively. Solid lines
represent the non-linear least square fit and recovered parameters are
shown in Table 7.4. .......................................................................................180
Figure 7.16 The backbone root-mean-square deviations (RMSD) of Apo, Mg2+,
and Ca2+ DREAM during a 100 ns simulation time. ....................................182
Figure 7.17 The root-mean-square fluctuation (RMSF) plot of C atoms
represents the fluctuations of individual residues with respect to the
average structure in the structures of Apo, Mg2+, and Ca2+ bound
forms of DREAM from 20 to 100 ns simulation time. .................................183

xxii

Figure 7.18 Graphic representation of the monomer structures averaged over 100
ns of MD simulations of Apo (green), Ca2+ bound at EF-hands 3 and
4 (blue), Ca2+ bound at EF-hand 4 in DREAM-E186Q mutant (light
blue), and Ca2+ bound at EF-hand 3 in DREAM-E234Q mutant
(pink). All nodes and edges of the communities are colored and
shown as ball and stick, respectively. ...........................................................185
Figure 7.19 Top: The path connecting residues E186 and R98 in ApoDREAM
(left), Ca2+DREAM-E234Q mutant (right), and Ca2+DREAM wildtype (bottom). The nodes in communities are shown as balls.
Communities are colored using the same color codes as shown in
Figure 7.18. The hydrophobic residues in the path connecting from
R98 to E186 in Ca2+DREAM wild-type are shown in stick (bottom). .........187
Figure 7.20 The path connecting residues R98 and E234 in ApoDREAM (green),
Ca2+DREAM (blue). The nodes in communities are shown as balls.
Communities are colored using the same color scheme as shown in
Figure 7.18. The hydrophobic residues within paths connecting from
R98 to E234 in Ca2+DREAM are shown in stick. Note that only two
hydrophobic residues I157 and L167 surrounding W169 were
observed in the path. .....................................................................................189
Figure 7.21 The MD simulation model of Mg2+DREAM: Association of Mg2+ at
EF-hand 2 forms a new hydrophobic cluster (shown as pink solid
surface), that has not been observed in either Apo or Ca2+DREAM.
The other two aromatic clusters identified in the C-terminus and Nterminus are conserved in the NMR structure of Ca2+DREAM and
shown as grey solid surface and blue solid surface. .....................................190
Figure 7.22 Left: Dynamical network analysis of the 100ns MD simulation of the
first 6 α-helices in Mg2+DREAM N-terminus displayed in
communities (each community has different color). Right: The
dynamical network Hydrophobic cluster L93, L96, and F100 on the
inner side of α2 contact with the hydrophobic residues F121 (from
α3), F148, F151, V151, L155, and L159 from α5 (exiting helix of EFhand 2) that is stabilized upon Mg2+ association to DREAM. The
basic and polar residues K90, K91, Q94, S95, R98, and K101
interfacing with DNA are shown on the outer site of α2. The leucine
residues L155 and L159 at the dimeric interface of DREAM are in
red, whereas the basic residues forming a salt bridge between α2 and
α5 are shown in light blue.............................................................................192
Figure 7.23 Left: Dynamical network analysis of the 100ns MD simulation of the
first 6 α-helices in ApoDREAM N-terminus displayed in
communities (each community colored differently). Right: In the

xxiii

absence of Mg2+, the α2 is not involved in an extended community
formed by α1, α5, and α6, suggesting a decrease in stability of the Nterminus domain despite of the salt bridge formation between
residues E92 and R160 (in light blue, bottom). ............................................193
Figure 7.24 Dynamical network analysis of the 100ns MD simulation of the first
6 α-helices in Ca2+DREAM N-terminus displayed in communities
(each community colored differently). Rearrangement of α1 partially
blocks the DNA binding site on α2. .............................................................194
Figure 7.25 (a): The MD simulation of docking complex between ApoDREAM
(residues 75-256) and 25 oligomers corresponding to the DRE
sequence of prodynorphin gene (namely DNA). (b): A closer view at
the interaction interface between ApoDREAM and DNA. Yellow dot
lines represent hydrogen bond interactions. (c): the sequence of 25
oligonucleotides corresponding to the DRE. (d): the sequence
alignment of 45 amino acid residues in the N-terminus of DREAM
(residues: 75-120, top) and that of the non-DNA binding recoverin
(residues: 12-57) to highlight the positively charged residues in
DREAM participating to the interaction with DNA. ....................................195
Figure 7.26 Left: Residue W169 is buried in a more hydrophobic environment
observed in ApoDREAM (yellow) compared to that obtained in
ApoDREAM-D150N mutant (green). Right: The superposition of
five α-helices in the N-terminal domain of ApoDREAM (yellow) and
ApoDREAM-D150N (green). ......................................................................197
Figure 7.27 Top: Amino acid sequence alignment of residues (K90 – N102) in α2
of ApoDREAM (green) and Ca2+DREAM (blue). Bottom: The dimer
Ca2+DREAM was constructed according to the model proposed by
Lusin et at. (Lusin et al., 2008). ....................................................................199
Figure 8.1 The schematic presentation of AOT molecule (left) and a reverse
micelle particle containing an Mb molecule encapsulated within
internal water pool (right). ............................................................................203
Figure 8.2 Optical absorption spectra of Mb (left) and MP-11 (right)
encapsulated within RM w=40. The traces for Fe3+Mb/Fe3+Mp-11
are shown as solid thick lines, for Fe2+Mb/Fe2+MP-11 as dashed lines
and for CO-Mb and CO-MP11 as solid thin lines. .......................................205
Figure 8.3 PAC traces for CO photo-dissociation from Fe2+Mb in AOT RM of
wo = 40 (thick black line), for the reference compound (Fe3+Mb in
AOT RM of wo = 40) and the fit (gray line). ................................................207

xxiv

Figure 8.4 Transient absorption trace for CO rebinding to Fe2+Mb encapsulated
within RM, wo = 40. Inset: Arrhenius plot of the rate constants for the
fast (circles) and slow (squares) phase of the CO rebinding to Mb. .............209

xxv

LIST OF ABBREVIATIONS
ABBREVIATION

FULL NAME

Ca2+

Calcium ion

CD

Circular dichroism

CTF

Carboxy-terminal fragment

DNA

Downstream regulatory elements sequence (5’GAAGCCGGAGTCAAGGAGGCCCCTG-3’) of
prodynorphin gene

DMSO

Dimethyl sulfoxide

DREAM

Downstream regulatory element antagonist modulator

DREAM-C

DREAM C-terminal domain

DREAM-D150N

DREAM mutant with an inactive EF-hand 2

DREAM-E186Q

DREAM mutant with an inactive EF-hand 3

DREAM-E234Q

DREAM mutant with an inactive EF-hand 4

DTT

Dithiothreitol

EGTA

Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′tetraacetic

EtBr

Ethidium bromide

EDTA

2-({2-[Bis(carboxymethyl)amino]ethyl}
(carboxymethyl)amino)acetic acid

EF-hand

Ca2+ binding helix-loop-helix motifs

FITC

Fluorescein isothiocyanate

GuHCl

Guanidine hydrochloride

IPTG

Isopropyl β-D-1-thiogalactopyranoside

xxvi

ITC

Isothermal titration calorimetry

Ka

Association constant

Kd

Dissociation constant

Ki

Inhibition constant

Mg2+

Magnesium ion

NLLS

Non-linear least squares

NS5806

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[2,4-dibromo-6(2H-tetrazol-5-yl)phenyl]urea

NTF

Amino-terminal fragment

NCS

Neuronal calcium sensor

PAC

Photoacoustic calorimetry

PS1

presenilin 1 protein

KChIP

Potassium channel interaction protein

RMSD

Root mean square deviation

RMSF

Root mean square fluctuation

SDS

Sodium dodecyl sulfate

SASA

Solvent accessible surface area

1,8-ANS

1-anilinonaphthalene-8-sulfonic acid

TRIS

2-Amino-2-hydroxymethyl-propane-1,3-diol

1,5-IAEDANS

(5-((((2-Iodoacetyl)amino)ethyl)amino)Naphthalene-1Sulfonic Acid)

α

alpha-helix

ΔH

Enthalpy change

Φ

Quantum yield

xxvii

PREFACE
This dissertation consists of the research studies carried out from January 2011 to
June 2016 by Khoa N. Pham. During this time, some of these results have been published
in peer-reviewed journals, particularly Chapter 4 (Pham and Miksovska, 2015), Chapter 6
(Pham and Miksovska, 2016), Chapter 8 (Larsen, Vetromile, Pham, Miksovska, 2011). The
results in Chapter 5 were described in a manuscript that will be submitted by Pham,
Gonzalez, and Miksovska. Data represented in Chapter 7 were described in a manuscript
that will be submitted to the Biochemistry journal by Pham and Miksovska.

1

1. INTRODUCTION
1.1 Calcium and intracellular Ca2+ signaling network
Calcium plays an important role in many biological processes. In the solid form,
calcium has a structurally supportive function (Bronner et al., 1992; Vogel et al., 2002).
Soluble calcium ions (Ca2+) act as an intracellular signaling ion that interacts with calcium
binding proteins to mediate numerous physiological functions, including fertilization,
contraction, metabolism, cell cycle progression, signal transduction, replication, gene
expression, and electrochemical responses (Carafoli et al., 2007; Gifford et al., 2007;
Berridge et al., 1997). In the cytoplasm, intracellular Ca2+ concentration at the resting level
is about 100 nM, while the extracellular Ca2+ concentration is about 2 mM, creating a
gradient between the intracellular and extracellular Ca2+ concentrations (Vogel et al., 1994;
Clapham, 2007). Such low cytoplasmic Ca2+ concentration is well maintained by ATPdependent Ca2+ pumps, which pump Ca2+ out of the cell or into specialized organelles such
as the sarcoplasmic reticulum in muscle cells. Intracellular Ca2+ mediates its effects and
signaling by association to numerous proteins including membrane binding proteins and
cytoplasmic proteins. Subsequently, the Ca2+ signal is transduced into biological functions
by triggering different intracellular pathways (Carafoli, 2007; Clapham, 2007).
The regulation of a single Ca2+ ion in numerous cellular processes remarkably
highlights its versatility in cellular functions (Carafoli et al., 2001; Berridge, 2001). The
versatility of Ca2+ signaling has been attributed to its speed, amplitude, and wide range of
spatial and temporal signals (Berridge, 2001). Each cell type has distinctive components to
create various Ca2+ signaling systems with different spatial and temporal dynamics
(Berridge et al., 2003). A common Ca2+ signaling network consists of four functional
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components with the Ca2+ transients being controlled by the ON/OFF reactions outlined in
Figure 1.1 (Berridge, 1997; Berridge, 2001; Berridge et al., 2003).

Figure 1.1: Scheme illustrating a common intracellular Ca2+ signaling network. Adapted
from (Berridge et al., 2000).
The Ca2+ signaling network is initiated by the entry of Ca2+ into the cell. During the
ON mechanism, the stimulus depolarizes a cell membrane causing a large electrochemical
gradient across the cell membrane to activate various Ca2+ entry channels, such as voltageoperated channels (VOCs), which allow Ca2+ entry from extracellular medium (Berridge
et al., 2003). In addition, Ca2+ can also be released into the cytoplasm from internal storage
held within the membranes of the endoplasmic reticulum (ER) and the sarcoplasmic
reticulum (SR). The process is tightly controlled by various channels such as inositol 1,4,5triphosphate receptor (InsP3R) and ryanodine receptor (RYR) (Berridge, 2001). The Ca2+
that flows into the cytoplasm during the ON mechanism does not remain free (Gifford et
al., 2007). Instead, most of the cytoplasmic Ca2+ is bound to calcium buffer proteins, while
only a small portion of free Ca2+ binds to calcium effectors such as calmodulin (CaM),
troponin, and neuronal Ca2+ sensor proteins in the brain. These Ca2+ effectors activate

3

various Ca2+ sensitive processes that translate Ca2+ signals into cellular responses by
triggering many different signaling pathways (Berridge, 2001). Finally, when the Ca2+
signal has carried out its functions, it is rapidly removed from the cytoplasm by various
pumps and exchangers via the OFF mechanism (Berridge, 2001; Berridge et al., 2003).
1.2 Intracellular calcium binding proteins
Intracellular Ca2+ binding proteins (CaBPs) are classified into two classes
depending on their functions: Ca2+ buffer proteins and Ca2+ sensor proteins (Gifford et al.,
2007). Ca2+ buffer proteins such as calbindin and parvalbumin, which are found in many
cell types of various organs, bind Ca2+ with high affinity but do not undergo any significant
conformational changes (Skelton et al., 1994; Ikura, 1996). The main function of Ca2+
buffer proteins is to modulate the Ca2+ signals as they load Ca2+ during the ON mechanism
and unload Ca2+ during the OFF mechanism (Gifford et al., 2007). Another important
function of Ca2+ buffers is to control Ca2+ signals transmitted throughout the cell as they
limit both the amplitude and duration of Ca2+ signal (Braunewell et al., 1999). In contrast,
Ca2+ sensor proteins bind to Ca2+ and undergo significant conformational changes, which
allows them to interact with diverse proteins and biomacromolecules to regulate various
Ca2+ sensitive processes (Braunewell et al., 1999; Burgoyne et al., 2001). Subsequently,
Ca2+ sensor proteins frequently serve as effector or modulator proteins to transduce Ca2+
signals into appropriate physiological responses (Braunewell et al., 1999). Calcium binding
proteins have been shown to be involved in several aspects of Ca2+ regulation in many cell
types including neurons (Burgoyne et al., 2001). Since the objectives of this dissertation
are focused on the Ca2+ signal transduction and target interactions of the downstream
regulatory element antagonist modulator (DREAM) protein, which is a particular member
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of neuronal Ca2+ sensor (NCS) proteins, general aspects of NCS proteins, including their
structure-function relationships, will be briefly discussed in the next section.
1.3 Neuronal calcium sensor (NCS) proteins and the biological functions of Ca2+
binding to NCS proteins
The NCS protein family constitutes the largest class of intracellular calcium binding
proteins found in many organisms ranging from yeast to humans. These NCS proteins are
characterized by their remarkable ability to bind and release Ca2+ over physiological ranges
of intracellular Ca2+ concentrations and to undergo conformational changes (Braunewell et
al., 1999; Burgoyne et al., 2001). Subsequently, these effectors interact with and regulate
various activities of the targeted proteins. All NCS proteins contain four calcium binding
helix-loop-helix motifs (namely EF-hands) (Burgoyne et al., 2001). The conserved
sequence CPxG (x is any residue) in the Ca2+ binding loop of the first EF-hand prevents
EF-hand 1 from binding to Ca2+ or Mg2+, an abundant intracellular divalent cation with
very similar chemical properties to Ca2+ (Romani and Scarpa, 1992; Gifford et al., 2007).
On the other hand, EF-hands 2, 3, and 4 are able to bind Ca2+ with micromolar or
submicromolar affinity (Braunewell et al., 1999; Burgoyne et al., 2001; Ames et al., 2012;
Burgoyne et al., 2015). The NCS proteins are primarily expressed in photoreceptor cells
and neurons. They control almost all aspects of neuronal functions including regulation of
neurotransmission, short-term synaptic plasticity, regulation of Ca2+ channel, neuronal
growth, learning (neuronal calcium sensor protein 1), anti-apoptosis (hippocalcin protein),
guanylyl cyclase activation and recycling (neurocalcin-δ, visinin-like proteins 1 and 2),
light adaptation (recoverin), regulation of retinal guanylyl cyclase (guanylate cyclaseactivating proteins 1, 2, and 3), regulation of Kv4.3 and Kv1.5 potassium channels
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(potassium channel interacting proteins (KChIP) 1, 2, 3, and 4), regulation of presenilin
processing (KChIP 3 and 4), and repression of gene transcription (KChIP 3) (Pongs et al.,
1993; Burgoyne et al., 2001; Burgoyne et al., 2004; Burgoyne et al., 2007).
The functions of NCS proteins are diverse as they control numerous neuronal events in
Ca2+ signaling pathways. The diversity has been attributed to distinct types of Ca2+ signals
that differ in magnitude, duration, and localization (Burgoyne et al., 2001; Burgoyne et al.,
2007). As a consequence of these actions of various NCS proteins, the Ca2+ signal is
transduced into specific changes in cellular function. In addition, these distinct outcomes
of the Ca2+ signal directly depend on the ability of Ca2+ sensing of different proteins in the
NCS family, the localization of NCS proteins relative to the Ca2+ signal, and interactions
of NCS proteins with specific targeted proteins (Burgoyne, 2007).
The ability of Ca2+ sensing, commonly known as Ca2+ binding affinity, varies in
different proteins of the NCS family. The adjustment to Ca2+ affinity of individual proteins
depends on the variation in the sequence of each EF-hand (Burgoyne, 2007). All members
of the NCS family possess four canonical EF-hands, each of which is composed of a nineresidue entering α-helix, a nine-residue Ca2+ binding loop, and an eleven-residue exiting
α-helix. The entering helix is oriented almost at a right angle to the exiting helix when Ca2+
is bound (Figure 1.2) (Gifford et al., 2007).
Most frequently, the Ca2+ ion is coordinated by seven ligands that are provided by
oxygen atoms in the side chain of residues in the EF-hand Ca2+ binding loop (namely EFhand loop) and in the peptide backbone. In some proteins, the oxygen atom is provided by
a water molecule stabilized by a hydrogen bond to one residue in the loop (Figure 1.2)
(Gifford et al., 2007).
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Figure 1.2: A single EF-hand 2 of recoverin (PDB code: 4YI8). The EF-hand consists of
an entering α-helix, a Ca2+ binding loop, and an exiting α-helix. The Ca2+ atom (green
sphere) is coordinated by a canonical Ca2+ binding loop illustrating the pentagonal
bipyramidal coordination of the Ca2+ ion (purple lines) and the hydrogen bonding found in
the loop (black lines). The side chain oxygen atoms are in red and the coordinating oxygen
atoms from water are shown as red spheres.
Amino acid residues that bind to Ca2+ typically contain an oxygen atom in the side
chain, such as asparagine, glutamine, aspartic acid, and glutamic acid (Falke et al., 1994;
Gifford et al., 2007). Indeed, Ca2+ ligands are more frequently provided by the side chain
of an aspartic acid residue, which reflects the preference of the EF-hand loop for ligands
of the less bulky side chain (McPhalen et al., 1991; Gifford et al., 2007). The geometry of
a canonical EF-hand is a pentagonal bipyramid, in which five of the seven Ca2+ ligands are
provided by side chains of amino acid residues in the Ca2+ binding loop, and the other two
ligands are supplied by the side chain of a glutamic acid residue located at the twelfth
position of the Ca2+ binding loop (Figure 1.3) (Gifford et al., 2007) .
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Figure 1.3: The sequence of a canonical Ca2+ binding loop. The Ca2+ ligands are indicated
by their positions in the loop. The ninth Ca2+ ligand (-X coordinate) is typically provided
by a water molecule. Adapted from reference (Gifford et al., 2007).
In addition, the residues in the Ca2+ binding loop are aligned on the pentagonal
bipyramid axes in a manner that the oxygen atoms in the side chain of residues at positions
3, 5, 7, and 12 align along the vertices +Y, +Z, -Y, and –Z of the planar pentagon,
respectively. Oxygen atoms in the side chain of residues at positions 1 and 9 chelate with
+X and –X axes respectively on the axial position, which is perpendicular to the Y/Z plane
as shown in Figure 1.2 (Strynadka et al., 1989; Gifford et al., 2007).
The four EF-hands in NCS proteins always occur in pairs, which form two discrete
domains: one is at the N-terminus, and the other is at the C-terminus (Figure 1.4) (Burgoyne
et al., 2001). The pairing of EF-hands in NCS and other EF-hand proteins often displays
the positive cooperativity for Ca2+ binding, which minimizes the required Ca2+ signal to
reach protein saturation, regulating their target proteins (Gifford et al., 2007).
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Figure 1.4: N-terminal domain of recoverin contains a pair of EF-hands (PDB code: 4YI8,
residues: 1-94). Alpha helices, denoted by α, 1 to 5 are respectively labeled. EF-hand 1 is
composed of α2 and α3; likewise EF-hand 2 contains α4 and α5. Ca2+ is shown as a green
sphere.
As previously mentioned, the diverse functions of NCS proteins in neuronal Ca2+
signaling pathways are related to the differences of structural properties of NCS proteins
such as the number of bound Ca2+ in the proteins and Ca2+ binding affinity (Burgoyne et
al., 2001; Burgoyne, 2007). The molecular details of the NCS proteins’ structures have
been extensively reviewed in literatures (Braunewell et al., 1999; Burgoyne et al., 2001;
Burgoyne et al., 2004; Burgoyne, 2007; Haynes et al., 2008; McCue et al., 2010; Burgoyne
et al., 2012; Ames et al., 2012; Burgoyne et al., 2015). Here, I highlight the differences in
the structure among proteins in the NCS family to exemplify the structure-function
relationship of these proteins in Ca2+ signal pathways.
According to Burgoyne et al., NCS proteins are classified into five classes on the
basis of their available sequences in the human genome (Figure 1.5) (Burgoyne et al.,
2001). In this context, class A contains only a single gene of frequenin protein, which is
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also known as neuronal Ca2+ sensor protein 1 (NCS 1). In contrast, class B is comprised of
three members of visinin-like proteins (VILIP 1, 2, and 3), hippocalcin, and neurocalcin-δ
protein. Class C is the second smallest class in the NCS family and contains a single
recoverin protein. Class D is composed of guanylate cyclase activating proteins (GCAPs)
1, 2, and 3. Class E is comprised of four potassium channel interacting proteins (KChIPs)
1, 2, 3, and 4 (Burgoyne et al., 2001).

Figure 1.5: Representation of phylogenetic relationships in NCS proteins. Adapted from
(Burgoyne et al., 2001).
Structurally, all members of the NCS family are small proteins containing between
190 and 270 amino acid residues, which are arranged into eight to twelve α-helices. Amino
acid sequences of NCS proteins are highly similar, particularly in the regions comprised of
Ca2+ binding loops (Figure 1.6). In addition, the structures of NCS proteins are
heterogeneous in Ca2+ free forms, but become more compact when Ca2+ is bound
(Burgoyne et al., 2001).
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Figure 1.6: Sequence alignment of NCS proteins from classes A to E. Conserved residues are represented by a star, whereas asterisks
indicate identical residues, colons indicate very similar residues, and periods are for weakly similar residues.
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1.3.1 Class A: Neuronal calcium sensor 1
Neuronal calcium sensor 1 (NCS 1) is the unique protein in class A. In NCS 1
protein, EF-hands 2, 3, and 4 can bind to two (Pongs et al., 1993) or three Ca2+ ions with
high affinity (Ames et al., 2000; Bourne et al., 2001; Heidarsson et al., 2012). NCS 1
protein also possesses a myristoyl group located at the N-terminal domain (Figure 1.7).

Figure 1.7: Top: Schematic diagram of EF-hands in NCS1 protein. Bottom left: structure
of myristoylated ApoNCS1 (PDB code: 2L2E). Bottom right: structure of three Ca2+ bound
at EF-hands 2, 3, and 4 of non-myristoylated NCS-1 (PDB code: 2LCP). The EF-hands 1,
2, 3, and 4 of NCS1 are colored in cyan, green, yellow, and red, respectively. The Ca2+ ions
are the yellow spheres and the myristoyl group is colored in pink.
In most NCS proteins, extrusion of the myristoyl group allows the proteins to
interact with the lipid bilayer membrane when Ca2+ is bound at EF-hands (Dason et al.,
2012). In contrast, exposure of the myristoyl group in NCS 1 protein is independent of Ca2+
binding (O'Callaghan et al., 2002). However, when Ca2+ is bound, NCS 1 associates more
strongly with the lipid bilayer membrane (Handley et al., 2010). The three dimensional
structure of myristoylated ApoNCS 1 reveals that the myristoyl group is sequestered inside
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a cavity formed by EF-hand 3 and 4 in the C-terminal domain. In addition, these EF-hands
and the fatty acyl chain are oriented in a parallel fashion, in which the myristoyl moiety is
surrounded by hydrophobic residues from EF-hands (Ames et al., 2000; Ames et al., 2012).
On the other hand, binding of Ca2+ at EF-hands 2, 3, and 4 in the non-myristoylated NCS
1 (Figure 1.7, left) enhances the association of NCS 1 with membranes to some degrees.
Therefore, the enhancement of membrane binding observed in Ca2+ bound NCS 1 cannot
be attributed solely to the N-myristoyl moiety. However, Ca2+ induced conformational
changes increase NCS 1 protein’s tendency to interact with a hydrophobic surface by
means independent of the N-myristoyl group.(Ames et al., 2000).
1.3.2 Class B: visinin-like proteins, hippocalcin, and neurocalcin
Class B of NCS proteins is comprised of three members of visinin-like proteins
(VILIP) 1, 2, and 3, hippocalcin, and neurocalcin-δ protein. The proteins in class B are
expressed primarily in the brain, but they are also found in peripheral organs (Braunewell
et al., 2009).

Figure 1.8: The crystal structure of Ca2+ bound non-myristoylated neurocalcin (PDB: 1BJF
(Vijay-Kumar, 1999)). The EF-hands 1-4 are labeled accordingly as EF-1, EF-2, EF-3, and
EF-4. The Ca2+ ion (yellow sphere) is bound at EF-2, EF-3, and EF-4. The EF-1 is disabled
from binding of Ca2+/Mg2+ due to a Cys-Pro sequence in its Ca2+ binding loop.
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The biological functions of proteins in class B have not been well established
because these proteins display differences in their Ca2+ affinities, membrane binding
kinetics, and interactions with intracellular targets (Braunewell et al., 2009). It was
proposed that VILIP-1 interacts with GCAPs (Spilker et al., 2002) and hippocalcin
interacts with neuronal apoptosis inhibitor proteins (Lindholm et al., 2002). The 3D
structure was resolved for neurocalcin and this protein exhibits similar fold as observed for
other NCS proteins (Figure 1.8) (Vijay-Kumar, 1999).
1.3.3 Class C: Recoverin
The single protein in class C is recoverin. Among NCS members, recoverin was
the first protein to be discovered (Dizhoor et al., 1991). It is expressed in photoreceptor
cells, where it performs the main physiological function in regulation of light sensitivity
by regulating rhodopsin kinase in a Ca2+ dependent manner (Calvert et al., 1995; Chen et
al., 1995; Makino et al., 2004). The NMR structures of ApoRecoverin (Tanaka et al., 1995),
Ca2+ bound at EF-hand 3 (Ames et al., 2002), and Ca2+ bound at both EF-hands 2 and 3
(Ames et al., 1997) were determined and are shown in Figure 1.9. Four EF-hands in
recoverin are organized into N- and C-terminal domains, connected together by a U-shape
linker (Ames et al., 2012). Unlike NCS1, the myristoyl group in ApoRecoverin is
sequestered inside the hydrophobic cavity formed by EF-hands 1 and 2 at the N-terminus
(Tanaka et al., 1995). When Ca2+ ion is bound at EF-hand 3, the myristoyl group remains
located inside the hydrophobic cavity, but the carbonyl end of the myristoyl group is
displaced away from EF-hand 3 and becomes somewhat solvent exposed (Ames et al.,
2012). When Ca2+ is bound at both EF-hands 2 and 3, the myristoyl group is completely
forced out of the hydrophobic cavity and interacts with the lipid bilayer membrane. This
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enables recoverin to translocate from the cytosol to the disc membrane (Ames et al., 2012).
Moreover, the similar structures of myristoylated and non-myristoylated Ca2+ bound
recoverin suggest that the extrusion of the myristoyl group in recoverin does not depend
on the interior protein structure as shown in Figure 1.9 (Ames et al., 2012).

Figure: 1.9: Top: Schematic diagram of EF-hands in recoverin. Bottom: (a) structure of
myristoylated ApoRecoverin (PDB code: 1IKU), (b) 1 Ca2+ ion bound at EF-3 (PDB code:
1OMR), and (c) Ca2+ ion is bound at EF-hands 2 and 3 (PDB code: 1JSA). The structure
of two Ca2+ bound non-myristoylated recoverin is shown in light blue in (c) (PDB code:
4YI8). EF-hands 1, 2, 3, and 4 in recoverin are colored in cyan, green, yellow, and red,
respectively. The Ca2+ ions (yellow spheres) are bound at EF-hand 2 and 3. The myristoyl
group is shown as pink spheres and the N-terminal eight-residue-flexible loop is
highlighted in yellow.
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1.3.4 Class D: Guanylyl cyclase activating proteins
Proteins in class D are guanylyl cyclase activating proteins (GCAPs) which are
expressed in photoreceptor cells. Their main function is to activate retinal guanylyl cyclase
(RetGC) at low cytosolic Ca2+ concentration upon light activation and to inhibit the RetGC
at high Ca2+ level in the dark (Dizhoor et al., 1994). Unlike recoverin, Ca2+ binding to
GCAPs induces small conformational changes and thus does not force the myristoyl group
out to the solvent exterior (Lim et al., 2014). In addition, EF-hands 2 and 3 in GCAPs can
bind both Mg2+ and Ca2+ ions, whereas EF-hand 4 only binds to Ca2+ (Peshenko et al.,
2006). Structures and molecular mechanisms of Mg2+ and/or Ca2+ binding to GCAP 1 have
been well established, yet information about GCAPs 2 and 3 remains unclear. Therefore,
GCAP 1 protein will be used as a model to depict the structure-function relationship of the
GCAP class. Biophysical characterization of GCAP 1 shows that ApoGCAP 1 exhibits a
flexible and unstructured molten-globule-like protein which does not bind and activate
RetGC (Peshenko et al., 2004; Lim et al., 2009).
Binding of Mg2+ to GCAP 1 at EF-hands 2 (Figure 1.10, bottom left) stabilizes the
protein tertiary structure which allows the protein to interact with and activate RetGC.
Binding of Ca2+ to GCAP 1 at EF-hands 2, 3, and 4 (Figure 1.10 bottom right) induces a
distinct conformation that inhibits RetGC (Dizhoor et al., 1994; Peshenko et al., 2004;
Peshenko et al., 2006; Lim et al., 2009; Lim et al., 2014).
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Figure 1.10: Top: Schematic diagram of EF-hands in GCAPs. Bottom: (left) structure of
Mg2+bound at EF-hand 2 of myristoylated GCAP 1 mutant V77E (Mg2+ is not shown, PDB
code: 2NA0) and (right) structure of Ca2+ bound at EF-hands 2, 3, and 4 in GCAP 1 (PDB
code: 2R2I). EF-hands 1 to 4 are highlighted in cyan, green, yellow, and red, respectively.
The Ca2+ ions are shown as yellow spheres.
1.3.5 Class E: Potassium channel interacting proteins
The proteins in class E are comprised of potassium channel interacting proteins
(KChIP) 1-4. The KChIPs share a high sequence similarity over the four EF-hands with
about 40% identity, whereas the N-terminal sequence is considerably diverse (Burgoyne,
2004). Alternative splicing of the four human KChIP genes generates different protein
variants with diverse N-terminal domains. Some of the isoforms have myristoylation or
palmitoylation sites that assist membrane association and localization (Figure 1.11).
However, the topology for KChIP isoforms remains unknown (Burgoyne, 2004). The four
KChIP proteins and additional splice variants are expressed in neuronal cells and KChIP2
is also expressed in cardiac myocytes (An et al., 2000; Morohashi et al., 2002; Holmqvist
et al., 2002). The expression patterns of KChIPs have considerable importance for
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understanding diverse functions of KChIP proteins in modulation of different aspects of
neuronal regulation.

Figure 1.11: KChIPs and splice variants in class E. Some KChIP isoforms have
myristoylation or palmitoylation sites, assisting membrane association and localization.
The GenBank accession number for human KChIP1 isoforms 1.1, 1.2, 1.3 DQ148478,
DQ148477, and DQ148476. The GenBank accession number for human KChIP2 isoforms
2.1, 2.2, 2.3, 2.4, and 2.5 are NM-01491, DQ148480, DQ148481, DQ148482, and
DQ148483. The GenBank accession number for human KChIP3 isoforms 3.1 and 3.2 are
DQ148485 and DQ148486. The GenBank accession number for human KChIP4 isoforms
are DQ148487, DQ148488, DQ148491, DQ148489, DQ148490, and DQ148492,
respectively. Adapted from (Burgoyne, 2007).
The crystallographic study revealed that KChIP1 interacts with the N-terminal of
Kv4.3 results in an octomeric structure of four primary Kv4 subunits and four KChIP
subunits forming heteromultimeric Kv channels. The crystal structure reveals that a
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monomer of KChIP1 interacts with two T1 domains of Kv4.3 (Pioletti et al., 2006). The
first binding site is through hydrophobic interaction between the N-terminus of Kv4.3 and
the hydrophobic cavity on the KChIP1 surface, being exposed upon Ca2+ association to
KChIP1 (Pioletti et al., 2006). The second binding site is through the helix 2 in KChIP1
and the residues in the loop of T1 domain (Pioletti et al., 2006). The interaction between
KChIP1 and Kv4 channel is Ca2+ independent, however, binding of Ca2+ to KChIP1
promotes the channel activity (An et al., 2000; Pioletti et al., 2006).
1.3.5.1 KChIP3/DREAM/calsenilin
Among proteins in class E, KChIP3 is also known as calsenilin or downstream
regulatory element antagonist modulator (DREAM) protein according to their identical
gene sequence (Buxbaum et al., 1998; Carrion et al., 1999; An et al., 2000). Because of
that, herein DREAM is used to avoid using different names for the same protein.
The DREAM protein has been shown to be a multifunctional neuronal calcium
sensor protein that is expressed in the central nervous system, thyroid glands, immune
system and testis (Carrion et al., 1999). The physiological functions of DREAM are
involved in various interactions with the targeted DNA and proteins both in and outside of
the nucleus. In the cytoplasm, KChIP3 interacts with Kv4.3 potassium channels to
modulate A-type potassium currents (An et al., 2000). KChIP3 also interacts with the Cterminal fragments of presenilins to facilitate the activity of gamma-secretase and increase
the production of β-amyloid plaques in Alzheimer’s disease (Buxbaum et al., 1998). In the
nucleus, Ca2+ free KChIP3 directly binds to specific downstream regulatory elements of
the prodynorphin and c-fos genes to repress the transcription of these genes. The DREAM
protein also interacts with a silencer sequence in the 3’ untranslated region of the apoptotic
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gene hrk and represses the expression of the downstream reporter genes in a Ca2+ dependent
manner (Sanz et al., 2001). In addition, at low level intracellular Ca2+ concentration, the
two leucine‐charged residue‐rich domains (LCDs) in DREAM interact with the two LCDs
located in the kinase‐inducible domain and in the leucine zipper domain of αCREM,
resulting in the loss of DREAM binding to DRE sites and derepression (Ledo et al., 2002).
1.3.5.2 Structural insight from DREAM
The DREAM protein contains 256 amino acid residues (~ 29 kDa) (Carrion et al.,
1999; Craig, et al., 2002), which constitute four EF-hands and a non-conserved N-terminal
region (residues 1 - 64) as shown in Figure 1.12 (Buxbaum et al., 1998; Carrion et al., 1999;
An et al., 2000). The N-terminal extension region contains a greater number of
hydrophobic residues that cause inclusion body formation and aggregation during protein
folding (Fink, 1998, Osawa et al., 2001). However, deletion of this region (residues 1-64)
does not inhibit binding of DNA or dimerization in DREAM (Osawa et al., 2001; Osawa
et al., 2005; Lusin et al., 2008). Furthermore, the truncated construct of DREAM (residues
65-265) also fully activates the Kv4 channels (An et al., 2000).
Structural characterization of DREAM reveals that EF-hand 1 does not bind Ca2+
or Mg2+ because of the conserved sequence CPxG (Figure 1.12) in the first Ca2+ binding
loop similar to that obtained in the crystal structure of recoverin (Flaherty et al., 1993),
KChIP1 (Zhou et al., 2004; Scannevin et al., 2004), frequenin (Bourne et al., 2001), and
neurocalcin (Vijay-Kumar et al., 1999). Substitution of the glutamic acid residue by an
aspartic acid residue at the twelfth position in the Ca2+ binding loop of EF-hand 2 causes
this site to selectively bind to Mg2+ with a high affinity (Kd ~ 13 μM) (da Silva et al., 1995,
Craig et al., 2002, Osawa et al., 2005). On the other hand, EF-hands 3 and 4 exclusively
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bind to Ca2+ with a relatively high affinity (Kd ~ 1 µM) due to the conserved glutamic acid
residue at the twelfth position in the Ca2+ binding loop of EF-hands 3 and 4 (Figure 1.12)
(Osawa et al., 2001).

Figure 1.12: The amino acid sequence of mouse DREAM (Gene code: Q9QXT8). The Ca2+
and/or Mg2+ binding loops of EF-hands 1, 2, 3, and 4 are underlined. The negatively
charged amino acids involved in Ca2+/Mg2+coordination are shown in red. The conserved
sequence CPxG (in brown) in the first EF-hand eliminates binding of Ca2+/Mg2+ at this
site. The flexible loop connecting α7 from EF-hands 3 and α8 from EF-hand 4 is shown in
light green and underlined, while the positively residues R200 and R207 in the loop are
shown in blue. The leucine residues (155LxxLL159, and L251) at Ca2+DREAM dimeric
interface are highlighted in purple.
The three-dimensional NMR structure of Ca2+ bound DREAM (residues 76 - 256,
PDB entry: 2JUL (Lusin et al., 2008)) as shown in Figure 1.13 reveals that DREAM
consists of 10 α-helices, evenly distributed into the N- and C-terminal domains. The Nterminal domain comprises EF-hand 1 (α2 and α3, residues 90 - 120) and EF-hand 2 (α4
and α5, residues 128 - 159). The C-terminal domain consists of EF-hand 3 (α6 and α7,
residues 163 - 198) and EF-hand 4 (α8 and α9, residues 184 - 240) (Figure 1.13) (Lusin et
al., 2008).

21

Figure 1.13: Three dimensional cartoon structure of Ca2+DREAM (PBS: 2JUL, residues
76 – 256) (Lusin et al., 2008). The structure DREAM consists of 10 α-helices (43%
secondary structure content) connected by random coils, turns, and a few beta sheets (2%).
From left to right, the positively charged residues postulated to facilitate DNA binding
(K87, K90, K91, R98, K101, R160) are shown in licorice. The EF-hands 1, 2, 3, and 4 are
shown in cyan, green, yellow, and orange, respectively. The N-terminal α-helix (α1) and
the C-terminal alpha helix (α10) are labeled in blue and red, respectively. The single
intrinsic tryptophan residue (W169) is shown in yellow licorice. The long flexible loop
connecting α7 and α8 is shown in blue. The Ca2+ ion (yellow sphere) is bound to EF-hands
3 and 4.
The two domains in Ca2+DREAM are linked together through the central
hydrophobic cluster comprising of residues Y130, F133, and A137 from α4 and residues
W160, L173, I190, and M197 from α6 and α7 of DREAM (Figure 1.14).
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Figure 1.14: The central hydrophobic cluster (shown in stick) connecting the N- and the Cterminal domains of DREAM (PDB: 2JUL) (Lusin et al., 2008).
Moreover, another hydrophobic cluster was also determined at the C-terminal
domain of Ca2+DREAM, comprising of residues M246, M249, F252, and I256 from α10
(in red), residues L167, A170, M191, and L194 from EF-hand 3 (in yellow) and residues
F218, and M222 from EF-hand 4 (in orange) of DREAM (Figure 1.15). The hydrophobic
clusters in DREAM structure were shown to be essential for DREAM interactions with the
T1 domain of KV4.3 channels as well as with small hydrophobic molecules as arachidonic
acid and NS5806. (Gonzalez and Miksovska, 2014; Gonzalez, Pham et al., 2014)
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Figure 1.15: The C-terminal hydrophobic cluster (as shown in stick) of DREAM (Lusin
et al., 2008).
1.3.5.3 The Ca2+ and Mg2+ binding properties in DREAM
The binding affinity for Mg2+ and Ca2+ in DREAM has been studied intensively.
Craig et al. demonstrated that one Ca2+ binds to the first EF-hand in DREAM with a high
affinity (Kd ~ 0.6 µM) and another Ca2+ binds to the second EF-hand with a lower affinity,
with a Kd ranging from 1 to 10 µM, relative to that of the first EF-hand (Craig et al., 2002).
Osawa et al. showed that the first Ca2+ ion binds to EF-hand 3 and the second Ca2+ ion
subsequently binds to EF- hand 4 in DREAM (Osawa et al., 2005). On the other hand, EFhand 2 in DREAM selectively binds to Mg2+ with a high affinity (Kd ~ 13 μM) (Osawa et
al., 2005; Lusin et al., 2008). Binding of Ca2+ has been shown to induce the dimeric
formation of DREAM. However, our current knowledge of the mechanism of Ca2+ induced
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dimeric formation is limited. The proposed structure of the DREAM dimer was determined
according to the directed mutational studies by Lusin et al. 2008 as well as the crystal
structure of KChIP1 (Zhou et al., 2004). By using size-exclusion chromatography and
pulsed-field gradient diffusion studies, Osawa et al. 2005 showed that the association of
Ca2+ stabilizes a dimeric DREAM. Lusin et al. 2008 derived a model for dimeric DREAM
in the Ca2+ bound form using the dimeric X-ray structure of KChIP1 (Zhou et al., 2004).
In this model, the residues L155, L158, and L159 (155LxxLL159, x: any amino acid
residue) on the N-terminal domain of the first DREAM molecule interact with residue L251
on the C-terminal domain of the second DREAM molecule and these two DREAM
monomers are oriented in the head-to-tail orientation (Lusin et al., 2008). Lusin et al. 2008
also speculated that residues in the C-terminal domain of the first DREAM molecule cover
the positively charged residues K90, K91, R98, and K101 in α2 of the second DREAM
molecule, subsequently eliminating the interaction of DREAM with DNA. In general,
binding of Ca2+ to DREAM induces significant conformational changes. However, the
proposed model structure of DREAM dimer has never been verified in experimental
studies. In addition, significantly less is known about the impact of Mg2+ and/or Ca2+ on
DREAM conformational dynamics as well as the role of conformational dynamics in
DREAM upon interaction with target proteins or DNA.
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2. OBJECTIVES
Understanding the conformational dynamics and stability associated with Ca2+ and/or
Mg2+ binding to DREAM is crucial for delineating the structure-dynamics-function
relationship of DREAM, as well as for elucidating the mechanisms of interaction of
DREAM with DNA or presenilins. The critical barrier for envisioning the molecular
mechanism of the interaction between DREAM and its interacting partners lies in the lack
of NMR/crystal structures of the Apo and Mg2+DREAM. The primary goal of this project
was to delineate the structure-dynamics-function relationship of DREAM upon binding
with Ca2+ and/or Mg2+ in modulation of the interaction with presenilin 1 and DNA. To
accomplish this goal, I employed a combination of fluorescence spectroscopy, circular
dichroism, isothermal titration calorimetry, molecular dynamics simulation, and
computational docking to investigate the impact of Mg2+ and/or Ca2+ on the conformational
dynamics of DREAM, the functional roles of individual EF-hands in DREAM, and the
binding interface between DREAM and DNA as well as between DREAM and presenilin
1.
Here, I hypothesize that the structural changes associated with Ca2+ binding to EFhands 3 and 4 are propagated from the C-terminal domain into the N-terminal domain
leading to the dissociation of the DREAM-DNA complex. In addition, I propose that there
is a high affinity binding site for DNA that is formed by the interfacing of residues from
DREAM with nucleotides at the target DRE site in prodynorphin gene for DREAM.
Finally, I speculate that residues in the hydrophobic cavity at the C-terminal domain and
residues in the long flexible loop connecting α7 and α8 in DREAM interface with residues
from the C-terminal fragment of presenilin 1. Findings from this project will provide
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insight into the molecular interaction of DREAM with presenilins and DNA at the amino
acid residue level. These findings also provide insight into the roles of individual EF-hands
in DREAM in regulating DREAM conformational transition under physiological
conditions, which can be used as a model to uncover the functional properties of EF-hands
in other neuronal calcium sensor proteins and to characterize the effects of Mg2+ on various
Ca2+ signaling pathways in cells. These results are also important to understand the role of
DREAM under physiological and pathological conditions and may provide a structure
based design of a novel drug compounds to treat Alzheimer’s disease and chronic pain. To
accomplish the research goals, the following objectives were carried out.
2.1 Objective 1
Characterize the structural changes associated with Mg2+/Ca2+ binding to DREAM
wild-type (residues 65 – 256), DREAM C-terminal domain (namely DREAM-C, residues
161 – 256), and DREAM EF-hand mutants (inactive EF-hand 2: D150  N, inactive EFhand 3: E186  Q, and inactive EF-hand 4: E234 Q)
Previous studies have shown that Ca2+ binds to ApoDREAM tetramer promoting
DREAM dimerization, whereas the Mg2+ binds to DREAM leading to an equilibrium
between tetramer and monomer of the protein. However, the detailed mechanism of
Ca2+/Mg2+ induced structural/dynamic changes remains unknown. To characterize the
conformational dynamics associated with Ca2+/Mg2+ binding to DREAM protein, I took
advantage of the single intrinsic tryptophan residue (W169) located in the central
hydrophobic pocket between EF-hand 2 and 3 to monitor conformational changes in
DREAM, DREAM-C, and DREAM EF-hand mutants (namely DREAM-D150N,
DREAM-E186Q, and DREAM-E234Q for DREAM mutants with an inactive EF-hand 2,
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3, or 4, respectively) using fluorescence steady-state and time-resolved spectroscopy. In
addition, DREAM stability in the Apo and Ca2+ and/or Mg2+ bound forms were probed in
unfolding studies. The outcomes of this part in the project are described in chapter 4
(published in Pham et al., 2015), chapter 5, and partially in chapter 7.
2.2 Objective 2
Characterize the molecular mechanism between DREAM and presenilin 1 as well as
the binding interface of the DREAM-presenilin 1 C-terminal fragment complex.
Previous studies demonstrated that DREAM interacts with the C-terminal fragment of
presenilins 1 and 2 leading to the formation of Aβ plaques in Alzheimer’s disease.
However, insight into the molecular mechanism of the interaction between DREAM and
presenilins as well as the impact of Mg2+ and/or Ca2+ on the complex formation remain
unknown. The binding between DREAM and presenilin 1 C-terminal fragment (PS1-CTF)
was probed by determining the binding constant between DREAM and peptides
constituting the PS1-CTF using steady-state and time-resolved fluorescence spectroscopy.
Subsequently, the oligomerization of the complex was characterized using time-resolved
polarization. The residues at DREAM-presenilin binding interface were identified using
computational approaches. The results of this part in the project are described in chapter 6
(published in Pham and Miksovska, 2016).
2.3 Objective 3
Determine the functional roles of individual EF-hands in DREAM as well as elucidate
molecular mechanism of interaction between DREAM and DNA.
Previous studies revealed that ApoDREAM tetramer binds to the DRE sequence of
prodynorphin gene (namely DNA), whereas association of Ca2+ at either EF-hand 3 or 4 in
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DREAM promotes DREAM dimerization and dissociates the DREAM-DNA complex.
However, in the absence of ApoDREAM structure, the mechanism of interaction between
DREAM and DNA remains unclear. To accomplish this goal, I employed isothermal
titration calorimetry (ITC) to determine thermodynamic parameters for DREAM and
DREAM mutants binding to 25-oligomer DNA. Furthermore, the interaction of DREAM
and DNA was also probed using time-resolved anisotropy to monitor oligomeric states of
the complex upon Mg2+ and Ca2+ association. Previously, according to the structure of
DREAM monomer, it was proposed that basic and positively charged residues K90, K91,
Q94, R98, and K101 in α2 of DREAM form hydrogen bonds and electrostatic interactions
with DNA (Lusin et al., 2008). The binding interface of the ApoDREAM-DNA complex
as well as the conformational dynamics of ApoDREAM upon DNA association were also
examined using computational approaches. The results of this part in the project are
described in chapter 7.
2.4 Objective 4
Characterize the kinetics and thermodynamics associated with CO binding or
releasing from horse heart myoglobin (Mb) and microperoxidase-11 (MP-11) encapsulated
in sodium bis-(2-ethylhexyl) sulfosuccinate (AOT) reverse micelles: A model system to
study myristoylated and palmitoylated NCS proteins in their lipid membrane association
state.
DREAM and most NCS proteins possess either a myristoylation or a palmitoylation
site at their N-terminus (Burgoyne, 2007), which serves as an element for membrane
targeting and anchoring of proteins (Valentine et al., 2010). Understanding membrane
association, controlled by Ca2+ triggered exposure of the myristoylation/palmitoylation, is
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crucial to delineate protein-protein interactions mediating signal transduction at the
membrane (Valentine et al., 2010). However, characterizations of the conformational
dynamics of DREAM and other NCS proteins at Ca2+ saturated state are often frustrated
due to the poor solubility of these proteins (Tanaka et al., 1995; Ames et al., 1997;
Valentine et al., 2010). One of the common approaches to obtain a highly soluble and wellbehaved protein is to delete the myristoylation/palmitoylation region containing
hydrophobic residues as done in DREAM (the most common form of purified DREAM
protein is the construct containing residues 65 – 256). However, this approach prevents our
understanding of the role of the myristoylation/palmitoylation site in the DREAM
interactions with targeted proteins. The long term goal of this project is to investigate the
conformational dynamics of DREAM full length construct (residues 1 - 256) in its
membrane-anchored state and the interaction of presenilins with DREAM full length
encapsulated in reverse micelles. The most critical and difficult stage of this project is to
develop a reverse micelle encapsulation model to investigate the impacts of aqueous
solvation and confinement on the structure, stability, and dynamics of full length DREAM.
Therefore, at the beginning stage of this project, I investigated the conformational
dynamics of myoglobin (Mb) and microperoxidase-11 (MP-11) proteins in the restricted
environment of reverse micelles. Photoacoustic calorimetry (PAC) and transient absorption
(TA) were used to characterize the kinetics and thermodynamics associated with carbon
monoxide (CO) binding or releasing from the heme pocket of horse heart Mb and MP-11.
The Mb and MP-11 proteins were chosen as model proteins for this study because the
mechanism of CO binding or releasing from the heme group of these proteins is well
understood. In addition, these proteins are highly soluble and stable in buffer solution.
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Therefore, the characterization of conformational dynamics of Mb and MP-11
encapsulated in reverse micelles is a good model system to study Ca2+ triggered exposure
of palmitoylation in DREAM encapsulated in reverse micelles upon photolysis of caged
Ca2+ compound. The results of this part are described in chapter 8 (partially published in
reference (Larsen et al., 2011)).
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3. MATERIALS AND METHODS
3.1 Materials
The plasmids encoding for constructs of mouse DREAM wild-type (DREAM,
residues 65 - 256), DREAM-C terminal domain (DREAM-C, residues 161 - 256),
DREAM-EF hand mutants: DREAM-D150N, DREAM-E186Q, and DREAM-E234Q
(where the EF-hands 2, 3, and 4 in DREAM are inactivated by site-direct mutations D150
 N, E186  Q, and E234  Q, respectively), DREAM-KChIP1, and DREAM-NCS1
chimera (where DREAM construct fused with KChIP1 or NCS1 flexible loop) with T7
promoter and six His tagged on the carboxyl terminus were purchased from GeneCopoeia
(Rockville, MD, USA). The DNA sequence ‘5CAGGGGCCTCCTTGACTCCGGCTTC-3’ and its complement sequence corresponding
to downstream regulatory elements (DRE) of human prodynorphin gene (namely DNA)
were also purchased from GeneCopoeia. The synthetic peptides derived for HLβ
(residues 355PESRAAVQELSSSIL369) and HL9 (residues
445FYFATDYLVQPFMDQLAFHQFYI467) of human presenilin 1 C-terminal fragment
(herein named HLβ and HL9) with FITC covalently attached to their amino-terminus
were purchased from ProImmune (Sarasota, FL, USA). Dithiothreitol (DTT), acrylamide,
1.0 M solution of magnesium chloride, and 1,8-ANS were purchased from SigmaAldrich. Guanidine hydrochloride (GuHCl), and 0.1 M solution of calcium chloride were
purchased from Fisher Scientific. The hydrophobic fluorescent probes 2,6-ANS and nile
red were purchased from Invitrogen and used without further purification. Nickel
nitrilotriacetic acid (Ni-NTA) super flow resin was purchased from Qiagen and
diethylaminoethyl Sepharose fast flow resin (DEAE) was purchased from GE Healthcare.
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All other reagents were purchased from Fisher Scientific and Sigma-Aldrich at analytical
grade and used without further purification.
3.2 Methods
3.2.1 DREAM protein expression
The expression vectors of DREAM, DREAM-C, DREAM-D150N, DREAME186Q, DREAM-E234Q, DREAM-KChIP1, and DREAM-NCS1 were transformed into
Escherichia coli strain BL21 (Stratagene) by using the heat shock technique for protein
expression.
3.2.2 DREAM protein isolation and purification
Recombinant DREAM protein isolation and purification were carried out using the
method described previously (Osawa et al. 2001; Osawa et al., 2005; Lusin et al., 2008). A
single colony of transformed DREAM cells was suspended in 50 mL of Luria-Bertani
medium supplemented with 100 mg L-1 of ampicillin and grown overnight at 37 °C and
250 RPM in a vigorous shaker (MaxQ 400) for a starter culture. Subsequently, 5 mL of
starter culture were transferred into 1 L of Terrific Broth medium supplemented with 100
mg L-1 ampicillin. Cells were incubated at 37 °C and 250 rpm until the optical density at
600 nm (OD600) reached between 0.8 to 1.0, then the protein expression was induced by
adding 700 µM isopropyl 1-thio-β-D-galactopyranoside (IPTG) to the cell culture. The
cells were further incubated at 25 °C for 16 h before harvesting by centrifugation at 4 °C
and 10,000 rpm for 10 min (Allegra 64R, Beckman Coulter).
After harvesting, one gram of DREAM wet cells was homogenized in 5 mL of lysis
buffer containing 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM -mercaptoethanol, 20%
glycerol, 1mM phenylmethyl sulfonyl fluoride (PMSF), 0.2% Tween 20, 20 g/mL DNase
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I, 5 g/mL lysozyme, and 5 mM MgCl2. The suspension was then sonicated with a sonic
dismembrator (model 100, Fisher Scientific) for 30 intervals of 20 seconds with 2 min of
resting on ice between each interval. The membrane debris and unbroken cells were
removed by high spin centrifugation at 4 °C and 10,000 rpm for 1 h (Allegra 64R, Beckman
Coulter).
The supernatant was collected and loaded into a Ni-NTA super flow column (Qiagen)
equilibrated with buffer A containing 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM mercaptoethanol, and 20% glycerol. The column was consecutively washed with buffer A
containing 5, 10, 20, 30, and 40 mM imidazole until absorbance at 280 nm (A280nm) was
less than 0.03 to remove impurities. DREAM protein was eluted with buffer A containing
250 mM imidazole. Purified DREAM protein was dialyzed overnight in 2 liters of buffer
B comprised of 20 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 1 mM DTT to remove
imidazole and NaCl. The DREAM protein was then applied onto a DEAE column
equilibrated with buffer B at 4 °C. The DEAE column was sequentially washed with buffer
B containing 20, 40, 60, and 80 mM NaCl until A280 nm was below 0.02. Finally, DREAM
protein was eluted with 300 mM NaCl in buffer B. The purity of protein was assessed using
SDS-PAGE electrophoresis.
3.2.3 Protein purity assay
3.2.3.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Purity of DREAM protein was verified using one-dimensional gel electrophoresis. In
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) method, the
negatively charged sodium dodecyl sulfate (SDS) coasted protein migrates in response to
an electrical field created by the negative cathode attached to the upper buffer chamber and
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the positive anode attached to the lower buffer chamber through pores formed by
polyacrylamide in the presence of sodium dodecyl sulfate (Gallagher, 2006). The standard
continuous SDS-PAGE, in which Tris-tricine was used for both gel and electrode solution,
was used in this experiment. Electrophoresis gels containing 4 - 20 % Tris - Glycine
gradient were purchased from Lonza (PAGErTM Gold Precast Gels). The electrophoresis
running buffer and treatment buffer were prepared according to the chemical compositions
in Tables 3.1 and Table 3.2, respectively. The samples were prepared by mixing protein
solution (about 3 mg/ml) with treatment buffer. The samples were then boiled for 10 min
in a water bath. Subsequently, 10 µL of the protein mixed with treatment buffer was loaded
into each well of the electrophoresis gel. Electrophoresis was carried out at a constant
voltage (120 V) with varying current using a power supply (Model FB300, Fisher
Scientific) until the protein samples reached the bottom. The gel was removed and stained
in the Coomassie blue solution containing 0.1% Coomassie blue dye, 50% methanol, and
10% acetic acid overnight. The gel was then de-stained in a solution containing 50%
methanol, 10% acetic acid, and 40% water for about 3 hours.
Table 3.1: Chemical components for electrophoresis running buffer
Chemical components

Concentration

Tris-HCl buffer (pH 8.3)

0.025 M

Glycine

0.192 M

SDS

0.1%
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Table 3.2: Chemical components for sample treatment buffer
Chemical components
Tris-HCl buffer (pH 6.8)
SDS
Glycerol
Bromophenol blue
DTT

Concentration
0.125 M
4%
20%
0.02%
0.2 M

3.2.4 DREAM protein concentration determination
3.2.4.1 Bicinchoninic acid assay (BCA)
Bicinchoninic acid forms a purple complex with Cu1+ in an alkaline solution, which
has a strong absorbance at 562 nm (Smith et al., 1985). Since amino acid residues such as
tryptophan, tyrosine, and cysteine reduce Cu2+ to Cu1+ at 37 ºC (Wiechelman et al., 1988),
the concentration of proteins can be determined by monitoring the color produced in the
reaction of bicinchoninic acid with Cu1+ (Smith et al., 1985). In this assay, the procedure
was followed as described in the BCA protein assay reagent kit (Pierce Biotechnology,
Rockford, IL). The standard curve was generated by measuring maximum absorption at
562 nm for bovine serum albumin standard protein with concentrations varying from 25
μg/ml to 2,000 μg/ml. DREAM protein concentration was then calculated from the
calibration curve of BSA. Consequently, the extinction coefficient of DREAM protein at
280 nm was determined (Table 3.3).
Table 3.3: DREAM protein extinction coefficient at 280 nm
ε280nm (M-1 cm-1)

Protein
DREAM, DREAM-D150N, DREAM-E186Q,
DREAM-E234Q, and DREAM-KChIP1

19,000

DREAM-C

11,000
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3.2.4.2 Ultraviolet-Visible (UV-Vis) spectroscopy assay
Since aromatic amino acid residues such as phenylalanine, tyrosine, and tryptophan
in protein absorb light with an absorbance maxima ranging from 260 nm to 280 nm, protein
concentration can be quickly determined using the Beer-Lambert law (equation 3.1) when
the protein extinction coefficient is known.
 I 
A   log     l  C
 I0 

(3.1)

In this expression, A is absorption, I0 and I are light intensity before and after transmitted
through a sample, which has concentration, C, in unit of M; path length, l, in unit of cm;
and the molar extinction coefficient, ε, in unit of M-1cm-1.
3.2.5 Fluorescence spectroscopy
Fluorescence spectroscopy has been widely used in many applications in
biochemistry and biophysics research. The advantage of this technique is its high
sensitivity, which allows the detection of signals at low concentration ranging from nM to
μM (Boens et al., 2007; Lakowicz, 2010).
3.2.5.1 The light absorption and emission of fluorophores
The process of light absorption and emission of fluorophores are often described
by a simple electronic state diagram, known as Jablonski diagram, as shown in Figure 3.1
(Lakowicz, 2006; Periasamy and Clegg, 2010).
After light is absorbed at a particular wavelength, fluorophores in an illuminated
volume of the sample undergo an instantaneous electronic transition from the singlet
ground state (S0) into the singlet of the first (S1) or second (S2) state. The transition time of
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the light absorption process is too short (10-15 s) for significant displacement of the nuclei,
a phenomenon known as the Frank-Codon principle (Lakowicz, 2006). At room
temperature, since the thermal energy is not adequate to populate higher vibrational levels,
light absorption typically occurs from the lowest vibrational level of the ground state.

Figure 3.1 The Perrin-Jablonski diagram. The arrows represent the transition of a quantum
change. The transitions begin at the lowest vibrational levels of each electronic state (S0,
S1, and S2) for both absorption (blue arrows) and de-excitation (green arrows). The
transition from the excited state to the ground state always happens from the first lowest
level of S1. The non-emissive de-excitation transitions are internal conversion (ic),
intersystem crossing (isc), excited state reaction, quenching, photolysis, and FRET. The
excited molecule passes from the singlet (S1) to the triplet (T1) state via isc. The emission
from T1 is phosphorescence (red arrow). The other de-excitation transitions from T1 are
similar to that of the S1. Adapted from (Lakowicz 2006; Periasamy and Clegg 2010).
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In general, fluorophores are usually excited to some higher vibrational levels (v1,
v2, or v3); however, they quickly relax to the lowest vibrational level (vo) of each electronic
state via the thermal relaxation pathway. In addition, the excited fluorophores in the S2
state also quickly relax to the v0 of S1 state in less than 10-14 s via an internal conversion
(IC) and vibrational relaxation pathways (Figure 3.1). Therefore, the transition from the
excited state to the ground state of fluorophores always occurs from the v0 level of S1 state.
When promoted to the v0 level of S1 state, fluorophores undergo fast vibration relaxation
before returning to the singlet ground state through either radiative pathway (emission of a
photon, kr) or non-radiative pathways including vibrational relaxation, and internal
conversion (kic). With a very low probability, the excited fluorophores can pass to the triplet
state (T1) via the intersystem crossing process (kisc); however, transition from T1 to S0 state
is forbidden (Figure 3.1). In the presence of quenching molecules, the excited fluorophores
may also be dynamically or statically quenched by surrounding quenchers (kq) (Lakowicz,
2006).
3.2.5.2 Characteristics of fluorescence emission
3.2.5.2.1 Fluorescence emission spectra
The interesting process of de-excitation transitions is the emission of photons. The
emission spectrum is represented by a plot of fluorescence intensity as a function of
emission wavelength. One important characteristics of the emissive process is that
fluorescence emission occurs at lower energies (or longer wavelengths) relative to its
absorption energy, known as the Stokes shift phenomenon. In addition, the same emission
spectrum is observed irrespective of its excitation wavelengths, also known as Kasha’s
rule. However, the shape and maxima of an emission spectrum also depend upon molecular
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relaxation of the solvent and energy transfer to quenchers surrounding the fluorophore’s
environment (Lakowicz, 2006).
3.2.5.2.2 Fluorescence quantum yield
The quantum yield () of fluorophores provides information about the efficiency
of the fluorescence process. Fluorescence quantum yield can be defined by the fraction of
rate constants of the radiative emission of a photon (kr) over the total rate constants of both
radiative and non-radiative processes, including internal conversion (kic) and intersystem
crossing (kisc) as shown in equation 3.2 (Lakowicz, 2006).



kr
k r  kic  kisc

(3.2)

3.2.5.2.2.1 Quantum yield measurements
Fluorescence quantum yield can be calculated by using either an absolute or a
relative method (Wurth et al., 2013). Quantum yield experiments performed in this
dissertation project were determined using the relative method described by Williams et al.
(Williams et al., 1983). The method involves the use of a well characterized standard
sample with known quantum yield (ST) and the quantum yield of testing sample (x) is
calculated by equation 3.3.
 Grad X
 X   ST 
 GradST

  X2
 2
  ST





(3.3)

In this expression, Grad is the gradient from the plot of integrated fluorescence intensity
versus absorbance, and η is the refractive index of the solvent. Subscript
the testing and standard samples, respectively.
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X

and ST denote

3.2.5.2.3 Fluorescence lifetime
Fluorescence lifetime is defined as the average time that the fluorophore resides in
its electronic excited state following excitation (Lakowicz, 2006). Thus, fluorescence
lifetime () of a fluorophore is the reciprocal of the sum of radiative and non-radiative rate
constants as shown in equation 3.4.



1
k r  kis  kisc

(3.4)

Fluorescence lifetime is important for biophysical studies because lifetime of a
fluorophore provides useful molecular information about structural fluctuation and
conformational heterogeneity as a result of structural perturbations near the fluorophore in
the investigating system (Valeur, 2002; Lakowicz, 2006; Periasamy, 2010). Fluorescence
lifetime measurements can be performed by either time-domain (TD) or frequency-domain
(FD), also known as phase-modulation approach. In the TD approach, the fluorophore is
excited with a short laser pulse and fluorescence emission intensity is recorded as a
function of time. On the other hand, in the FD approach, when a fluorophore is excited
with a modulated sinusoidally light source at high frequencies, the lifetime of the
fluorophore causes the emission to be delayed in time, called phase shift (), and a decrease
in the peak-to-peak height, also known as modulation, with respect to that of modulated
excitation (Figure 3.2) (Gratton et al. 1984; Lakowicz, 2006; Ross and Jameson 2008). The
phase shift is measured from the zero-crossing times of the modulated components,
whereas modulation (M) is the ratio of signal amplitude (AC) at modulation frequency, ,
to the average signal (DC) (Figure 3.2) (Gratton et al., 1984; Ross and Jameson, 2008,
Lakowicz, 2006). Since throughout my dissertation project fluorescence lifetime
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measurements were performed with a FD fluorimeter, a brief discussion about the theory
and data analysis of FD fluorescence lifetimes is introduced to give insight into the
significance of fluorescence lifetimes of the studies in this project.

Figure 3.2: Relative phase shift () and modulation of the excitation (subscript E) and
emission light (subscript F) in FD fluorescence spectroscopy. AC and DC indicate the
amplitude and offset of the respective waves. Adapted from (Ross and Jameson, 2008).
3.2.5.2.3.1 Basic principles of frequency-domain lifetime
measurements
For a sample containing n fluorophores, each of which has the same probability of
emitting in a given period of time, the excitation intensity and the fluorescence emission
intensity are described by equations 3.5 and 3.6, respectively (Ross and Jameson, 2008).
E (t )  E0 1  M E sin(t )

(3.5)

F (t )  F0 1  M F sin(t   )

(3.6)

In these expressions, E(t) and E0 are the excitation intensities, F(t) and F0 are the
fluorescence emission intensities at time t and time zero, respectively, ϕ is the phase shift
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between the excitation and emission, and  is the angular modulation frequency equal to
2 of the linear frequency f (in radian/s). The modulation of excitation (ME) and the
modulation of emission (MF) are described by equations 3.7, 3.8, and 3.9.

MF 

AC F
DCF

ME 

AC E
DCE

M 

MF
ME

(3.7)

(3.8)

(3.9)

In these expressions, AC and DC are signal amplitude and the average signal at modulation
frequency, , respectively. The subscripts E and F indicate excitation and fluorescence
emission, respectively. M is the relative modulation of the emission and excitation
modulations.
The characteristic phase lifetime () and modulation lifetime (M) at any single
modulation frequency can be calculated by using equations 3.10 and 3.11 (Ross and
Jameson 2008).

    1 tan 

M 

1 1

 2  1
M


(3.10)
1
2

(3.11)
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These phases and modulation lifetimes are equal ( = M) only if the intensity decay
is a single exponential. However, most samples of interest display more than one lifetime,
which cannot be resolved by using equations 3.10 and 3.11. In this case, the lifetimes (
and M) measured at a particular frequency are the result of the weighting various
components in the emission (Lakowicz, 2006). In addition, the phase lifetime is shorter
than the modulation lifetime ( < M), and both  and M decrease at higher modulation
frequencies (Lakowicz, 2006).
For a multi-exponential decay system, the phase and modulation values have to be
measured in a wide range of modulation frequencies using a variable-frequency instrument.
Alternatively, the phase and modulation values can be expressed in the waveforms of sine
(S) and cosine (G) functions as shown in equations 3.12 and 3.13 (Ross and Jameson,
2008):

S   f i M i sin i

(3.12)

i

G   f i M i cos i

(3.13)

i

The parameters i and Mi are described in equations 3.14 and 3.15, respectively. Parameter
fi is the fractional intensity of the ith components (fi = 1).

S
  tan 1  
G

(3.14)

M  S 2  G 2 2
1

(3.15)
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The functions S and G are sine and cosine transforms of the impulse response
function according to equations 3.14 and 3.15 (Ross and Jameson, 2008). These
expressions can be used for any intensity decay law such as Gaussian distribution or
discrete distribution and can also be transformed numerically into expressions 3.16 and
3.17 (Lakowicz, 2006).

 i i2
 (1   2 2 )
i
S i
  i i

(3.16)

i

 i i

 (1   
G
 
2

i

2
i

)

(3.17)

i i

i

In these above expressions, αi corresponds to the pre-exponential decay factor, i represents
the individual lifetimes, and


i

i i

is proportional to the steady-state intensity. The

relationship between αi and fi in equations 3.16 and 3.17 is given by expression 3.18,
assuming that the quantum yield of emitting species are proportional to their lifetimes
(Lakowicz, 2006; Ross and Jameson, 2008).

fi 

 i i
  j j

(3.18)

j

In the least-square analysis, the parameters αi and i are varied to yield the best fit
between the measured data and calculated values justified by a minimum value for the
reduced chi-squared value (χ2) in 3.19 (Lakowicz, 2006).
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2

  c 
1
 M  Mc 
   m
  m




 M
  
2

1

2

(3.19)

In this expression,  and M correspond to the phase and modulation values, respectively,
the subscripts c and m indicate the calculated and measured values, and δ and δM are the
standard deviations of each phase and modulation measurement, respectively. The value ν
is the number of degrees of freedom, which is equal to twice the number of frequencies
minus the number of variable parameters. The best fit between the calculated values and
the experimental values are typically characterized by a χ2 value close to 1 (Lakowicz,
2006). In the frequency-domain approach, Fluorescence lifetime data are often described
in terms of the contributions of various components to the emission or fractional intensities,
fi, which correspond to the contribution of the ith component to the photocurrent. On the
other hand, the pre-exponential, αi, is usually reported in the time-domain approach (Ross
and Jameson, 2008).
3.2.5.2.4 Fluorescence quenching
Fluorescence quenching provides useful information on the accessibility of the
fluorophore to the solvent. The accessible process depends not only on the structure of the
molecules surrounding the fluorophore, but also on the fluorophore charged environment
(Jameson, 2014). The quenching process can occur via dynamic quenching (also known as
collisional quenching), static quenching, or simultaneous dynamic and static quenching
(Jameson, 2014).
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3.2.5.2.4.1 Collisional quenching
Collisional quenching occurs when the excited fluorophore comes in contact with
an atom or molecule that can facilitate the non-radiative transitions to the ground state
(Valeur, 2002). Thus, fluorescence quantum yield and fluorescence lifetime of a single
exponential system in the presence of quenchers are given by equations 3.20 and 3.21
(Valeur, 2002).



kr

kr  kis  kisc  kq [Q] 1

0

kr
 k q [Q]

0
 1  kq [Q]


(3.20)

(3.21)

In these expressions, kq is the rate of quenching, [Q] is the quencher concentration, and 0
and  are lifetimes in the absence and presence of quenchers, respectively. Other
parameters have the same meaning as described previously.
Since quantum yield is proportional to fluorescence emission intensity, the combination
of equations 3.20 and 3.21 gives the Stern-Volmer equation (Valeur, 2002).

0
I
 0  1  kq 0 [Q]  1  K SV [Q]

I

(3.22)

In this expression, I0 and I are steady-state fluorescence intensities in the absence and
presence of quencher Q, respectively. The Stern-Volmer constant Ksv is equal to kq0. Thus,
the bimolecular quenching constant (kq) can be calculated from Ksv and determined from
the plot of I0/I against the quencher concentration [Q] when the excited-state lifetime in the
absence of quencher (0) is known (Valeur, 2002).
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3.2.5.2.4.2 Static quenching
Static quenching occurs when a fluorophore interacts with a quencher to form a
non-fluorescent complex in the ground state. Upon light absorption, the complex rapidly
returns to the ground state without emission of a photon. Thus, the steady-state
fluorescence intensity decreases upon addition of Q, but lifetime of the fluorophore is
unaffected (Lakowicz, 2006; Valeur, 2002). The static quenching can be described by
equation 3.23.

I0
 1  K sv [Q]
I

(3.23)

The linear dependence of I0/I in the expression for static quenching (equation 3.23) is
identical to that of dynamic quenching in equation 3.22, except that the quenching constant
(Ksv) is the association constant.
3.2.5.5 Fluorescence anisotropy
Fluorescence anisotropy measurement provides useful information on molecular
mobility, size, shape, and flexibility of molecules, fluidity of a medium, and other
parameters (Valeur, 2002).
3.2.5.5.1. Basic principles and theory of fluorescence anisotropy
In a homogenous solution, fluorophores are randomly oriented in the ground state.
When these fluorophores are excited with vertically polarized light, whose electric vector
has transition moments oriented along the z-axis (Figure 3.3), the intensity of emission can
be measured through a polarizer. If the emission polarizer is oriented parallel (||) to the zaxis, the observed intensity is called I||. Likewise, if the polarizer is perpendicular () to z-
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axis, the observed intensity is called I. The anisotropy (r) is calculated from these I|| and
I intensity components by using equation 3.24 (Lakowicz, 2006).

r

I||  I 
I||  2 I 

(3.24)

Since the intensity difference between parallel and perpendicular components ( I||  I  ) is
normalized by the total intensity ( I||  2 I  ), anisotropy is independent of the fluorophore
concentration (Lakowicz, 2006).

Figure 3.3: Schematic diagram for measurement of fluorescence anisotropy. Adapted from
(Lakowicz, 2006).
Upon excitation by polarized light, a fluorophore, whose dipole is oriented with
angles  and  respectively relative to the z-axis and y-axis as shown in Figure 3.4, creates
the electric field (E), described by equation 3.25.
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E ( , )  k

sin  

r

(3.25)


In this expression, k is a constant, r is the distance from the fluorophore, and  is the unit
vector along the  coordinate.
The intensity of emission of that fluorophore is proportional to the square of the
electric field, described by equation 3.26 (Lakowicz, 2006).

I ( ,  )  k 2

sin 2  
r
r2

(3.26)



where r is a unit vector in the direction of propagation.

Figure 3.4: Schematic diagram illustrating emission intensities for a single fluorophore in
a coordinate system. Adapted from (Lakowicz, 2006).
Since the electric field points in the same direction as the emission transition
moment, the projection of the field onto the z-axis is proportional to cos and the intensity
is proportional to cos2. Likewise, the field along the x-axis is proportional to sinsin and
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the intensity is proportional to sin2sin2. Hence, I|| and I components can be expressed
by equations 3.27 and 3.28 (Lakowicz, 2006).
I|| ( ,  )  cos 2 

(3.27)

I  ( ,  )  sin 2  sin 2 

(3.28)

Because all the excited fluorophores at angle  from the y-axis are symmetrically
distributed around the z-axis, the population of excited fluorophores is oriented with values
of  from 0 to 2 with equal probability. The average value of sin2 is given by equation
3.29.
2

sin 2  

 sin
0

2

d


2

 d

1
2

(3.29)

0

Therefore, equation 3.28 can be written as equation 3.30.
I  ( ,  ) 

1
sin 2 
2

(3.30)

Assuming that the probability of a collection of fluorophores, oriented at an angle between
 and  + d relative to z-axis, is f(), then, I|| and I can be rewritten by equations 3.31 and
3.32.
 2

I|| 

 f ( ) cos

2

d  k cos 2 

(3.31)

0

1
I 
2

 2



f ( ) sin 2 d 

0

k
sin 2 
2

where k is an instrumental constant.
Using sin2 = 1 – cos2, equation 3.32 can be rewritten by equation 3.33.
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(3.32)

r

3 cos 2   1

(3.33)

2

In this expression, the anisotropy is determined by the average value of cos2, where  is
the angle of the emission dipole relative to the z-axis (Lakowicz, 2006).
3.2.5.5.2 Steady-state anisotropy
The steady-state anisotropy can be calculated from an average of the anisotropy
decay r(t) over the intensity decay I(t) by using equation 3.34 (Lakowicz, 2006).


r

 I (t )r (t )dt
0

(3.34)



 I (t )dt
0

For a single-exponential intensity decay with lifetime,, the steady-state anisotropy is given
by equation 3.35.

r

r0
1 

(3.35)

In this expression, r0 is the limiting anisotropy and  is the angle of the emission dipole
relative to the z-axis.
3.2.5.5.3 Frequency-domain anisotropy decay
Frequency-domain (FD) anisotropy decay is also known as the dynamic
polarization method (Jameson, 2014). Anisotropy decay provides information on rotational
modalities of a fluorophore as a function of time. Thus, it allows us to investigate the
dynamics of the system such as size, shape, and flexibility (Lakowicz, 2006; Ross and
Jameson, 2008).
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3.2.5.5.3.1 Theory of FD anisotropy decay
In FD anisotropy decay, a fluorophore is illuminated with vertically polarized,
modulated light, and the parallel and perpendicular emission intensities are observed
through a rotatable polarizer. The observable quantities for the anisotropy decay
measurements are the phase shift (Δ) between perpendicular () and parallel (||)
emission components at the modulation frequency () and the ratio of the modulated
amplitudes of the parallel (M||) and perpendicular (M) components of emission (Figure
3.5) (Lakowicz, 2002).
The changes of Δ and  are because of the rotation of the excited fluorophore
during the excited state lifetime, which changes the orientation of the emission dipole of
the fluorophore (Ross and Jameson, 2008). The relation between the observed Δ and 
with respect to rotational parameters of fluorophores in a single rotating spherical system
is displayed in equations 3.36 and 3.37 (Weber, 1977; Ross and Jameson, 2008).



18r0 R
  tan1  2

2
2
 (k   )(1  r0  2r0 )  6 R(6 R  2k  kr0 ) 





 1  r0   6 R   1  r0   
  
2
2 2
 1  2r0 k  6 R  1  2r0   
2

2

2

(3.36)

1
2

(3.37)

In these expressions, r0 is the limiting anisotropy, which is observed in the absence of
rotation, k is the radiative rate constant (1/) of the fluorophore, and R is the rotational
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diffusion coefficient, which is equal to twice the reciprocal of the rotational relaxation time
(), where  is equal three times the rotational correlation time (Ross and Jameson, 2008).

Figure 3.5: Schematic diagram for measurement of anisotropy decays with frequencydomain. Adapted from (Lakowicz, 2002).
3.2.5.5.3.2 Data analysis of anisotropy decay
In FD anisotropy decay approach, the phase shift (Δc) and modulation ratio (c)
are measured using equations 3.38 and 3.39.

 D N  N|| D 

 c  tan 1  || 
N N DD 
||  
 || 

(3.38)
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 N||2  D||2  2
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N

D
 
 

(3.39)
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In these expressions, parameters D and N are expressions for the sine and cosine transforms
of the individual polarized decays as shown in equations 3.40 and 3.41 (Weber, 1977;
Lakowicz, 2006).


N k   I k (t ) sin tdt

(3.40)

0



Dk   I k (t ) cos tdt

(3.41)

0

where k indicates the perpendicular and parallel orientations.
Thus, anisotropy decay parameters can be obtained by minimizing the squared deviations
between measured and calculated values using equation 3.42.

2 

1
  
  
   c      c 
        
1

2

2

(3.42)

where δΔ and δ are the uncertainties in the differential phase and modulation ratio,
respectively (Joseph R. Lakowicz 2006).
3.2.5.5.3.3 Anisotropy decay fitting models
Anisotropy decay models are varied since the size, shape, and flexibility of the
fluorophore, and its local environment can affect anisotropy decays of the investigated
system. A spherical molecule displays a single rotational correlation time. However, the
anisotropy decay for a non-spherical fluorophore is more complicated because there are
different rotational rates around each axis (Lakowicz, 2006). Several anisotropy decay
models routinely used for data analysis throughout my dissertation project are described
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below. For the first case of a spherical system, the decay of anisotropy with time, I(t), is
given by 3.43 (Jameson, 2014).

r

I||  I 
I ||2 I 

 r0e t 

(3.43)

In the case of a mixture of large and small particles, anisotropy decay reflects the
sum of exponential components as displayed in equation 3.44a (Jameson, 2014).

r(t )  r1e t 1  r2 e t 2

(3.44a)

In the case of a local rotation of a probe attached to a spherical particle, the decay
anisotropy is given by equation 3.44b (Jameson, 2014).

r (t )  r1et 1  r2et 1t 2 

(3.44b)

In these expressions, r1 and r2 are anisotropy amplitudes, 1 and 2 are respectively the
rotational correlation time of fast (local) motion and slow (global) motion of a mixed
system.
The experimentally determined rotational correlation times can be compared to
expected values (calc) for a spherical protein calculated by using the Stokes-Einstein
equation 3.45 (Lakowicz, 2006).
 calc 

V

(3.45)

RT

where η is the viscosity of water (η = 1.02 cP) (Korson et al., 1969), V is the hydrodynamic
molecular volume, R is the ideal gas constant, and T is the temperature (20° C).
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3.2.5.6 Fluorescence stopped-flow kinetics
3.2.5.6.1 Basic principles of fluorescence stopped-flow kinetics
Fluorescence stopped-flow kinetics is a useful method that directly measures the
kinetics of a bi-molecular reaction. Kinetics parameters provide reaction rates, which can
be used to investigate mechanisms and binding constants (Gibson, 1969; Hargrove, 2005).
In this method, small volumes of protein and ligand, such as a short peptide, are rapidly
driven from syringes A and B through valves A and B into an observation mixer chamber
as shown in Figure 3.6.

Figure 3.6: Schematic diagram of a stopped-flow mixer. Reaction A and B are driven into
the mixer through valves A and B. The previous content of the tube and cuvette are flushed
out the stopping syringe via valve S that is open during flow. When the plunger of the
stopping syringe hits the block, the valve S is closed and the contents of the cuvette can be
probed during reaction mixture. Adapted from (Hargrove, 2005).
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The resultant reaction volume displaces the content of an observation cuvette and
thus fills it with freshly mixed reagents. As long as the stopping syringe is filled with old
reaction solution, the plunger hits a block causing the flow to be stopped instantaneously
(Figure 3.6). The time during which the solution enters the observation cuvette is known
as the dead time of a stopped-flow system, which is less than 8 ms for a fast kinetic stoppedflow system, model SFA-20 (TgK Scientific).
3.2.5.6.2 Fluorescence stop-flow kinetics measurements and data
analysis
The kinetics measurements were performed with a ChronosFD spectrofluorometer
(ISS, Champaign, IL) coupled to a SFA-20 rapid stopped-flow apparatus (TgK Scientific,
Bradford-on-Avon, UK). Kinetics data were analyzed using single and double exponential
decay models (Origin 8 software, OriginLab Corp. Northampton, MA).
3.2.5.7 Fluorophores
Fluorophores are classified into intrinsic and extrinsic probes. The intrinsic
fluorophores are natural aromatic amino acid residues in proteins including tryptophan,
tyrosine, and phenylalanine. On the other hand, extrinsic fluorophores are fluorescence
emissive compounds such as FITC, DNS-Cl, ethidium bromide (EtBr), or ANS. Since
many proteins and DNA of interest are nonfluorescent, extrinsic fluorophores are
frequently labeled on the proteins or DNA to create a fluorescent system. The fluorophores,
routinely used in this project, are listed in Table 3.4.
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Table 3.4: List of extinction coefficients (nm), emission maximum wavelength (Em.max)
of fluorophores used.
Chemical

nm
(M-1cm-1)
7,800
(ɛ372nm)
27,000
(ɛ319nm)
19,600
(ɛ552nm)

1,8-ANS
2,6-ANS
Nile red

Solvent

References

Manufactures

Methanol

Diwu et al., 1997

Sigma

Methanol

Diwu et al., 1997

Molecular Probes

DMSO

Castro et al., 2005

Molecular Probes

Fluorescein
isothyocyanate (FITC)

75,000
(ɛ493nm)

Water

Jobbágy et al., 1973

Molecular Probes

Ethidium bromide
(EtBr)

5,680
(ɛ478nm)

Water

Garbett et al. 2004

Thermal Fisher

3.2.6 Circular dichroism spectroscopy
Circular dichroism (CD) is an excellent method to evaluate the secondary structure,
folding, and binding properties of proteins because CD measurements can be performed
with low concentration of protein (< 20 µg/ml) in a physiological buffer within a few hours
(Greenfield, 2006). The principle, applications, and analysis of CD data have been
intensively described by Greenfield (Greenfield, 2004; Greenfield, 2004; Greenfield, 2006;
Greenfield, 2006; Greenfield, 2006; Greenfield, 2015). Therefore, the basic principles of
CD spectroscopy and its applications in evaluating the secondary structure of the DREAM
protein as well as protein stability will be concisely highlighted in the next sections.
3.2.6.1 Basic principles of circular dichroism
A beam of light consists of electric and magnetic fields which oscillate in all planes
perpendicular to the propagating direction. Linearly polarized light, generated by passing
the light through a prism, has an electric field (E) that vibrates sinusoidally in a single plane
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(Kuball, 1999). If linearly polarized light passes through a birefringent material, the electric
field will be separated into two components of equal magnitude.
Superposition of these two sinusoidal waves with a phase-shift equal to a quarter
of its wavelength (λ/4) creates circular polarized waves, whose electric field rotates
circularly about their propagating direction while the vector retains constant magnitude
(Figure 3.7) (Berova et al., 2000). If observed from the front, the circularly polarized light
can be seen as the result of two vectors of equal length: one rotating clockwise (right
handed, ER) and the other rotating counter-clockwise (left handed, EL) as shown in Figure
3.7 (Greenfield, 2006).

Figure 3.7: Scheme representing linearly polarized light that is converted using a linear
polarizer and the circularly polarized light that is created using a quarter-wave (/4) plate.
Adapted from (Berova et al., 2000).
If the circular polarized light passes through an isotropic environment (achiral
samples), it will not experience any difference as shown in Figure 3.8A. However, when
circular polarized light passes through chiral samples such as amino acids (except glycine),
the EL and ER components are absorbed differently, resulting in an elliptical polarization
as shown in Figure 3.8B (Kelly et al., 2005).

60

The unequal absorption (ΔA) of the EL and ER components of circular polarized
light by chiral samples is known as CD. The CD instrument measures the difference in
absorbance (ΔA) between EL and ER components of circular polarized light (AL - AR)
described in equation 3.46 (Berova et al., 2000; Kelly et al., 2005).

A  AL  AR  ( L   R )  l  C    l  C

(3.46)

In this expression, parameters L and R are extinction coefficients of the sample for EL and
ER components, respectively. C is concentration of the sample, and l is the path length of
the optical cell.

Figure 3.8: A: when circularly polarized light passes through achiral samples, its E L and
ER components of are constant. B: when circularly polarized light passes through chiral
samples, EL (blue) and ER (green) components are absorbed in distinctly, resulting in
elliptical polarized light (red). Adapted from (Kelly et al., 2005).
The unit of CD is reported in degrees of ellipticity (), whose tangent is the ratio of
the minor (b) to the major (a) axis of ellipse as shown in Figure 3.8B, as a function of
wavelength (Berova et al., 2000).
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  32.98A

(3.47)

The molar ellipticity ([]) in deg cm2 dmol-1 is converted using equation 3.48
(Berova et al., 2000).

   100A

(3.48)

C l

In measurements of proteins or peptides, the molar concentration unit is calculated
using mean residue weight (MRW), which is the molar weight of the protein divided by
the number of amino acid residues per molecule. Thus, the residue ellipticity ([]MR) can
be reported in the unit of degrees cm2 dmol-1 by equation 3.49, where C is concentration
expressed in mg ml-1 (Berova et al., 2000).

 

MR



  MRW 

(3.49)

10  C  l

3.2.6.2. Information from CD studies of proteins
Analysis of a CD spectrum in the far and near UV regions provides information
about the proteins’ secondary and tertiary structures. Chromophores of interest in proteins
widely absorb circularly polarized light ranging from 190 nm to 650 nm (Berova et al.,
2000).
Information on the secondary structure of a protein can be characterized using a far
UV CD spectrum (between 190 nm and 250 nm). For instance, α-helical structure shows a
strong peak centered at 192 nm according to perpendicular     transition and
intensively negative peaks centered at 208 nm and 222 nm according to parallel    
transition and n    transition, respectively (Figure 3.9). On the other hand, β-sheet
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displays a positive peak at 196 nm according to n    transition and a negative peak at
218 nm according to     transition. The random coil shows a positive peak at 212 nm
and 195 nm according to the transitions of     , and n    , respectively (Figure 3.9)
(Berova et al., 2000).

Figure 3.9: Far UV CD spectra associated with various types of secondary structure of
proteins. Adapted from (Berova et al., 2000).
Aromatic side chains of phenylalanine, tyrosine, tryptophan, and disulphide bonds
absorb circular polarized light near the UV region ranging from 260 nm to 320 nm. A near
UV CD spectrum reflects the micro environment of aromatic amino acid side chains such
as the types of aromatic amino acids present, their mobility, the nature of their environment,
and their spatial disposition in the protein (Kelly et al., 2005). For instance, tryptophan
shows a fine peak between 290 nm and 305 nm, while tyrosine displays a broad peak
between 275 nm and 282 nm and a shoulder at 285 nm. Phenylalanine shows a sharp band
between 255 nm and 270 nm (Figure 3.10), whereas a disulphile bond has a weak and
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broad peak centered at 260 nm (Kelly et al., 2005). However, the actual shape and
magnitude of the near UV CD spectrum of a protein containing aromatic side chains
depends on the nature of their environment as previously mentioned (Kelly et al., 2005).

Figure 3.10: Near UV CD spectrum for various aromatic side chains of proteins. Adapted
from (Kelly, Jess et al. 2005).
Furthermore, cofactors such as heme and flavin only display a strong CD signal
when associated with protein partners. Thus, the CD signals in the appropriate spectral
region are excellent probes for cofactor association (Kelly et al., 2005). For instance, a CD
spectrum of hemeproteins shows a strong peak centered around 410 nm with other bands
in range from 350 to 650 nm depending on spin state and coordination of the heme iron
(Kelly et al., 2005).
3.2.6.3 CD measurements of DREAM protein
The CD measurements of DREAM protein were performed on a JASCO J-810 CD
spectropolarimeter (JASCO Inc. Easton, MD). A sample containing 40 µM of purified
DREAM protein was placed in a quartz cuvette with 0.1 cm path length. The far UV CD
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spectra were collected at 20 nm/min scan rate from 190 to 260 nm with 1 nm band width,
8 seconds response time, 1 nm data pitch, and 5 accumulations. The baseline was acquired
in the same way with buffer solution and the CD spectra of protein were corrected by
subtracting from the baseline. All the CD spectra were recorded at 16 °C.
3.2.6.4 Sample preparation for CD measurements
To investigate Mg2+ and/or Ca2+ induced conformational changes in DREAM
protein, Ca2+ and Ca2+Mg2+ bound DREAM samples were prepared by adding CaCl2 or
MgCl2 solutions to protein samples to a final concentration of 1 mM Ca2+ or 5 mM Mg2+.
Apo and Mg2+DREAM and DREAM-C samples were prepared by adding 1 mM EDTA
and 1mM EGTA with 5 mM MgCl2 to protein solutions, respectively. To minimize the
difference on CD spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ bound forms due to the
mismatch of protein concentration, four samples with identical protein concentration (40
µM) were prepared from an initial stock protein which was split into individual sample and
EDTA, EGTA, Mg2+, or Ca2+ was added in equal volumes.
Table 3.5: Volumes and concentrations of protein and chemicals used to prepare CD
samples of Apo, Mg2+,Ca2+, and Ca2+Mg2+ bound DREAM with identical concentration
of DREAM protein
Vol. of
500 µM
DREAM
(µL)

Vol. of
0.1 M
EDTA
(µL)

Apo

32

4

Mg2+

32

Ca2+

32

Ca2+Mg2+

32

DREAM
Samples

Vol. of
0.1 M
EGTA
(µL)

Vol. of
0.5 M
MgCl2
(µL)

Vol. of
0.1 M
CaCl2
(µL)

Vol. of
CD buffer
(µL)
364

4

4

4
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360
4

364

4

360

The buffer used for CD experiments contains 20 mM Tris-HCl pH 7.4, 1 mM DTT, and 10
mM LDAO freshly prepared in decalcified water. The concentrations and volumes of stock
DREAM protein, EDTA, EGTA, CaCl2, MgCl2, and CD buffer are listed in Table 3.5.
3.2.7 Isothermal titration calorimetry (ITC)
3.2.7.1 Principle of ITC
The technical details and the principle of isothermal titration calorimetry have been
described elsewhere (McKinnon et al., 1984; Jelesarov and Bosshard 1999; VelazquezCampoy et al., 2004; Privalov and Ebrary, 2012). Briefly, consider the simplest binding
reaction between a macromolecule (M) which has a single binding site for the ligand (L).
The association constant (Ka) is defined as:

Ka 

ML
M  L

(3.50)

In this expression, [ML], [M], and [L] are the corresponding concentrations.
The thermodynamic relationship between the association constant Ka and Gibbs
energy of association ΔG can be expressed in terms of enthalpy (ΔH) and entropy (ΔS)
change in the process displayed by equation 3.51.

G   RT ln Ka  H  TS

(3.51)

In this expression, R is the gas constant (1.9872 cal K-1 mol-1) and T is the absolute
temperature (in Kelvin).
Isothermal Titration Calorimetry is the only method that directly determines all the
thermodynamics parameters n (binding stoichiometry), Ka, and ΔH associated with binding
reaction in a single experiment. In addition, by performing the same experiment at several
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temperatures and constant pressure, the heat capacity, C, can be obtained from the slope of
enthalpy versus temperature plot.
Thermodynamic experiments were performed with VP-ITC MicroCalorimeter
(MicroCal LLC, Northampton MA). ITC measures heat released or absorbed by the
binding reaction of liquid samples. The VP-ITC instrument contains two identical coin
shaped reference and sample cells which are accessible from the top and enclosed in an
adiabatic outer shield as shown in Figure 3.11 (Ladbury and Chowdhry, 1996; Ladbury,
2004).
The reference cell is loaded with water or buffer and the sample cell is filled with
macromolecule solution (DREAM protein or DNA). These two cells are in contact with
the thermal reservoir and initially the temperature in both cells is maintained constant by
an electronic power source. Any change in temperature (ΔT) between the reference and the
sample cells results from either more or less heat being added to the sample cell which is
balanced by the power feedback mechanism. During operation, the precise amounts of
reactants (ligand) are titrated into the sample cell via the rotating microsyringe.
An injection of ligand (DREAM) into the macromolecule (DNA) sample results in
the release (exothermic) or absorption (endothermic) of heat within the sample cell which
causes a respectively negative or positive change in the power difference (DP) between
reference and sample cells. Since DP has units of power (Js-1), the time integral of the peak
of each injection gives thermal energy (ΔH) (Ladbury and Chowdhry, 1996; Ladbury,
2004). The ITC data are then analyzed using fitting models in Origin 7 software to calculate
binding stoichiometry (n), Ka, ΔH, and ΔS (MicroCal, LLC, Northampton, USA).
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Figure 3.11: Schematic representation of an ITC instrument. The sample cell and the
reference cell are kept at the same temperature. The reference cell is always kept at the
experimental temperature. The ligand component of the interaction is placed in the syringe
and the other in the cell. Upon the first titration (injection), the change in heat associated
with binding (endothermic or exothermic) results in a change in temperature in the sample
cell. A change in power (heat/s) is required to return the cells to identical temperatures (T)
(ΔT = 0). This change in power is recorded during injections. The binding isotherm and
the integrated thermogram are shown in the top right. Adapted from (Ladbury and
Chowdhry, 1996; Ladbury, 2004).
3.2.7.2 ITC data analysis
The heat released or absorbed (q) associated with each change of state after each
injection is measured. The heat, qi, is proportional to the increment in the concentration of
the complex [ML] (the parameters [ML], M, and L were defined previously in equation
3.50) in the calorimetric cell after each injection, i, as shown in equation 3.52.

qi  VH a MLi  MLi 1 

(3.52)
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In this expression, ΔHa is the enthalpy of binding and V is the calorimetric cell volume.
Equation 3.52 is used for a single titration (injection). However, an actual ITC experiment
is done with series of injections. Thus, equation 3.53a is used.

 K [ L]
K [ L] 
qi  H (T )V [ M T ] a i  a i1 
 1  K a [ L]i 1  K a [ L]i1 

(3.53a)

The isothermal parameters n, Ka, and ΔHa are directly obtained from the fitting
curve of an isotherm using equation 3.53b because the total concentration of ligand ([L])
and the ratio of total ligand relative to the total protein concentration ([M]) are known
(Figure 3.12).

[ LT ]  [ M T ]  1 / K a  ([ LT ]  [ M T ]  1 / K a ) 2  4[ LT ]
[ L]i 
2

(3.53b)

Figure 3.12: A schematic diagram illustrating isothermal parameters being generated
from an isotherm fitting curve.
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3.3 Methods used in chapter 4
3.3.1 Steady-state fluorescence measurements
Steady-state emission spectra were measured using a PC1 fluorimeter (ISS,
Champaign, IL). For steady-state emission measurements, 40 µM DREAM in 20 mM Tris
buffer pH 7.4, 1 mM DTT and 10 mM N,N-dimethyldodecylamine N-oxide (LDAO) was
placed in a 0.2 x 1.0 cm quartz cell and emission spectra were recorded using 295 nm
excitation. The spectra were corrected for the inner filter effect and the quantum yield for
W169 emission was calculated using equation 3.3 in section 3.2.5.2.2.1, and the quantum
yield of tryptophan ( = 0.13) as a standard (Lakowicz, 2006).
3.3.2 Fluorescence quenching
Quenching studies were performed by measuring W169 fluorescence emission
intensity in the range from 300 nm to 450 nm using an excitation wavelength of 295 nm,
after addition of small aliquots of freshly prepared 10 M acrylamide solution following 5
min incubation. The decrease in the emission intensity at 340 nm and 335 nm for the Ca2+
free and Ca2+ bound form of DREAM, respectively, was corrected for the inner filter effect.
The data were analyzed using the Stern-Volmer equation (equation 3.22 in section
3.2.5.2.4.1). Before determination of the Stern-Volmer constant, the emission spectra were
corrected for an inner filter effect as described above (Stegemeyer, 1969; Puchalski et al.,
1991).
3.3.3 Fluorescence lifetime measurements
The fluorescence lifetime measurements were performed on a ChronoFD
fluorimeter (ISS, Illinois-Champaign). The output of a 280 nm light emitting diode was
frequency modulated in the range between 5 to 250 MHz. The emission was collected
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through a 320 nm long pass filter (Andover Inc.) and detected using a photomultiplier tube
(PMT) (R928, Hamamatsu).

The fluorescence decay data were analyzed using a

combination of a single Gaussian distribution and a single discrete component according
to equations 3.54 and 3.55 (Togashi et al., 2010).


I (t )  a1   ( )

t / 

d  a2 exp  (t /  2 )

(3.54)

0

 ( ) 

1
1   1 2
exp[  (
) ]
2 w1
w1 2

(3.55)

In these expressions, a1 and a2 represent the amplitude of each term in equation 3.54 and
1 is the mean decay time of the Gaussian distribution with a width of distribution, w1,
whereas 2 is the lifetime of the discrete single exponential term. The data analysis was
performed using the Globals for Spectroscopy Software (Laboratory of Fluorescence
Dynamics, University of California, Irvine, USA). The reference compound used in
lifetime measurements was 2,5-diphenyloxazole (PPO) in ethanol ( = 1.40 ns) (Boens et
al., 2007).
The average lifetimes <> in were calculated using equations 3.56 and 3.57.

1 12   2 2 2
  
1 1   2 2

(3.56)
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In these expressions, 1 and 2 are fluorescence lifetime components corresponding to the
normalized pre-exponential decay α1 and α2 calculated from the exponential decay
fraction (fi) using equation 3.57, respectively.
3.3.4 DREAM stability studies
Guanidine hydrochloride (GuHCl) induced protein unfolding was monitored by
measuring the CD spectra as a function of increasing GuHCl concentration. Samples for
CD measurements were prepared by solubilizing 40 μM DREAM in 20 mM Tris-HCl, 1
mM DTT, 10 mM LDAO, pH 7.4, and incubated in the presence of GuHCl for 30 min prior
to CD measurements. The CD spectra were recorded using a Jasco J-810 CD-spectrometer
at 16 C. DREAM unfolding traces were analyzed as a two-step process involving an
intermediate state described by expression 3.58.
N  I U

(3.58)

In this expression, N corresponds to the native state, I to the partially unfolded intermediate
state, and U to the unfolded state.
The unfolding curves were fit using the following equation (Santoro and Bolen,
1988; Hung et al., 2003).
  (G I  mI [ D]  GU  mU [ D]) 
  (G I  mI [ D]) 
YN  YI exp 

Y
exp


 U
RT
RT




Y (GuHCl) 



  (G I  mI [ D]  GU  mU [ D]) 
  (G I  mI [ D]) 
1  exp 

  exp 
RT
RT





(3.59)

In this equation, Y(GuHCl) is the CD signal at 220 nm, ΔG is the standard free energy for
the unfolding, m is the dependence of the free energy on the denaturant concentration, T is
the temperature (T = 289 K), [D] is the concentration of GuHCl, and R is the ideal gas
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constant, R = 8.314 J K-1 mol-1. The parameters YN, YI, and YU represent the CD signal at
220 nm CD signal for each molecular species at zero GuHCl concentration.
3.3.5 Molecular dynamics simulations
The molecular dynamics (MD) simulations in this chapter were performed in
collaboration with Dr. Prem Chapagain in the Department of Physics, Florida International
University. The time series MD trajectories were obtained from explicit solvent, all-atom
simulations using the molecular dynamics simulation package NAMD (Phillips et al.,
2005) with the CHARMM27 force field (Brooks et al., 1983). The initial NMR structure
of the DREAM protein was obtained from the Protein Data Bank (PBS code: 2JUL (Lusin
et al., 2008)). The protein was solvated using the VMD package (Humphrey et al., 1996)
with a box cutoff set to 10 Å. This resulted in a simulation box of dimensions
81.5×68.6×58.1 Å. The solvated system was electrically neutralized by adding 12 Na+ ions
randomly in the bulk water using the VMD autoionize plugin. The particle mesh Ewald
method (van Dijk et al., 2006) was used to treat long-range interactions with a 12 Å
nonbonding cutoff. Energy minimization (50000 steps) was performed using the conjugate
gradient and line search algorithm. The system was then heated for 90 ps with a linear
gradient of 20 K/6 ps from 20 to 300 K. At 300 K, the system was equilibrated for 910 ps
with a 2 fs integration time step in the NVT (constant number, volume, and temperature)
ensemble. Langevin dynamics was used to maintain the temperature at 300 K. The
production run was 67 ns using NVT dynamics with 2 fs time steps. The same procedure
was used to setup another system of a DREAM protein without calcium ions to simulate
the Apo state of the protein. An additional 270 ns simulation was conducted for calcium
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bound DREAM using AMBER03 force fields with a 10 Å PME cut off and 1.25 fs
integration time, all other parameters being identical.
3.4 Methods used in chapter 5
3.4.1 Fluorescence steady-state measurements
Samples for fluorescence measurements were prepared by diluting DREAM-C in
20 mM Tris-HCl, pH 7.4, and 1 mM DTT. Appropriate volume of 1 mM EDTA, 5 mM
Mg2+, 1 mM EGTA, or 1 mM Ca2+, was added into 40 µM DREAM-C samples to prepare
Apo, Mg2+, Ca2+, or Ca2+Mg2+ bound protein.
Steady-state emission spectra of W169 and acrylamide quenching measurements
were carried out similar to that performed with DREAM wild-type (sections 3.2.3).
Emission spectra of 1, 8-ANS and nile red in the presence of DREAM-C were
measured using 370 nm and 470 nm excitation, respectively. The concentration of 1, 8ANS (ε372nm = 7,800 M-1cm-1) (Diwu et al., 1997) and nile red (ε552nm = 19,600 M-1cm-1 in
DMSO) (Castro et al., 2005) were determined spectrophotometrically. Equilibrium
dissociation constants for 1,8-ANS or nile red were obtained by titrating concentrated
protein into 1,8-ANS or nile red solution, while keeping the concentration of the
fluorescence probe constant. Dissociation constants were recovered by nonlinear fit of the
titration curves using a non-cooperative single binding site Hill equation as described in
reference (Hawe et al., 2011).
3.4.2 Fluorescence lifetime measurements
Frequency-domain fluorescence lifetime and anisotropy decay measurements were
performed using a ChronosFD spectrofluorometer (ISS, Champaign, IL). The frequency
modulated output of a 280 nm laser diode was used as excitation light in Trp lifetime

74

measurements and the emission was collected through a 320 nm long pass filter. 2,5diphenyloxazole (PPO) in ethanol ( = 1.40 ns) was used as a lifetime reference (Boens et
al., 2007). The lifetime of 1,8-ANS and nile red were determined using a frequency
modulated 370 nm and 470 nm laser diode as an excitation source, respectively, and
emission was collected using 400 - 600 nm and 550 - 700 nm band pass filters, respectively.
The fluorescence lifetime of 1,4-bis(5-phenyloxazol-2-yl)benzene (POPOP) in ethanol (
= 1.35 ns) (Boens et al., 2007) and rhodamine B in water ( = 1.7 ns) (Boens et al, 2007)
were employed as lifetime references for 1,8-ANS and nile red, respectively. Multiple
lifetime data from at least three different protein preparations were simultaneously fit using
the global analysis approach with the lifetime parameters set as linked variables (Global
WE software, Laboratory of Fluorescence Dynamics).
The time-resolved anisotropy measurements of 1, 8-ANS:DREAM-C complexes
were performed as described previously(Gonzalez and Miksovska, 2014). A double
associative decay model was used to determine the rotational correlation times. The 2
parameter and residuals were used as criterion for goodness of fit for all the models used.
3.4.3 DREAM-C stability measurements
Guanidine hydrochloride (GuHCl) stock solution was prepared by dissolving
GuHCl in 20 mM Tris-HCl, pH 7.4, and 1 mM DTT buffer to obtain a final concentration
of GuHCl of 8.0 M. Thirty eight samples for each form of Apo, Mg2+, Ca2+, or Ca2+/Mg2+
bound DREAM-C at a constant protein concentration (40 µM) and various GuHCl
concentrations (0.2 - 7.4 M) were prepared for unfolding measurements. To ensure that an
unfolding equilibrium was reached, samples were incubated at 20 oC for 30 min prior to
each measurement.
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Far UV-CD spectra were recorded on JASCO J-810 CD spectropolarimeter
(JASCO Inc. Easton, MD) from 260 to 200 nm using 0.1 cm path length quartz cell. Protein
unfolding curves were obtained by monitoring changes in ellipticity at 220 nm as a function
of GuHCl concentrations. Unfolding curves were analyzed using two-state unfolding
model N ↔ U (Santoro and Bolen, 1988; Hung et al., 2001).


  GU  mU D  
  GU  mU D 
Yobs  YN  YU exp 
 1  exp 

RT
RT

 




(3.60)

In this expression, the observed CD signal (Yobs) is expressed in terms of the signal of the
native state (YN) and unfolded state (YU). ΔGU represents the unfolding free energy change,
mU describes the free energy dependences on the denaturant concentration ([D]), R is the
universal gas constant (1.987 cal mol-1 K-1), and T is the temperature.
The fraction of the native state was determined from the unfolding equilibrium
constant using equations 3.61 and 3.62.

  GU 
KU  exp 

 RT 

(3.61)

1
(1  KU )

(3.62)

fN 

3.4.4 Isothermal Titration Calorimetry (ITC) measurements
Thermodynamic parameters for Ca2+ and Mg2+ binding to DREAM-C were
determined using a VP-ITC titration calorimeter (Microcal Inc. Northampton, MA). ITC
buffer (20 mM Tris-HCl, pH 7.6, 0.5 mM DTT, and 150 mM NaCl) was prepared using
decalcified water and filtered through Chelex-100 resin (Bio-Rad). The protein stock
solution was dialyzed against ITC buffer overnight. To minimize artifacts from
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mismatched buffers, 1.2 mM CaCl2 and 5 mM Mg Cl2 solutions were prepared by diluting
0.1 M CaCl2 standard solution and 1.0 M MgCl2 solution in the final ITC buffer,
respectively. All buffer solutions were stored in plastic bottles previously boiled in
decalcified water. The cell sample and injection syringe were extensively cleaned with
decalcified water and then with ITC buffer. The reaction cell was loaded with 70 µM
DREAM-C solution (1.40 mL) and the concentration of Ca2+ or Mg2+ in syringe (297 µL)
was 1.2 mM or 5.0 mM, respectively. For Ca2+ binding to DREAM-C in presence of Mg2+,
1.2 mM solution of Ca2+ was titrated into 70 µM DREAM-C that was pre-saturated with 5
mM Mg2+. Twenty eight aliquots (10 µL each) of Ca2+ or Mg2+ solutions were titrated into
protein solution with 2 min intervals between injections. Parallel experiments were carried
out for titration of Ca2+ or Mg2+ solution into the dialysate buffer as a control for heats of
dilutions of ligand. The temperature was kept at 25 oC and the stirring speed was kept at
307 rpm. ITC data were analyzed using Origin 7 ITC data analysis software (OriginLab
Corp. Northampton, MA). The data obtained for Ca2+ binding to DREAM-C and
Mg2+DREAM-C were analyzed using a two binding sites model as described previously
(Jelesarov and Bosshard, 1999; Martinez et al., 2013).
3.5 Methods used in chapter 6
3.5.1 Sample preparation
Fluorescence samples were prepared from stock protein diluted in a buffer
containing 20 mM Tris-HCl, pH 7.4, and 1 mM DTT. Presenilin 1 C-terminal fragment
(PS1-CTF) peptides were freshly solubilized in the same buffer and stored at 4 ºC. The
peptide concentration was determined spectrophotometrically using extinction coefficient
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of fluorescein isothyocyanate (FITC), ε493nm = 75,000 M-1 cm-1. Absorption spectra were
measured using a single beam spectrophotometer (Cary-50, Varian).
3.5.2 Fluorescence steady-state measurements
Fluorescence steady-state anisotropy measurements were performed on a
ChronosFD spectrofluorometer (ISS Inc., Champaign, IL). The samples were excited at
470 nm and the emission was collected using 500-700 nm band pass filters (Andover corp.
Salem, NH). Titrations of HLβ and HL9 into DREAM were conducted in a 2 mm x 10
mm quartz cuvette with excitation along the short path-length. Equilibrium dissociation
constants (Kd) were determined by a non-linear fit of the change in fluorescence anisotropy
using equation 1 (Leon et al., 2009).
A 

F
K d  nPt  Lt 
2 

K d  nPt  Lt 2  4nPt Lt 



(3.63)

where ∆A is change in fluorescence anisotropy, Kd is dissociation constant, n is the number
of binding sites, Pt is the total DREAM protein concentration, Lt is total PS1 peptide
concentration, and F is the fluorescence anisotropy scaling factor.
For PS1 peptide displacement studies, the NS5806 drug compound (Calloe et al.,
2009) was titrated into Ca2+DREAM and PS1-HL9 complex. The dissociation constant of
NS5806 for Ca2+DREAM was recovered using a single binding site displacement equation
3.64 (Epps et al., 1995; Chuang et al., 2008; Gonzalez et al., 2014).
Anisotropy measured
 
Anisotropy max

 [ Lt ]


Ki  Lt 1  I t 
Kd 
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(3.64)

In this expression, ΔAnisotropy is change in fluorescence steady-state anisotropy.
Parameters α and β are proportionality constants, Ki is the dissociation constant of PS1HL9 and Ca2+DREAM (measured separately, mentioned in previous sections), It is the total
concentration of NS5806 and Kd is its dissociation constant.
3.5.3 Fluorescence time-resolved anisotropy measurements
Anisotropy decay was measured using a 470 nm laser diode, and the emission was
collected through 500-700 nm band pass filters (Andover corp. Salem, NH). Anisotropy
data were analyzed using a double-exponential decay model (VINCI software, ISS Inc.,
Champaign, IL) described by equation 3.44 or 3.45 in section 3.2.5.3, assuming a spherical
shape of DREAM-peptide complex (Jameson, 2014).
3.5.4 Fluorescence stop-flow kinetics
The kinetics of DREAM binding to HL9 were measured with a ChronosFD
spectrofluorometer coupled to a SFA-20 rapid stopped-flow apparatus (TgK Scientific,
Bradford-on-Avon, UK). The cell was illuminated with 295 nm excitation and fluorescence
emission at 520 nm due to fluorescence resonance energy transfer (FRET) from the single
tryptophan residue (W169) in DREAM (donor) to FITC (acceptor) labeled on HL9 was
monitored. In control experiments, the buffer (20 mM Tris-HCl, pH 7.4, 1 mM CaCl2, and
1 mM DTT) was used instead of Ca2+DREAM protein. Kinetics data were analyzed using
single and double exponential decay models (Origin 8 software, OriginLab Corp.
Northampton, MA).
3.5.5 Computational protein-protein docking study
The NMR structures of Ca2+ bound DREAM (PDB: 2JUL, molecule 1) and PS1CTF (PDB: 2KR6, molecule 1) were used as receptor and ligand inputs, respectively. The
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inter-protein complex of DREAM and PS1-CTF was performed on the ClusPro 2.0 proteinprotein docking server (Kozakov et al., 2006; Kozakov et al. 2013; Comeau et al, 2004;
Comeau et al., 2004). In the first step, ClusPro 2.0 program uses PIPER, a fast Fourier
transform based docking program, to calculate a pairwise interaction potential as part of its
scoring as shown in equation 3.65.

E  Eattr  w1Erep  w2 Eelec  w3 E pair

(3.65)

where Eattr and Erep are the attractive and repulsive forces contributing to the van der Waals
interaction energy (Evdw), whereas Eelec and Epair are electrostatic and desolvation energies,
respectively. The coefficients w1, w2, and w3 are the weights of the corresponding energetic
terms (Kozakov et al., 2006; Kozakov et al., 2013). After performing PIPER docking, the
best 1,000 energy structures were clustered for ranging by using pairwise root mean square
deviation (RMSD) as the distance measured (Comeau et al., 2004). The biophysical
meaning of clustering is to isolate energy basins of highly populated energy areas (Kozakov
et al., 2013). Finally, the output clusters are displayed in scoring schemes namely balanced,
electrostatic-favored, hydrophobic favored, and van der Waals and electrostatics
complexes. There are several available protein-protein docking programs such as ZDOCK
(Pierce et al., 2014), RosettaDock (Lyskov et al., 2008), and HADDOCK (de Vries et al.,
2010). However, ClusPro 2.0 was chosen for performing Ca2+DREAM and PS1 docking
as it uses the PIPER algorithm to rapidly evaluate protein-protein interactions. In addition,
since experimental results showed that interactions between Ca2+DREAM and PS1-HL9
are driven by not only electrostatic interactions but also hydrophobic interactions, various
post-docking processing methods available in ClusPro 2.0 score the resultant complexes of
Ca2+DREAM-PS1-CTF in a manner that can be comparable with experimental data. The
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predicted Ca2+DREAM-PS1-CTF structure was analyzed using the YASARA Structure
program version 13.1.25 (Krieger et al., 2002) and the academic version of PyMOL 1.7.4
software (Schrodinger, 2015).
3.6 Methods used in chapter 7
3.6.1 Tryptophan steady-state emission measurements
The fluorescence emission of tryptophan (W169) in DREAM-EF hand mutants
D150N, E186Q, and E234Q was measured as described for DREAM wild-type in chapter
4 (section 3.3.1).
3.6.2 Tryptophan fluorescence lifetime measurements
The frequency-domain fluorescence lifetime measurements of W169 in DREAMEF hand mutants D150N, E186Q, and E234Q and fluorescence data analysis were carried
out as described for DREAM wild-type in chapter 4 (section 3.3.3).
3.6.3 Fluorescence anisotropy decay measurements
Oligomeric states of the DREAM-DNA complex were resolved by fluorescence
anisotropy decay measurements. Ethidium bromide was (EtBr) used as a fluorescence
probe since its fluorescence emission and lifetime significantly increase in the presence of
double stranded DNA (Garbett et al., 2004; Lakowicz, 2006). Time-resolved anisotropy
was measured using a 470 nm laser diode and the emission was collected through 500 -700
nm band pass filters (Andover corp. Salem, NH). Anisotropy decay data were analyzed
using equations 3.44 and 3.45 as described previously in section 3.2.5.3 for a mixed system
of free DNA and the DNA bound DREAM complex, assuming a spherical shape for both
systems. (VINCI software, ISS Inc., Champaign, IL) (Jameson, 2014).
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3.6.4 Circular dichroism measurements of DREAM mutants
Circular dichroism (CD) measurements of DREAM EF-hand mutants were
performed with a Jasco J-815 CD spectropolarimeter. All CD spectra of DREAM mutants
were measured at 40 μM protein concentration through a 1 mm path in 20 mM Tris-HCl
buffer, pH 7.4, 1 mM DTT, and 10 mM LDAO. All measurements were conducted at 16
°C, and each CD spectrum represents an average of 5 scans.
3.6.5 Thermodynamics of DREAM and DNA complex
Isothermal titration calorimetry (ITC) was employed to measure the
thermodynamic interactions between DREAM/DREAM mutants and DNA. These
measurements were performed using a VP-ITC MicroCalorimeter (MicroCal LLC,
Northampton MA). The ITC buffer (20 mM Tris-HCl, 0.5 mM DTT, and 10 mM LDAO,
pH 7.4) was prepared using decalcified water filtered through a Chelex-100 resin (BioRad) column. Purified DREAM and DREAM EF-hand mutants were dialyzed overnight
against the ITC buffer, and the DNA sample was prepared in the ITC buffer (20 mM TrisHCl, 0.5 mM DTT, and 10 mM LDAO, pH 7.4) in order to minimize artifacts due to
mismatched buffers. The cell sample and injection syringe were extensively cleaned with
decalcified water and then with the ITC buffer. The reaction cell was filled with 15 µM
dsDNA solution (1.40 mL), and the injection syringe was loaded with 500-550 μM
DREAM protein solution (297 µL). For measurements of Mg2+DREAM and Ca2+DREAM
binding to DNA, both DREAM and DNA samples were prepared in the presence of 100
μM Mg2+ and 1 mM Ca2+, respectively. Twenty nine aliquots (with injection volume set to
4 µL for the first injection, and 10 µL for the following injections) of DREAM were titrated
into DNA solution with 2 min intervals between injections. The temperature was kept at
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25 oC and the stirring speed was set at 307 rpm. Parallel experiments were carried out for
titration of DREAM into the dialysate buffer as a control for the heats of dilution. ITC data
were analyzed using the Origin 7 software package provided by the manufacturer
(OriginLab Corp. Northampton, MA). The first titration point from each ITC experiment
was deleted when fitting to binding models due to possible diffusive mixing of protein near
the tip of the syringe. The data obtained for DREAM and DREAM EF-hand mutants
binding to DNA were analyzed using a two binding sites model, except for the analysis of
Ca2+DREAM binding to DNA which was fitted using a sequential binding sites model
(Jelesarov and Bosshard, 1999; Martinez et al., 2013).
3.6.6 Molecular dynamics simulations and modeling of DREAM and
DREAM mutants
Since 3D structures of both Apo and Mg2+DREAM are not available, the MD
simulation structure of ApoDREAM was constructed from the NMR structure of
Ca2+DREAM (PDB: 2JUL, molecule #1 (Lusin et al., 2008)) by deleting the two Ca2+
atoms. In addition, the structure of Mg2+DREAM was also constructed from the NMR
structure of Ca2+DREAM (PDB: 2JUL, molecule #1 (Lusin et al., 2008)) with the Mg2+
binding coordination at EF-hand 2 (residues 139 - 150) being replaced by the Mg2+ binding
coordination (residues 116 - 127) from the NMR structure of Mg2+ bound calcium-andintegrin-binding protein 1 (Mg2+CIB1, PDB entry: 2L4I) (Huang et al., 2011). The other
mismatched residues within the Mg2+ binding loop of Mg2+CIB1 were also replaced with
the corresponding residues from the Mg2+ binding loop of DREAM. The coordinative
binding of Mg2+ in the structure of Mg2+CIB1 was chosen because the critical residues at
positions 1, 3, 5, and 12 in the EF-hand Mg2+ binding loop of CIB1 (DxDxDxxxxxxD; x
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is any amino acid) are close in homology to that of DREAM EF-hand 2 (DxDxNxxxxxxD;
x is any amino acid). In addition, I observed that the geometry of the Mg2+ binding loop in
CIB1 is very close to that of DREAM protein. Moreover, the structures of DREAM EFhand mutants (D150  N, E186  Q, and E234  Q) were constructed using the plugin
mutagenesis feature in the CHARMM-GUI web server (Jo et al., 2008) using the NMR
structure of Ca2+DREAM (PDB: 2JUL, molecule #1 (Lusin et al., 2008)) as the initial
structure. The CHARMM-GUI web server was utilized to prepare the initial coordination
files for MD simulations (Jo et al., 2008). The DREAM models were solvated using TIP3P
waters, in a rectangular box with 10 Å distance between edges of a biomolecule and those
of the solvation box. The system was neutralized with 0.15 M NaCl (59 Na+ ions and 39
Cl- ions), and the initial configuration of ions was determined through short Monte Carlo
(MC) simulation (2000 steps) using a primitive model (Jo et al., 2008). The simulations
were performed under periodic boundary conditions (PBC) and with the Particle-Mesh
Ewald (PME) method (van Dijk et al., 2006) with a 12 Å nonbonding cutoff (Jo et al.,
2008). Energy minimization (50000 steps) was performed using the SHAKE algorithm,
while the system was set at a temperature of 303.15 K and a 2 fs time step in NVT (constant
volume and temperature) (Jo et al., 2008). The production run was 100 ns using NPT
(constant pressure and temperature) dynamics with 2 fs time steps (Jo et al., 2008). All the
bond lengths involving hydrogen atoms were fixed for both energy minimization and
production runs. Simulations were carried out using the NAMD (Phillips et al., 2005)
simulation software and the CHARMM27 force field with CMAP corrections (Mackerell,
2004; Bjelkmar et al., 2010). All simulations of ApoDREAM, ApoDREAM-D150N,
Mg2+DREAM, Ca2+DREAM, Ca2+DREAM-E186Q, and Ca2+DREAM-E234Q were

84

performed on an Intel i7-4770 and GTX-TITAN black super-clocked (1072 MHz) system
using NAMD 2.11 (NVIDIA CUDA acceleration) (Phillips et al., 2005). Trajectory files
were saved every 20 ps. The frames of all simulations of Apo and Ca2+DREAM were then
compared with that obtained for Apo and Ca2+DREAM from our previous studies in
chapter 4 (Pham et al., 2015) to verify accuracy of the simulations.
3.6.7 Analysis of MD simulations
Calculations of root mean square deviations (RMSD) and root mean squared
fluctuations (RMSF) of DREAM protein were performed using VMD 1.9.2 software
(Humphrey et al., 1996). The RMSD was calculated for the alpha carbons (Cα) of the whole
protein (residues 76 to 256) using the equilibrated structure of the corresponding DREAM
as the frame of reference. The RMSF were calculated using an average trajectory
simulation of all alpha carbons of DREAM protein between 20 and 100 ns simulation time
(to skip the relaxation period at the beginning of the simulation time (0 - 20 ns)).
Conformational dynamics of DREAM and DREAM mutants were analyzed using dynamic
network analysis of 100 ns simulation trajectory. The dynamical network analysis was
performed using the VMD plugin Network Setup feature (Sethi et al., 2009). In dynamic
network analysis, each node represents the alpha carbon of an amino acid, and the edges
connecting non-neighboring alpha carbons represent atoms which interacted over 75 % of
the time within 4.5 Å. The thickness of the edges represents the degree of correlation
between the nodes. These networks were then classified into communities of dynamically
coupled residues by using the Girvan-Newman algorithm (Girvan and Newman, 2002).
Within a given community, the amino acids are more correlated to each other than to the
amino acids in the neighboring communities. The connections between communities
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represent dynamic hubs, which reflects the dynamic fluctuations from the most propagated
community to the rest.
3.6.8 Computational docking of DREAM and DNA interaction
The initial structure of ApoDREAM protein was obtained from 100 ns MD
simulation of ApoDREAM. The standard B-DNA conformation of the DRE sequence (5’GAAGCCGGAGTCAAGGAGGCCCCTG-3’) of prodynorphin gene was built using a
3D-DART (3DNA-Driven DNA analysis and rebuilding tools) modelling server (van Dijk
and Bonvin, 2009). There are several available programs including 3D-DART that convert
the sequence of DNA into a 3D structure using regular nucleotide building blocks (Dixit
and Beveridge, 2006; Lu and Olson, 2003; van Dijk and Bonvin, 2009). The high accuracy
of these programs was discussed elsewhere (van Dijk and Bonvin, 2009). In this study, 3DDART program was chosen because the server not only returns the 3D-structural models
of the double stranded DNA, but it also allows us to generate the DNA restraint file for
DREAM and DNA docking input used in the HADDOCK (High Ambiguity-Driven
DOCKing) program (van Dijk and Bonvin 2009; de Vries et al., 2010; Wassenaar et al.,
2012). The ambiguous interaction restraints (AIR), including the active residues and
nucleotides in DREAM and DNA located at the predicted interaction interface, were
determined based on experimental results previously published (Carrion et al. 1999; Ledo
et al., 2000; Lusin et al., 2008). The HADDOCK 2.2 web server was used to build models
for ApoDREAM-DNA complexes from the unbound structures of ApoDREAM and
double stranded DNA (Wassenaar et al., 2012; de Vries et al., 2010). The HADDOCK
docking program was run with default settings. Residues K87, K90, K91, R98, K101,
R160, and K166 in the ApoDREAM protein and nucleotides G10, T11, C12, A13, T38,
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G39, A40, and C41 in the double stranded DNA were designated as active restraints to
drive the docking. Passive residues and nucleotides, defined as the solvent accessible
neighbors of active residues, were automatically determined by the HADDOCK program
(Wassenaar et al., 2012; de Vries et al., 2010).

Initially, 1000 complexes of the

ApoDREAM and DNA were generated by performing rigid-body docking and the lowest
rigid body score (R.B. score), calculated using equation 3.66, was selected (van Dijk and
Bonvin, 2009).

R.B.score  1.0 * Elec  1.0  vdW  0.05 * BSA  1.0 * Dsolv  1.0 AIR

(3.66)

In this expression, the parameters Elec, vdW, BSA, Dsolv, and AIR are intermolecular
electrostatic, van der Waals, buried surface are, desolvation, and AIR energies,
respectively. Following rigid-body docking, 200 complexes with best rigid-body scores
were selected for further refinement using the semi-flexible docking, in which side chains
and the backbone of the protein at the predicted interface and the entire DNA were allowed
to move (van Dijk and Bonvin 2009). Finally, water refinement of the ApoDREAM-DNA
complex was performed with 100 MD heating steps at 100, 200, and 300 K followed by
sampling steps at 300 K and 500 MD cooling steps at 300, 200, and 100 K in a water box
(van Dijk and Bonvin, 2009). The final HADDOCK score (H.D. score) was recalculated
using equation 3.67 (van Dijk and Bonvin, 2009).

H .D.score  1.0 * Elc  1.0 * vdW  1.0 * Dsolv  1.0 * AIR

(3.67)

The parameters Elc, vdW, Dsolv, and AIR were defined previously in equation 3.66.
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3.7 Materials and methods used in chapter 8
3.7.1 Materials
Chemicals such as urea, Tris buffer and proteins including horse heart myoglobin
(Mb) and microperoxidase 11 (MP-11) were purchased from Sigma-Aldrich Chemical Co
(St. Louis, MO). Bis (2-ethylhexyl) sulfosuccinate sodium salt (AOT) and sodium
dithionite were purchased from Fluka Chemical Corp (Milwaukee, WI). ACS grade
heptane (C7H16) was purchased from Fisher Scientific (New Jersey 07410). Argon (Ar) and
carbon monoxide (CO) gases are in pressure bottles and purchased at purities at 99.97%.
3.7.2 Sample preparation
A solution of 0.1 M AOT reverse micelles was prepared by adding AOT to the
mixture of heptane and varying amounts of water. The AOT mixture was stirred until the
solution became transparent. The AOT sample was placed into a 1 x 1 cm quartz cuvette,
sealed with a rubber septum cap and purged with Ar gas for 20 min. Next, the desired
volume of a stock solution of horse heart Fe2+Mb or Fe2+MP-11 in 100 mM Tris buffer, pH
7.0, was anaerobically injected into the AOT reverse micelle solution to achieve a final
value of wo = 40 in a total solution volume of 3 mL. The sample was then flushed with CO
for at least 5 min and allowed to equilibrate for an additional 20 min. Complete formation
of CO-Mb or CO-MP-11 was optically determined.
3.7.3 Absorption measurements
The UV/Vis absorption spectra were measured using a spectrophotometer
(Varian/Carry 400, Varian Instruments, Walnut Creek, CA) from 350 to 700 nm using 1
nm steps, 0.5 s/step and an auto adjusted baseline. The UV/Vis spectra provide
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verifications for the formation of the deoxy form (ferrous heme iron) and CO ligated
formation by visual inspection absorbance at the Soret band.
3.7.4 Transient absorption
The ligand (CO) dynamic rebinding kinetics was studied by employing a homebuilt transient absorption instrument described in detail in (Miksovska et al., 2006, Larsen
et al., 2011). Briefly, the photodissociation was trigged by a 532 nm, 7 ns width, and 1 Hz
repetition pulse initiated by a double Nd:YAG laser pulse (Minilite II, Continuum). The
probe beam generated from the 150-W Xe arc lamp (Thermo-Oriel) was passed through a
monochromator, and guided through the sample housed in a 1.0 cm variable temperature
controlled cell holder (Quantum Northwest). The emerging light was focused on the slit of
the second monochromator (Micro HR, Jobin Yvon) and detected by a photomultiplier tube
(PMT) connected to a high-gain amplifier. The photocurrent was converted into voltage
and digitized by digital oscilloscope (Tektronix). Data were analyzed using OriginPro 8.0
software (OriginLab Corpration).
3.7.5 Photoacoustic calorimetry
The experimental setup has been described previously (Larsen et al. 2011). Briefly,
a 7 ns pulse from a frequency doubled Nd:YAG laser (532 nm, Continuum Minilite II
Nd:YAG laser) is passed through a pin-hole and directed onto the face of a temperature
regulated cell holder (Quantum Northwest, temperature controled to within 0.01oC)
adapted for a 2MHz PZT piezoelectric transducer which is coupled to the face of the quartz
sample cell via a thin layer of vacuum grease. The signal is amplified using a Panametrics
model 5978 ultrasonic preamplifier and digitized by a Picoscope 3200 Oscilloscope
running on a desktop PC. Deconvolution of the acoustic waves is performed with software
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developed by Dr. Randy Larsen in the department of Chemistry, University of South
Florida (LarsenWare2009V1). Acoustic simulation software is also available. The
LarsenWare2009V1 can deconvolute both single exponential decay models as well as
stretched exponential decays.
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4. CALCIUM AND MAGNESIUM MODULATE CONFORMATIONAL
DYNAMICS AND STABILITY OF DOWNSTREAM REGULATORY ELEMENT
ANTAGONIST MODULATOR
(The work described in this chapter was published in K., Pham, G., Dhulipala, W. G.,
Gonzalez, B. S., Gerstman, C., Regmi, P.P., Chapagain, J., Miksovska (2015), Protein
Sci.,24(5):741-751)
4.1 Background and significance
The EF-hand motif Ca2+ binding proteins are involved in the regulation of
numerous intracellular processes ranging from gene expression, cell division, cell growth,
as well as apoptosis. All members of this family carry at least one pair of EF-hand calcium
binding sites that bind calcium with equilibrium affinity constants ranging from 104 M in
the case of S100 proteins, to 108 M as found for parvalbumin (Gifford et al., 2007). The
protein affinity for Ca2+ is fine-tuned by the amino acid sequence of the EF-hand binding
site, overall structure of the Ca2+ sensor, and interactions with other intracellular partners.
Despite relatively high sequence similarities, EF-hand proteins exhibit large structural
diversity in the Apo and Ca2+ bound forms that is essential for specific interactions with
intracellular partners and functional diversity (Bhattacharya et al., 2004).
Depending on the amino acid sequence, structural and functional properties, and
the organization of the N- and C- terminal domains, the intracellular EF-hand proteins can
be divided into three groups. The members of the first group that includes calmodulin and
troponin C have two independent domains connected by a flexible -helical linker.
Calcium association leads to a substantial reorganization of the C- and N-terminal domains
and exposure of hydrophobic patches on the protein surface. In calmodulin, the highly
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dynamic protein structure enables specific interactions with a large number of intracellular
targets (Bhattacharya et al., 2004). The second group of EF-hand proteins includes dimeric
S100 proteins. Unlike the calmodulin family, structural changes linked to Ca2+ binding to
EF-hands in S100 proteins are relatively modest and result in exposure of a wider and
flatter hydrophobic crevice on the protein surface that facilitates binding to intracellular
partners (Chazin, 2011).
The third group of EF-hand proteins consists of neuronal calcium sensors (NCS)
that are predominantly expressed in neuronal tissue where they regulate numerous
intracellular processes including vision transduction, potassium voltage channel kinetics,
and DNA expression (Burgoyne and Weiss, 2001; Burgoyne, 2007; Ames and Lim, 2012).
All members of NCS family carry four EF-hand binding sites, although only two or three
EF-hands are active and bind bivalent ions with a high affinity (Ames and Lim, 2012).
Some members of the NCS family undergo post-translational modifications such as fatty
acid esterification at the N-terminus. The presence of the fatty acid modulates the range of
Ca2+ triggered conformational switching and facilitates protein association to the
membrane (Haynes and Burgoyne, 2008). The C- and N-terminal domains in NCS are each
organized in a globular arrangement and are connected by a short U-shaped linker with a
solvent-exposed hydrophobic groove stretching between the C- and N-terminal domains
(Ames and Lim, 2012).
The DREAM protein, also known as KChIP3 or calsenilin, belongs to the subfamily
of NCS potassium channel interacting proteins (KChIP), which includes three additional
members (KChIP1, KChIP2, and KChIP4) (An et al., 2000). All members share a
conserved region of 180 residues along with highly variable N-termini of 35 to 100 residues
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(Schwenk et al., 2008). In DREAM, EF-hand 1 has no function due to the conserved
residues C104 and P105 on the first Ca2+ binding loop which prevent this site from binding
to Ca2+ and/or Mg2+. On the other hand, the canonical EF-hand 3 and EF-hand 4
functionally bind Ca2+ with a high affinity (Kd ~ 1 - 10 µM) and EF-hand 2 structurally
binds Mg2+ (Kd ~ 14 µM) (Osawa et al., 2005). KChIP1, DREAM, and KChIP4 are
predominantly expressed in the brain where they regulate gating properties of Kv4.3
channels and the surface expression of the Kv4.3 complex (Jerng et al., 2004; Zhou et al.,
2004). Unlike other members of the KChIP subfamily, DREAM interacts with numerous
intracellular partners including calmodulin (Ramachandran et al., 2012), DNA (Carrion et
al., 1999), presenilin (Buxbaum et al., 1998; Jo et al., 2003; Jo et al., 2005; Buxbaum,
2004), and CREB/CREM transcription factors (Ledo et al., 2000; Ledo et al., 2002).
The role of Ca2+ in regulating DREAM functions and the structural basis of
DREAM interactions with multiple partners are not fully understood. Although the solution
structure of Ca2+ bound DREAM (residues 76 - 256) is known (Lusin et al., 2008) as well
as the solution structure of the C-terminal domain (residues 161 - 256) of Ca2+ bound
DREAM (Yu et al., 2007), it remains unclear how the Ca2+/Mg2+ association to the EFhands alters the structural properties of DREAM. Considering the large number of
DREAM interacting proteins, understanding the structural diversity could provide
important insight into the relationship between the sequence, structure, and target diversity
of DREAM and NCS proteins in general. Since the unique tryptophan (W169) positions
between the N- and C-terminal hydrophobic clusters in DREAM (Figure 4.1) is ideal for
monitoring conformational response to changes in Ca2+/Mg2+concentration, I have
combined time-resolved fluorescence, CD spectroscopy, and molecular dynamics
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simulations to probe the dynamics and structural diversity of DREAM under various
conditions. The heterogeneous W169 emission decay indicates that DREAM adopts
multiple conformations in the apo and Ca2+ bound forms. Ca2+ binding to EF-hands is
associated with an increase in protein rigidity and a decrease of W169 solvent exposure.
DREAM unfolds through a transition state that is populated at a GuHCl concentration
around 4.5 – 5.0 M. The transition state is stabilized by Ca2+ binding to EF-hands 3 and 4
in DREAM. The presence of Mg2+ stabilizes the native structure of Ca2+ bound DREAM
with respect to the transition state.

Figure 4.1: The aromatic clusters identified in DREAM C-terminus (grey solid surface)
and N-terminus (blue solid surface). EF-hand 1 in DREAM is shown in cyan, EF-hand 2
in green, EF-hand 3 in yellow, EF-hand 4 in orange, W169 in wireframe surface, and
calcium ions shown as yellow spheres
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4.2. Results
4.2.1 Steady-state emission spectra
The emission spectra of ApoDREAM and Mg2+DREAM are almost identical, and
are broad with a maximum at 340 nm (Figure 4.2). Upon Ca2+ association to DREAM or
Mg2+DREAM, I observed that the two spectra change in the same manner with a decrease
in the emission intensity (-18% relative to that of Apo or Mg2+DREAM) along with a
concomitant hypsochromic shift of 5 nm. Analogous Ca2+ triggered bathochromic shifts
were reported previously, although the emission spectra presented here are approximately
5 nm blue shifted compared to the published results (Osawa et al., 2001). The protein was
purified and studied in the presence of LDAO since the previous study had shown that the
addition of LDAO reduces protein aggregation and stabilizes ApoDREAM and
Ca2+DREAM in its tetrameric and dimeric form, respectively (Osawa et al., 2001). I have
observed that the presence of LDAO strongly affects the emission spectra of Ca2+ free and
Ca2+ bound DREAM. For example, DREAM samples dialyzed against 20 mM Tris buffer,
1 mM DTT, and 10 mM LDAO at pH 7.4 for 48 hours provided emission spectra with a
max of 340 nm and 335 nm for Apo and Ca2+DREAM, respectively, which are comparable
to those reported by Osawa et al. (Osawa et al. 2001). On the other hand, emission spectra
of DREAM samples prepared in the absence of LDAO are blue shifted with an emission
maximum at ~ 330 nm for Ca2+DREAM and 335 nm for ApoDREAM suggesting that
LDAO binding to DREAM increases the solvent exposure of the W169 side-chain. The
fluorescence quantum yield was determined to be 0.105 ± 0.009 for Apo and Mg2+DREAM
and 0.090 ± 0.011 in Ca2+ and Ca2+Mg2+DREAM. The bathochromic shift of the W169
emission maximum suggest that Ca2+ association to DREAM leads to a conformational
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transition upon which the W169 residue moves towards the hydrophobic core of the
protein.

Figure 4.2: Fluorescence emission spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+DREAM
upon excitation at 295 nm. Note that the emission spectrum of ApoDREAM and
Mg2+DREAM are almost identical, and likewise for Ca2+DREAM and Ca2+Mg2+DREAM.
4.2.2 Fluorescence quenching
Acrylamide, a polar, uncharged water-soluble molecule, was used in quenching
studies to further probe the solvent accessibility of W169 in DREAM. The plot of the ratio
of the DREAM fluorescence emission intensities in the absence and presence of the
acrylamide quencher exhibits a linear dependence (Figure 4.3).
The Stern-Volmer constants were determined using equation 3.22 in section
3.2.5.2.4.1. The determined Ksv constants are 2.80 ± 0.01 M-1 for ApoDREAM, 2.03 ±
0.10 M-1 for Ca2+DREAM, and 1.78 ± 0.01 M-1 for Ca2+Mg2+DREAM, confirming that the
W169 side chain is less solvent accessible in the structure of Ca2+ bound DREAM. In the
case of collisional quenching, the bimolecular quenching rate constant, kq = KSV/<>,
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where <> is the lifetime in the absence of the quencher, provides a better estimate of the
quenching efficiency.

Figure 4.3: Stern-Volmer plot for acrylamide quenching of DREAM in the
absence/presence of Ca2+ and Mg2+. Error bar represents standard deviations of three
independent measurements.
Using the average value for the fluorescence lifetime (Table 4.2), the kq value was
determined to be 6.2 x 108 M-1s-1 for ApoDREAM, 4.2 x 108 M-1s-1 for Ca2+DREAM, and
3.7 x 108 M-1s-1 for Ca2+Mg2+DREAM (Table 4.1). Interestingly, Mg2+ association to
DREAM results in a small but reproducible decrease in the Stern-Volmer constant and the
bimolecular quenching constant, Ksv = 2.29 ± 0.06 M-1 and kq = 5.0 x 108 M-1s-1 (Table
4.1), indicating that Mg2+ binding to EF-hand 2 causes a minor structural reorganization
that impacts the W169 solvent accessibility. These quenching constants are listed in Table
4.1. Previously, I have shown that Mg2+ binding to DREAM leads to small changes in the
fluorescence properties of 1,8-ANS DREAM complexes (Gonzalez et al., 2014),
supporting the role of Mg2+ in stabilizing the tertiary structure of the DREAM protein.
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Table 4.1: Stern-Volmer constant (Ksv) and bimolecular quenching constant (kq) of
DREAM protein
Protein
ApoDREAM
Mg2+DREAM
Ca2+DREAM
Ca2+Mg2+DREAM

Ksv (M-1)

kq (x108 M-1s-1)

2.80
2.29
2.03
1.78

6.2
5.0
4.2
3.7

4.2.3. Fluorescence lifetime
Since the tryptophan fluorescence lifetime is highly sensitive to small variations in
the fluorophore environment, probing the lifetime of the single W169 residue in DREAM
provides further insight into Mg2+/Ca2+ induced conformational changes, including
alteration of local dynamics. The W169 lifetime was determined using phase modulation
fluorescence spectroscopy. The phase shift and modulation ratio data were monitored in
the frequency range from 5 MHz to 250 MHz and are presented in Figure 4.4.
Fluorescence lifetime data were analyzed using a combination of discrete
exponentials and various distribution models (Gaussian, Lorentzian or uniform). The best
fits based on residuals and 2 values were obtained with a model composed of a discrete
single exponential decay component and a continuous Gaussian distribution (Table 4.2).
The discrete component exhibits a calcium independent lifetime of ~ 7.5 ns whereas the
Gaussian distribution is centered at 3.5 ns and 1.7 ns for Ca2+ free and Ca2+ bound DREAM,
respectively. The width of the distribution is w1 = 1.8 ns and 2.0 ns in the ApoDREAM
and Mg2+DREAM, respectively, and narrows upon Ca2+ binding to w1 = 0.8 ns and 0.9 ns
in Ca2+DREAM and Ca2+Mg2+DREAM, respectively (Figure 4.5). In addition, the
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fractional contribution of the 7.5 ns component is ~ 0.12 in the Apo and Mg2+ DREAM
and increases to 0.20 in Ca2+ bound forms of DREAM.

Figure 4.4: Frequency-domain intensity decay of 40 µM ApoDREAM (open squares),
Mg2+DREAM (open circles), Ca2+DREAM (closed squares), and Mg2+Ca2+DREAM
(closed circles). The solid lines represent the data fitting using a Gaussian distribution
model and single exponential decay model. Note that the experimental data for
ApoDREAM and Mg2+DREAM are nearly identical, and likewise for the data for
Ca2+DREAM and Ca2+Mg2+DREAM.
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Figure 4.5: Fluorescence lifetime rotational distribution of Mg2+DREAM and
Ca2+Mg2+DREAM using a continuous Gaussian distribution and a discrete single
exponential decay component. To simplify, the lifetime rotational distribution curves of
ApoDREAM and Ca2+DREAM are not shown.
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Table 4.2: Emission decay parameters for DREAM using a continuous Gaussian
distribution and a discrete component
1
(ns)

w1
(ns)

f1

1

2
(ns)

f2

α2

<>
(ns)

2

ApoDREAM

3.6

2.0

0.77

0.88

7.5

0.23

0.12

4.5

1.7

Mg2+DREAM

3.4

1.8

0.75

0.87

7.5

0.25

0.13

4.4

2.0

Ca2+DREAM

1.8

0.8

0.44

0.78

7.4

0.56

0.22

4.8

1.7

Ca2+Mg2+DREAM

1.8

0.9

0.48

0.80

7.6

0.52

0.20

4.8

1.0

Protein

1 is the mean decay time of the Gaussian distribution with a width of distribution w 1.
2 is the lifetime of the discrete single exponential term. The average lifetime <> was
calculated using equations 3.54 and 3.55 in Method section 3.2.10.3. Parameters α1 and
α2 are normalized pre-exponential decay and f1 and f2 are exponential decay fractions.
4.2.4. CD measurements
The far-UV CD spectra of DREAM show the characteristic of alpha-helical
proteins, with negative peaks at 222 nm and 208 nm (Figure 4.6). The magnitudes of the
CD signals of ApoDREAM and Mg2+DREAM are identical. However, when Ca2+ is bound
to Apo and Mg2+DREAM, magnitude of CD signal becomes more negative.
These results suggest that binding of Ca2+ to DREAM increases the alpha-helical
content of the protein. Analysis of the far-UV CD spectra of DREAM using K2D protein
secondary prediction software shows that DREAM protein increases about 16% of its
alpha-helical content in the Ca2+ bound form relative to that of Apo and Mg2+ forms.
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Figure 4.6: CD spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ DREAM in the far-UV region.
The concentration of the protein was 40 μM in 10 mM Tris buffer (pH 7.4), 1 mM DTT,
and 10 mM LDAO. Spectra were corrected for the baseline of the buffer.
4.2.5 DREAM stability
The impact of Ca2+/Mg2+ binding to EF-hands on the protein stability was
characterized by monitoring the CD signal at 220 nm as a function of increasing GuHCl
concentration as shown in Figure 4.7 (a). The unfolding curves, shown in Figure 4.7 (b),
clearly indicate the presence of a partially folded intermediate at GuHCl concentrations
between 4.0 and 5.0 M. The experimental data were analyzed using a three-state model
according to equation 3.60 in section 3.2.3.4 and the recovered thermodynamic parameters
(ΔG, m, and Cm) are summarized in Table 4.2. Ca2+ association to DREAM increases the
stability of the native state compared to the unfolded state by ~ 4 kcal mol -1, whereas the
contribution of Mg2+ to DREAM stability is significantly smaller. Interestingly, Ca2+
binding to EF-hands increases the stability of the native state with respect to the partially
unfolded intermediate state by ~ 2 kcal mol-1 in the presence of Mg2+, whereas the stability
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of the intermediate state with respect to the unfolded state is increased in both Ca2+DREAM
and Ca2+Mg2+DREAM by ~ 2 kcal mol-1. The shallow folding transition between the native
and partially unfolded intermediate state points to a low energy barrier between the native
and intermediate state for Apo, Mg2+, and Ca2+DREAM. The native state is more strongly
stabilized with respect to the intermediate state in Ca2+Mg2+DREAM, as evident from the
steep transition between the folded and partially folded intermediate state.

Figure 4.7: (a): CD spectra of 40 µM ApoDREAM in the presence of 0, 1, 2, 3, 4, 5, 6, 7,
and 7.4 M GuHCl. (b): Representative equilibrium unfolding traces of DREAM as
determined by the CD signal change at 220 nm. Solid black lines are fitting curves of
experimental data using equation 3.60 in section 3.2.10.4. The thermodynamic parameters
are reported in Table 4.3.
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Table 4.3: Thermodynamic parameters for GuHCl induced denaturation of DREAM in the absence/presence of Ca2+ and Mg2+
GN I

mNI

CNI

GIU

mIU

CIU

GNU

kcal mol-1

kcal M-1 mol-1

M

kcal mol-1

kcal M-1 mol-1

M

kcal mol-1

ApoDREAM

1.6  0.1

0.8  0.1

2.0

7.7  0.8

1.3  0.1

5.9

9.3  0.8

Mg2+DREAM

1.7  0.2

0.8  0.1

2.1

8.4  0.9

1.4  0.2

6.0

10.1  0.9

Ca2+DREAM

1.6  0.3

0.6  0.1

2.0

11.3  0.1

1.7  0.1

6.5

12.9  0.3

Ca2+Mg2+DREAM

3.8  0.4

1.2  0.2

3.2

10.5  1.2

1.6  0.2

6.5

14.3 ± 1.3

Protein

The thermodynamic parameters were calculated using equation 3.60 in section 3.2.10.4 where N, I, and U correspond to
the native state, transition state, and unfolded state, respectively. ΔG is the standard free energy for the transition, m is the
dependence of the free energy on the denaturant concentration, and CNI and CNU represent denaturant concentration of
half unfold from native to transition state and from transition state to unfolded state, respectively. GNU represents the
overall unfolding free energy from native to unfolded state. Errors were determined from standard deviations of at least
three independent measurements.
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4.2.6 Molecular dynamics studies
Molecular dynamics simulations provide a complementary approach to monitor
structural transitions in DREAM. Molecular dynamics simulations of Apo and Ca2+ bound
DREAM were performed in collaboration with Dr. Prem Chapagain (Department of
Physics, Florida International University). The root mean square fluctuation (RMSF) of C
atoms can be used to probe fluctuations of individual residues with respect to the average
structure in the Apo and Ca2+ bound form of DREAM. The RMSF profile for a 40 ns time
window is shown in Figure 4.8. The overall profiles are similar for Apo and Ca2+ bound
DREAM. Ca2+ association to EF-hands 3 and 4 reduces the fluctuations of the Ca2+ binding
loop in EF-hand 3 (residues 174 to 183), and to a smaller extent reduces the fluctuations in
the binding loop of EF-hand 4 (residues 222 to 231). The flexibility of the long loop
connecting -helix 7 to -helix 8 (residues 198 to 211) remains high in the Ca2+ bound
form of the protein, in agreement with NMR results that show increased structural
deviations in this region (Lusin et al., 2008). Interestingly, the C- terminal loop (residues
242 to 244) connecting -helix 9 and -helix10 in the C-terminal domain exhibits high
flexibility in the Ca2+ bound structure. As expected, smaller changes in protein flexibility
due to Ca2+ binding to DREAM are observed for the N-terminal domain of the protein.
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Figure 4.8: Root-mean-square fluctuations (RMSF) of the C backbone in ApoDREAM
and Ca2+DREAM.
The superposition of MD simulation structures of ApoDREAM and Ca2+DREAM
monomers (Figure 4.9) shows high structural similarity. Detailed inspection of these
structures reveals that the N-terminal domain containing the non-functional EF-hand 1 and
EF-hand 2 does not show significant structural differences between the Apo and Ca2+
bound forms apart from -helix 2, which moves away from -helix 5 in the Ca2+ bound
protein. A larger structural reorganization is observed for the C-terminal domain and
includes repositioning of the -helices within the individual EF-hand binding sites.
Interestingly, the entering and exiting helices of the EF-hand 3 undergo a minor
reorientation in the calcium bound state with respect to the Apostate, whereas Ca2+
association to EF-hand 4 is accompanied by the clear transition of the -helices from a
perpendicular to a parallel orientation (Figure 4.9). Also, the C-terminal helix (-helix 10)
moves away from -helix 6 in the Ca2+ bound protein.
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Figure 4.9: Top panel: Overlaid MD simulations structures of ApoDREAM (in red) and
Ca2+ bound DREAM (in yellow). Alpha-helices 1 – 10 in DREAM are labeled by α1 – α10,
respectively. EF-hand 1 is composed of α2 and α3, EF-hand 2 composed of α4 and α5, EFhand 3 composed of α6 and α7, EF-hand 4 composed of α8 and α9. The position of the
W169 residue is shown with sticks. Bottom panel: Ca2+ triggered reorganization of the EFhand 3 (left) and EF-hand 4 (right).

4.3 Discussion
Previous studies have demonstrated that Ca2+ association to EF-hands 3 and 4 in
the C-terminal domain of DREAM leads to the dissociation of the ApoDREAM tetramer
into dimers, which decreases DREAM affinity for intracellular partners (Osawa et al.,
2005), as well as DREAM monomer affinity for small hydrophobic molecules (Gonzalez
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and Miksovska, 2014). However, the detailed molecular mechanism of how Ca2+
association to the C-terminal domain EF-hands modulates the conformation of the
DREAM monomer and the impact of Ca2+/Mg2+ association on DREAM affinity for
intracellular partners remains elusive. Tryptophan emission has been widely used as a
sensitive probe of structural transitions in proteins including protein folding, Ca2+/Mg2+
association to proteins and protein-protein interactions. In the DREAM structure (residues
65 to 256), the single W169 residue that is located at the interface between the N- and Cterminal domains provides a unique tool for characterization of Ca2+/Mg2+ triggered
conformational dynamics of DREAM.
4.3.1 Impact of Ca2+ binding on conformational dynamics of DREAM
Steady-state emission data of W169 indicate that Ca2+ association to EF-hand 3 and
EF-hand 4 triggers the reorganization of the interface between EF-hand 2 and EF-hand 3
with the W169 side chain being located in a less polar environment in the Ca2+ bound form.
This is further supported by the emission quenching and fluorescence lifetime data. The
smaller bimolecular quenching rate constant observed for Ca2+ and Ca2+Mg2+DREAM is
consistent with a reduced solvent accessibility to the W169 residue due to tertiary structure
alterations and/or decreased conformational flexibility in the Ca2+ bound form of DREAM.
The decrease in the structural flexibility is supported by the W169 lifetime data (Figure
4.4). The major fraction of the W169 emission decay can be described using a continuous
Gaussian distribution model centered at 3.5 ns for Apo and Mg2+ DREAM and 1.7 ns for
Ca2+DREAM and Ca2+Mg2+DREAM. The minor fraction (~ 10 % in ApoDREAM and 20
% in Mg2+ and/or Ca2+ bound DREAM) exhibits a discrete single exponential decay with
lifetime of ~ 7.5 ns. The full width at half maximum value of the lifetime distribution
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parameter, w, was found to be 2.0 ns for Apo and Mg2+DREAM and ~ 0.9 ns for Ca2+
bound DREAM. The observed decrease in the w value suggests that Ca2+ binding to EFhands reduces the distribution of conformational microstates and/or modulates the
dynamics of the inter-conversion between individual sub-states in DREAM (Alcala et al.,
1987; Bodis et al., 2013). Several mechanisms were proposed to explain the observed
heterogeneity of the tryptophan lifetime in single tryptophan proteins including the
presence of tryptophan side chain rotamers, quenching by water molecules, electron
transfer to the peptide carbonyl group, excited state electron or proton transfer, and
intersystem crossing (Szabo and Rayner, 1980; Moncrieffe et al., 2000; Ross and Jameson,
2008). Interestingly, an overlay of the 15 lowest energy structures of Ca2+ bound DREAM
determined by NMR spectroscopy (Lusin et al., 2008) and the structure of the DREAM Cterminal domain (residues 161-256) (Yu et al., 2007; Bodis et al., 2013) displays the
presence of a single tryptophan rotamer (t rotamer) in the DREAM structure. However, as
shown in Figure 4.9, a transition from the t to g+ rotamer of W169 side chain is observed
during molecular dynamic simulations, which supports the idea that the bimodal
distribution could arise from two rotameric orientations of W169 with the side chain of the
g+ rotamer being more solvent exposed.
Inspection of the DREAM and DREAM C-terminal domain structures (PDB entry
2JUL and 2E6W, respectively) reveals four charged amino acid residues located within 6
Å of the W169 indole ring that may serve as efficient quenchers for the t rotamer. Residues
E165, K168, and N172 are located on the same -helix as W169, whereas E253 is found
at the end of -helix 10 (Figure 4.10).
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Figure 4.10: Top panel: charged and polar amino acid residues surrounding W169 in the
structure of DREAM (PBD entry 2JUL, shown in blue) and C-terminal domain of DREAM
(PBD entry 2E6W, shown in green). Bottom left panel: SASA of W169 in DREAM during
270 ns of the MD trajectory. Bottom right panel: Partially buried (in blue) and solvent
exposed (in green) orientation of W169 side chain in DREAM structure.
In addition, the side chains of these residues are disordered in the NMR structures,
which likely contribute to the observed heterogeneity of the W169 emission decay. In the
absence of the NMR structure of ApoDREAM, it is difficult to pinpoint the origin of the
slower W169 decay in Apo and Mg2+DREAM. However, I speculate that the re-positioning
of -helix 10 upon Ca2+ binding brings the E253 side chain closer to the W169 indole ring
resulting in more efficient W169 emission quenching. Indeed, -helix 10 was found to be
flexible in the structure of KChIP1 as it moves away from -helix 8 in the KChIP1:Kv4
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channel T1 domain complex (Wang et al., 2007). Also, the reorientation of -helix 10 was
associated with increased affinity of Ca2+ bound DREAM for arachidonic acid and small
hydrophobic molecules (Gonzalez and Miksovska, 2014).
The second W169 decay component is characterized by an unusually long lifetime
of ~ 7.5 ns. It is unlikely that the presence of the second lifetime reflects other
oligomerization forms of DREAM (monomer/tetramer in the case of Ca2+ free DREAM
and monomer/dimer in the case of Ca2+ bound protein) since two comparable lifetimes
were found for the C-terminal DREAM construct (residues 161-256) in the Apo form
which does not form a tetramer or dimer in solution. On the other hand, a similar lifetime
of 7.3 ns was detected in the multi-tryptophan protein beta-glycosidase from Sulfolobus
solfataricus, and was associated with a rigid cluster of eight tryptophan residues (Bismuto,
Nucci et al. 1999). However, the NMR structure (Figure 4.9, top) and RMSF from MD
simulations (Figure 4.8) are not consistent with the presence of a rigid hydrophobic cluster
surrounding W169 in DREAM. On the other hand, a single tryptophan residue in the
calcium binding protein annexin was reported to exhibit two distinct lifetimes of 2.0 ns and
7.0 ns when annexin is associated to lipid vesicles (Follenius-Wund et al., 1997). The 7.0
ns decay was associated with the tryptophan side chain located in a more polar
environment, at the interface between the protein surface and the lipid membrane
(Follenius-Wund et al., 1997).
Thus, to further explore the dynamic behavior of the W169 side chain, a 250 ns
molecular dynamics simulation was analyzed and the solvent accessible surface area
(SASA) plot for W169 is shown in Figure 4.10. The W169 side chain samples three major
conformations with distinct SASA values. The major and minor conformations are
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characterized by SASA values of 376 Å2 and 370 Å2, respectively, and can be attributed to
the partially buried W169 side-chain within the interface between the C- and N-terminal
domains of DREAM. The additional conformation with a SASA of 385 Å2 corresponds to
the solvent exposed indole ring (Figure 4.10). The binding site for the LDAO molecule on
the DREAM surface is not known. The detergent molecule may bind into the hydrophobic
cleft between the N- and C-terminal domains in a similar way as a myristoyl group binds
to ApoRecoverin protein. Thus, the interactions between the W169 indole ring and the
polar head of the LDAO molecule bound to DREAM can contribute to a 7.5 ns W169
decay and the red-shifted emission spectra of DREAM samples prepared in the presence
of LDAO. Furthermore, Liao et al. (Liao et al., 2009) have shown that the C-terminal
domain of KChIP1 is required for KChIP1 association to phospholipid vesicles and the
formation of KChIP1 - phospholipid vesicle complexes alters the protein structure. Taking
into account a high sequence and structural homology of the C-terminal domain among the
members of the KChIP subfamily, it is likely that DREAM forms similar complexes with
phospholipid vesicles. Indeed, one can speculate that the DREAM conformation that is
characterized by the 7.5 ns Trp lifetime reflects the conformation of DREAM associated
with lipid vesicles or membranes.
4.3.2 DREAM stability increases in the presence of Ca2+/Mg2+
Association of Mg2+ and/or Ca2+ to DREAM EF-hands increases the stability of the
protein, although to different extent. The unfolding data (Figure 4.7b) show that DREAM
unfolds through a partially unfolded intermediate state that is populated at ~ 4.5 M GuHCl
in the case of Apo and Mg2+ DREAM and at ~ 5.0 M GuHCl for Ca2+ and
Ca2+Mg2+DREAM. Further increase in the GuHCl concentration promotes protein

111

destabilization towards the unfolded state. Unlike small, single domain proteins that fold
with two-state kinetics without populating intermediate state, multi-domain proteins
commonly exhibit unfolding intermediates. Furthermore, protein stability and folding is
modified by the presence of higher order clusters of aromatic residues (Burley et al., 1985;
Song et al., 2013). Such residues are usually highly conserved and their substitution often
leads to the destabilization of protein structure. I have identified two aromatic hydrophobic
cores in the DREAM structure (Figure 4.1) that i) are formed by residues conserved among
NCS members, ii) have a relative solvent accessibility smaller than 10 % (Rost and Sander,
1994), and iii) groups side chains that are within a distance of 4.5 Å of each other
(Arunachalam and Gautham 2008). One hydrophobic core is formed by an aromatic
tetramer of F171, Y174, F218, and F235 and is found at the C-terminal domain (Figure
4.1). All these residues are in a helical structural motif. The cluster formation brings
together -helices 6, 8, and 9, which may stabilize the C-terminal domain. The second
hydrophobic core was found within the N-terminal domain and is a trimer of phenylalanine
residues (F114, F135, and F138) that are found in -helices 3 and 4. Analogously to the C
terminal domain, the interactions between these residues increase the stability of the Nterminal domain. In addition, W169 from the C-terminal domain interacts with F138 from
the N-terminal domain and such inter-domain interactions may contribute to DREAM
stability.
Considering that the Ca2+ association to EF-hand 3 and EF-hand 4 increases the
stability of the partially unfolded intermediate with respect to the unfolded protein, I
propose that -helices 6, 8, and 9 form a stable hydrophobic core that unfolds during the
intermediate between the transition and unfolded states. The N-terminal domain that lacks
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more extended hydrophobic core(s) may be less stable than the C-terminal domain and thus
may be destabilized during the initial unfolding transition. This is further supported by the
fact that the stability of the N-terminal domain is increased by the Mg2+ association to EFhand 2, which is located in the N-terminal domain. Thus the unfolding data suggest that
the N-terminal domain unfolds during the first transition whereas the C-terminal domain
is destabilized at increased denaturant concentration. An analogous unfolding mechanism
was reported previously for another member of the NCS family, neuronal calcium sensor
1 (NCS-1) (Muralidhar et al., 2005; Aravind et al., 2008; Heidarsson et al. 2013). That
study reported that the folding mechanism and protein stability of NCS-1 are altered by the
presence of Ca2+ and Mg2+ ions as well as by the protein myristoylation at the N-terminus.
Non-myristoylated NCS1 unfolds through a three step mechanism with an overall stability
of GNU = 12.9 ± 0.7 kcal mol-1 for ApoNCS1, and GNU = 14.5 ± 1.6 kcal mol-1 for
holo-NCS1. These values are comparable to those determined here for Apo and Ca2+ bound
DREAM. These results indicate a similar folding mechanism for NCS1 and DREAM, and
possibly other members of the NCS family. This is further supported by a kinetic study of
folding mechanisms using optical tweezers (Heidarsson et al., 2013). The authors have
reported that the folding of the C-terminal domain precedes the folding of the N-terminal
domain, and that the C-terminal domain is stabilized by aromatic interactions between helices 6, 8, and 9.
4.3.2 Summary
Despite the low impact of Mg2+ association with EF-hand 2 on the DREAM tertiary
structure, the presence of Mg2+ stabilizes the native state with respect to a partially unfolded
state. The W169 lifetime data indicates that DREAM can adopt an additional conformation
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with a long W169 lifetime of 7.5 ns that may reflect conformations of DREAM populated
in the presence of lipid membranes and vesicles. The results show that DREAM unfolding
is a complex process that occurs through a partially unfolded, intermediate state. The Ca2+
association to EF-hand 3 and 4 stabilizes the partially unfolded state with respect to the
unfolded state, whereas the association of Mg2+ increases the stability of the native state
only in the presence of Ca2+. These results suggest that the intracellular fluctuations in Ca2+
and Mg2+ concentrations control the global conformation and stability of DREAM and
likely regulate its interactions with intracellular partners.
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5. CALCIUM AND MAGNESIUM BINDING TO THE C-TERMINAL DOMAIN
MODULATES DREAM STRUCTURE, DYNAMICS, AND STABILITY
(The results in this chapter were described in a manuscript that will be submitted by
Pham, Gonzalez, and Miksovska)
5.1 Background and significance
Downstream regulatory element antagonist modulator (DREAM), also known as
calsenilin or KChIP3, is a neuronal calcium sensor (NCS) involved in regulation of
important neuronal processes including pain modulation, A-amyloid production, and
potassium channel activity (Buxbaum et al., 1998; Carrion et al., 1999; An et al., 2000).
The intracellular function of DREAM depends on its intracellular localization and
interactions with target proteins. Ca2+ free DREAM forms a tetramer that binds to the
downstream regulatory element (DRE) sequence of prodynorphin and c-fos genes to
repress transcription of these genes. Upon binding to Ca2+, DREAM tetramer dissociates
into a stable dimer with a decreased affinity toward DRE (Carrion et al., 1999; Ledo et al.,
2000; Osawa et al., 2001, Osawa et al., 2005). In the cytoplasm, DREAM interacts with
the C terminal portion of Alzheimer’s disease associated proteins, presenilin 1 and
presenilin 2, and elevates the formation of A-amyloid peptides (Buxbaum et al., 1998).
In vivo studies have shown that DREAM overexpression is associated with an increased
formation of Aβ-amyloid peptide and concomitant cell death (Jo et al. 2001; Jo et al., 2003;
Jo et al., 2004). In addition, the level of Aβ peptide was significantly reduced in the
cerebellum and in the cortex of DREAM knock-out mice (Lilliehook et al., 2003). DREAM
also interacts with A-type voltage-gated potassium channels (Kv4) and modulates both the
kinetic properties and cell surface accumulation of Kv4 channels (An et al., 2000).
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Recently, it has been proposed that Ca2+ DREAM forms a complex with calmodulin,
whereas ApoDREAM binds to a regulatory subunit of calcineurin (Ramachandran et al.,
2012). The interactions with multiple neuronal proteins highlight a wide range of DREAM
neuronal functions under physiological and pathological conditions.
Unlike traditional EF-hand calcium sensors, such as calmodulin and troponin C,
that carry four EF-hands with a high affinity for Ca2+, members of the NCS family carry
only 2 or 3 functional EF-hands that bind Ca2+ with a high affinity. In DREAM, EF-hand
1 does not bind to Mg2+ or Ca2+ ion due to the presence of conserved residues C104 and
P105 on the first Ca2+ binding loop, which abolishes the affinity for Mg2+ and Ca2+ (Osawa
et al., 2005; Lusin et al., 2008). The presence of Asp (D150) at the 12th position of the EFhand 2 binding loop promotes specific binding to Mg2+ with relatively high affinity (Kd =
13 µM), whereas EF-hands 3 and 4 functionally bind to Ca2+ (Kd ~ 1-10 µM) (Osawa et
al., 2005; Yu et al., 2007; Lusin et al., 2008). Association of Ca2+ with DREAM triggers
protein dimerization that inhibits the interaction with DNA (Lusin et al., 2008). The 3dimensional structures of DREAM and DREAM-C reveal that the C-terminal α-helix
(residues 243-254) and the residues from EF-hand 3 (L161, A170, M191, and L194) and
EF-hand 4 (F218, M222, and C239) form a large hydrophobic cavity (Lusin et al., 2008)
on at the C-terminal domain that provides a binding interface for the site 1 of the Kv4.3
channels as well as for small hydrophobic molecules (Gonzalez and Miksovska 2014,
Gonzalez et al., 2014). In addition, a hydrophobic cleft located between the flexible loop
connecting EF-hand 3 and EF-hand 4 (residues 198 - 211) and the C-terminal α-helix was
thought as a binding site for interaction with target proteins during calcium signaling (Yu
et al., 2007).
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However, the structure of Apo and Mg2+ bound DREAM are currently unknown
that prevents us from a full understanding of conformational transition associated with
Ca2+ or Mg2+ binding to this neuronal regulator and the role of the Ca2+/Mg2+ in DREAM
interactions with intracellular partners. Despite considerable efforts to understand the
mechanism of Ca2+ signal transduction within DREAM protein, little information is known
about the dynamics of Ca2+ induced conformational changes in the full length protein as
well as in the C-terminal domain. In addition, the impact of Ca2+ and/or Mg2+ association
on DREAM-C (residues 161-256) structure and its stability has not been fully established.
In this study I have characterized the conformational transition induced by Ca2+ or
Mg2+ binding to DREAM-C by monitoring the fluorescence properties of an intrinsic
tryptophan residue (W169). In addition, extrinsic fluorescent probes: 8-anilino-1naphthalenesulfonic

acid

ammonium

salt

(1,8-ANS)

and

9-diethylamino-5H-

benzo[alpha]phenoxazine-5-one (nile red) were employed to monitor the hydrophobic
properties on DREAM-C surface and the oligomerization state of DREAM-C as a function
of Ca2+ or Mg2+. The thermodynamic parameters for Ca2+ or Mg2+ binding to DREAM-C
were probed using isothermal titration calorimetry (ITC), and the effects of Ca2+/Mg2+
binding on DREAM-C stability were investigated in protein unfolding experiments.
5.2 Results
5.2.1 Thermodynamics of Ca2+ and/or Mg2+ binding to DREAM-C
The isotherm for Ca2+ association to ApoDREAM-C is shown in Figure 5.1 and the
thermodynamic parameters are summarized in Table 5.1.
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Figure 5.1: Binding isotherm for Ca2+ association to DREAM-C in the absence of Mg2+.
The top panel represents a raw power titration curve, the bottom panel shows integration
data, and the solid line represents the two sets of sites fitting curve.
Association of Ca2+ at EF-hands 3 and 4 of DREAM-C endothermically (ΔH1 = 5.5
kcal mol-1 and ΔH2 = 1.1 kcal mol-1) with a sub-micromolar affinity (Kd1 = 0.3 ± 0.1 µM
and Kd2 = 0.9 ± 0.2 µM), respectively. The positive enthalpy change is consistent with the
high dehydration energy of the divalent Ca2+ ions upon binding to DREAM-C (Osawa et
al., 2005). The binding isotherm for Ca2+ association to Mg2+DREAM-C resulted in
approximately a two-fold larger equilibrium dissociation constant for one binding site (Kd1
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= 0.6 ± 0.1 µM and Kd2 = 1.0 ± 0.3 µM) with the Ca2+ binding to one site being endothermic
(ΔH1 = 9.4 ± 4.0 kcal mol-1) and to the other site being exothermic (ΔH2 = -15.0 ± 1.4 kcal
mol-1). The analysis of the binding isotherm for Mg2+ association to ApoDREAM reveals
the presence of two binding sites, with one site being a high affinity site (Kd1 = 180 ± 10
M and ΔH1 = 1.5 ± 0.1 kcal mol-1) and another site with a milimolar affinity (Kd2 = 1.7 ±
0.1 mM and ΔH2 = 3.5 ± 0.1 kcal mol-1). The endothermic Mg2+ association to
ApoDREAM-C points out towards the absence of pronounced structural changes
associated with Mg2+ binding to DREAM-C.
Table 5.1: Thermodynamic parameters for Ca2+ and/or Mg2+ binding to DREAM-C

DREAM-C

Kd1

ΔH1

(µM)

(kcal/mol)

0.9 ± 0.1

0.3 ± 0.1

5.5 ± 0.8

49

1.2 ± 0.1

1.3 ± 0.2

0.6 ± 0.1

9.4 ± 4.0

60

0.7 ± 0.2

1.0

180 ± 10

1.5 ± 0.1

22

0.97

n1

ΔS1

n2

(cal/mol K)

Kd2

ΔH2

ΔS2

(µM)

(kcal/mol)

(cal/mol K)

0.9 ± 0.2

1.1 ± 0.7

31

1.0 ± 0.3

-15.0 ± 1

-24

3.5 ± 0.1

25

Ca2+ versus
Apo
Ca2+ versus
Mg2+ bound
Mg2+versus
Apo

1.7x103 ±
0.1x103

5.2.2 Secondary structural changes induced by Mg2+ and/or Ca2+ binding
Changes in the secondary structure of DREAM-C upon Ca2+ and/or Mg2+ biding
were monitored by near-UV circular dichroism (Figure 5.2). A small, but reproducible
decrease in the CD signal was observed at 220 nm upon addition of Mg2+ to ApoDREAMC, and an additional increase in the 220 nm signal was recorded upon Ca2+ binding to
Mg2+DREAM, indicating that association of both divalent ions leads to an increase in the
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protein α-helical structure. The CD signal for the Ca2+DREAM-C in the absence of Mg2+
is identical to that measured in the presence of Mg2+, highlighting that Ca2+ association to
Mg2+DREAM-C cancels out structural changes triggered by Mg2+ binding. The increase in
the -helical structure upon Ca2+ binding to EF-hands is common among the calcium
binding proteins and has been observed previously for other EF-hand proteins (Burgoyne
and Weiss, 2001).

Figure 5.2: The CD spectra of DREAM-C in the presence/absence of Ca2+ and/or Mg2+
5.2.3 Tertiary structural changes triggered by Mg2+ binding differ from those
associated with Ca2+ binding
The single tryptophan residue in DREAM-C (W169) provides an excellent probe
to monitor changes in tertiary structure induced by the binding of Mg2+ and/or Ca2+ to
DREAM-C. The W169 emission spectrum of ApoDREAM-C is broad with a maximum
at 349 nm (Figure 5.3) and the emission intensity of DREAM-C increases, without a
concomitant shift in the maximum wavelength, upon addition of Mg2+, indicating that in
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the W169 quenching is reduced in the Mg2+ bound form. The emission maximum at 349
nm observed for Apo and Mg2+DREAM-C is similar to that of tryptophan in aqueous
solution (~ 350 nm), pointing out that the W169 side chain is located near a polar
environment. Addition of Ca2+ to Apo or Mg2+DREAM leads to a decrease in W169
emission intensity and a concomitant hypsochromic shift to 344 nm due to the transfer of
the W169 side chain into a less polar surrounding. Analogously, as observed in CD
measurements, the identical emission spectra of the Ca2+ and Ca2+Mg2+ bound form of
DREAM-C suggest that Ca2+ binding to EF-hands cancels the structural changes induced
by Mg2+ association to DREAM.

Figure 5.3: The fluorescence steady-state emission spectra of intrinsic W169 residue in
DREAM-C.
The W169 emission quenching by acrylamide was used to further investigate the
solvent accessibility of W169 site chain in ligand free and ligand bound DREAM-C and
thus reflects ligand induced alteration of the tertiary structure and/or and conformational
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dynamics (Augusteyn et al., 1988). The Stern-Volmer plots are shown in Figure 5.4 and
the Stern-Volmer constants are shown in Table 5.2.

Figure 5.4: Stern-Volmer plot for acrylamide quenching of DREAM-C in the
absence/presence of Ca2+ and Mg2+.
Table 5.2: The Stern-Volmer constants (Ksv) for acrylamide quenching of DREAM-C
Protein

KSV (M-1)

ApoDREAM-C

10.4  0.1

Ca2+DREAM-C

5.1  0.1

Mg2+DREAM-C

9.9  0.2

Ca2+Mg2+DREAM-C

5.7  0.1

Protein

KSV (M-1)

The increased KSV values for the ApoDREAM-C and Mg2+DREAM-C (Ksv = 10.4
± 0.1 M-1 and 9.9 ± 0.2 M-1, respectively) suggest that the W169 indole ring is nearly fully
exposed to the solvent, in agreement with the steady-state emission data. Association of
Ca2+ to Apo or Mg2+ DREAM-C induces a conformational change that significantly
reduces the solvent accessibility of the W169 residue as evident from the Ksv values of 5.1
± 0.1 M-1 and 5.7 ± 0.1 M-1, respectively.
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The frequency-domain intensity decay data for DREAM-C are shown in Figure 5.5.
The data were analyzed using a Gaussian-Discrete double decay model and the recovered
parameters are shown in Table 5.3.

Figure 5.5: Frequency-domain intensity decays for W169 in the presence/absence of Ca2+
and/or Mg2+. Phase delays are solid symbols, modulation ratios are empty symbols, and
the solid lines represent the calculated fitting curves.
The discrete component of the emission decay has a long lifetime of ~ 7.3 ns that
is independent of the presence of Mg2+ or Ca2+. The continuous Gaussian distribution
model has a center value of distribution of 3.0 ns for ApoDREAM and 3.5 ns for
Mg2+DREAM-C, and decreases to 2.5 ns in the presence of Ca2+. The Gaussian distribution
width decreases in the presence of Ca2+ from 1.6 ns as observed for ApoDREAM-C to 1.3
ns determined, for Ca2+DREAM-C.
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Table 5.3: Fluorescence decay parameters for DREAM-C intrinsic tryptophan residue.
Data were analyzed using a Gaussian-discrete model
Protein

1
(ns)

w1
(ns)

f1

2
(ns)

f2

2

ApoDREAM-C

3.0

1.6

0.52

7.4

0.48

0.9

Mg2+DREAM-C

3.5

1.7

0.56

7.3

0.44

1.4

Ca2+DREAM-C

2.5

1.3

0.49

7.2

0.51

1.3

Ca2+Mg2+DREAM-C

2.5

1.3

0.49

7.2

0.51

1.4

1 is the center of Gaussian distribution, f is fractional contribution, w is the Gaussian
distribution width, and τ2 is lifetime of the discrete component. The constant
standard error of 0.2° for the phase angle and 0.004 for modulation were used for
data analysis
5.2.3 Binding of Ca2+ and/or Mg2+ triggers distinct changes in hydrophobic
surface of DREAM-C protein
The structural transition induced by Ca2+ and/or Mg2+ binding to DREAM-C in
terms of changes in the hydrophobic surface was probed using the hydrophobic
fluorescence probes 1,8-ANS and nile red. The steady-state emission spectra demonstrate
that both probes bind to DREAM. However, unlike 1,8-ANS emission, the emission of nile
red is sensitive to the structural changes triggered by Mg2+ association to DREAM-C
(Figure 5.6, panels A and B).
Nile red in 20 mM Tris buffer exhibits weak emission intensity with a maximum at
657 nm. In the presence of ApoDREAM-C, the emission intensity increases approximately
2 times and the maximum shifts to 642 nm. A further increase in the emission intensity and
concomitant bathochromic shift to 628 nm were observed for nile red: Mg2+DREAM-C
complex.
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Figure 5.6: Fluorescence steady-state emission spectra of nile red (A) and 1,8-ANS (B)
binding to DREAM-C in the presence or absence of Ca2+ and/or Mg2+.
In the presence of Ca2+DREAM and Ca2+Mg2+DREAM-C, the emission intensity
of nile red increases approximately 5 times and exhibits a maximum at 616 nm. These data
are consistent with Mg2+ and Ca2+ triggered structural changes that result in a more
hydrophobic binding site for nile red. The increase in the emission intensity of nile
red:Mg2+DREAM-C and nile red:Ca2+DREAM-C complexes is consistent with the
observed equilibrium dissociation constants (Table 5.4). Overall, the nile red binding to
DREAM-C is relatively weak, (Kd = 122 ± 53 M) and increases in the presence of Mg2+
and Ca2+, Kd = 50 ± 5 M and 10 ± 1 M, respectively.
Table 5.4: Fluorescence decay parameters for nile red:DREAM-C. The experimental data
were analyzed using a discrete component and continuous Gaussian distribution model.
DREAM-C

Kd (μM)

1 (ns)

f1

τ2 (ns)

f2

w

2

Apo

122 ± 53

0.23

0.17

3.4 ± 0.3

0.83

1.6

0.86

Mg2+
50 ± 5
0.23
0.09
4.1 ± 0.4
0.91
1.3
0.85
2+
Ca
10 ± 1
0.23
0.05
3.5 ± 0.1
0.95
1.7
0.69
Ca2+ Mg2+
12 ± 2
0.23
0.06
3.4 ± 0.2
0.94
1.7
0.77
The lifetime of the discrete component was set as a linked variable. Phase and modulation
errors were set at ≤ 0.2⁰ and ≤ 0.002 respectively.
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5.2.4 Contribution of Mg2+ and Ca2+ in the stability of DREAM-C
In order to investigate the impact of Ca2+/Mg2+ on DREAM-C stability, GuHCl
induced unfolding of DREAM-C was monitored using circular dichroism. The unfolding
profiles (Figure 5.7) were then analyzed using equation 3.61 in section 3.2.4.3 for a twostate unfolding model. The thermodynamic parameters are summarized in Table 5.5.

Figure 5.7: GuHCl induced unfolding DREAM-C in the presence or absence of Ca2+ and/or
Mg2+. Unfolding parameters were recovered using equation 3.61 in section 3.2.4.3 for a
two-state unfolding model.
The stability of Apo and Mg2+DREAM-C is low with ΔG ~ 0.3 kcal mol-1
suggesting that the DREAM-C is partially destabilized under native like conditions. Both
unfolding curves have a non-sigmoidal profile that can be associated with a noncooperative protein unfolding. On the other hand, the unfolding profiles of Ca2+DREAMC in the absence and presence of 5 mM Mg2+ has a midpoint at ~ 4 M GuHCl and are
characterized with sigmoidal unfolding curves indicative of a cooperative unfolding
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transition. In addition, a small increase in the -helical structure at sub-denaturant
concentration (0 to 1 M) was observed for Ca2+ bound DREAM-C. Analogous increase in
the negative ellipticity was reported for Ca2+ bound form of the non-myristoylated neuronal
calcium sensor 1 and were associated with the binding of denaturant molecules and
concomitant changes in dihedral angles. The Ca2+ association to EF-hands 3 and 4 increases
the protein stability by ~ 3.0 kcal mol-1 compared to the Apo protein.
Table 5.5: Thermodynamic parameters for DREAM-C unfolding

Protein

GU
(kcal mol-1)

mU
(kcal mol-1M-1)

CU
(M)

ApoDREAM-C

0.35  0.01

0.30  0.01

1.2

Mg2+DREAM-C

0.31  0.01

0.37  0.01

0.8

Ca2+DREAM-C

3.45  0.17

0.87  0.04

4.0

Ca2+Mg2+DREAM-C

3.60  0.17

0.94  0.04

3.8

ΔGU, mU, and CU represent the unfolding free energy change describes, the free
energy dependent on the denaturant concentration, and denaturant concentration
of half unfold from native to unfolding state (subscript U).
Discussion
On the basics of the Ca2+ and Mg2+ binding properties, the canonical EF- hand
binding sites can be divided into two classes: regulatory sites and structural sites. The
structural sites bind Mg2+ at the resting Ca2+ concentration and Mg2+ is replaced by Ca2+ in
response to an intracellular increase in the Ca2+ concentration. On the other hand, the
regulatory binding sites are Ca2+ specific with a moderate affinity for Ca2+. The Mg2+
association to EF-hands was shown to be physiologically important as it modulates the EFhand affinity for Ca2+, stabilizes protein structure, and in DREAM directly alters protein
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function (Yamniuk et al. 2004; Wingard et al., 2005; Peshenko and Dizhoor 2006). The
metal biding specificity of individual EF-hands cannot be determined based on the protein
sequence, because the side chain of the 12th loop residue is dynamically rotated. EF-hand
loop flexibility and electrostatic potential are likely to contribute to the observed specificity
(Henzl et al., 1998).
Both classes of EF-hand sites have been found among members of NCS family but
the role of individual EF-hands varies among the NCS subfamilies. The EF-hand 1 is not
functional among all members of this family, whereas the EF-hands 2, 3, and 4 can be
classified either as a structural or regulatory binding sites (Osawa et al., 2005). Visinin-like
protein 1 binds functionally to Mg2+ at EF-hand 3 in the absence of Ca2+, whereas upon
increase in the Ca2+ concentration, the EF-hand 2 and EF-hand 3 binds Ca2+ cooperatively
while EF- hand 4 is nonfunctional. In guanylyl cyclase activating protein-1, EF-hands 2,
3, and 4 are occupied by either Mg2+ or Ca2+, with Mg2+ binding to EF-hands 2 and 3 being
essential for activation of photoreceptor membrane guanylyl cyclase (Peshenko and
Dizhoor 2006). On the other hand, EF-hands 2 and 3 in neuronal calcium sensor 1 function
as the structural binding sites, whereas EF-hand 4 binds calcium specifically (Aravind et
al., 2008).
Among the members of the KChIP subclass, KChIP2, KChIP4 and DREAM bind
selectively to Mg2+ at EF-hand 2 due to the substitution of Glu by Asp in the 12th position,
whereas the EF-hand 2 is nonfunctional in KChIP1 due to the Thr substitution in the
position of the 3rd and 5th ligand. In all KChIPs, EF-hand 3 and 4 are regulatory sites that
specifically bind Ca2+. In DREAM, EF hand 3 and 4 bind Ca2+ cooperatively with a Kd
value of 1 - 10 µM (Osawa et al., 2001; Osawa et al., 2005; Ames et al., 2006; Lusin et al.,
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2008). According to the results of NMR spectroscopy, it was proposed that Mg2+
association to EF-hand 2 stabilizes DREAM conformation and promotes DREAM
association to the downstream regulatory element (DRE) sequence (Osawa et al., 2005).
However, no significant changes in the protein secondary or tertiary structure takes place
due to the Mg2+ association to EF-hand 2, as evident from the absence of W169 emission
enhancement and/or increase in the α-helical contain upon Mg2+ association to
ApoDREAM (Osawa et al., 2005; Lusin et al., 2008; Pham et al. 2015; Gonzalez et al.,
2016).
The ITC data presented here clearly show that the truncated form of DREAM that
lacks the EF-hand 2, binds to Mg2+ with a sub-micromolar affinity, Kd1 = 180 ± 10 µM.
The association of Mg2+ to ApoDREAM-C alters the affinity of C-terminal domain EFhands for Ca2+ as the overall equilibrium dissociation constant increases from 520 nM in
the absence of Mg2+ to 770 nM in the presence of Mg2+, respectively. The modulation of
the affinity of EF-hand binding sites for Ca2+ by Mg2+ was observed previously in
calmodulin and troponin C and attributed to the reduction of the on rate for Ca2+ binding
(Gifford et al., 2007).
In addition, Mg2+ association alters DREAM-C secondary and tertiary structure, as
evident from the increase in the α-helical structure, enhancement of W169 emission, and a
hypsochromic shift of the emission spectra in the nile red:Mg2+DREAM-C complex
compared to nile:red:ApoDREAM-C complex. The relatively modest increase in the helical structure and the small enhancement of the nile red emission in Mg2+DREAM-C
indicates that the structural changes triggered by Mg2+ association to EF-hand 3 or EFhand 4 are minor compared to the conformational changes triggered by the Ca2+ binding.
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This is commonly observed in the EF-hand proteins as the absence of the structural
transition due to Mg2+ association to EF-hands is commonly attributed to the six-fold
coordination of Mg2+ compared to seven-fold ligation geometry for Ca2+ ions (Cates et al.,
1999). The Mg2+ association to the isolated C-terminal domain of DREAM (residues 154
- 256) was reported previously by Craig et al (Craig et al., 2002) using micro-electrospray
ionization spectrometry. The authors proposed that Mg2+ binds to EF-hand 3 or EF-hand 4
in the C-terminal domain with an affinity that is comparable to the results reported in this
study.
Importantly, the structural changes induced by Mg2+ association to ApoDREAMC are reversed by addition of Ca2+ suggesting that DREAM-C can populate three distinct
structures ApoDREAM-C, Mg2+DREAM-C and Ca2+DREAM-C. Such reversal of Mg2+
induced structural changes have been reported for another member of NCS family,
neuronal calcium sensor 1 (Jeromin et al., 2004). Indeed, Mg2+ binding to the Apo form of
NCS-1 leads to a comparable increase in the tryptophan emission and the subsequent Ca2+
addition to Mg2+ bound NCS-1 resulted in the Trp emission properties that were identical
to those of Ca2+ bound NCS-1 as observed here for DREAM-C (Jeromin et al., 2004).
Unlike DREAM, NCS-1 binds Mg2+ ion at both EF-hands 2 and 3 and the Mg2+ ion is
replaced by Ca2+ as increased intracellular Ca2+ concentration suggesting that both sites
belongs to the structural sites. Considering a high sequence similarity between the Cterminal domains of members of neuronal calcium sensor family, I hypothesize that the
EF-hand 3 in DREAM-C binds Mg2+ ion with a high affinity. Since the EF-hand 3 is a
regulatory site that does not bind Mg2+ in the full length DREAM, the results presented
here suggest that the inter-domain interactions between the C- and N-terminal domains
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modulate the metal binding properties of the EF-hand 3. The NMR structure of the
DREAM protein reveals numerous contacts between the exiting -helix of EF-hand 2 and
the residues from EF-hand 3, including a hydrogen bond between N136 and a carbonyl
oxygen of D176 (+Y ligand in EF-hand 3) (previously described in chapter 1). The
extensive inter-domain contacts include hydrophobic interactions between residues F133,
L1733, I190, and W169 contribute to the overall stability of DREAM protein but may also
modulate the Ca2+ binding properties of the EF-hand 3. Indeed, I speculate that in
ApoDREAM-C, without contacts between EF-hand 2 and 3, allows an increase in
flexibility of the EF-hand 3, which increases the affinity of the EF-hand 2 for Mg2+ in the
absence of Ca2+.
Summary
The ITC data determined for association of Ca2+ to ApoDREAM-C shows that the
binding affinity for Ca2+ association to EF-hand 3 and 4 in DREAM-C is consistent with
that determined previously for DREAM (residues 65 – 256) (Osawa et al., 2005). However,
the association of Mg2+ to ApoDREAM-C alters the affinity of C-terminal domain EFhands for Ca2+ as the overall equilibrium dissociation constant increases from 520 nM in
the absence of Mg2+ to 770 nM in the presence of Mg2+, respectively. I have also shown
that association of Mg2+ alters the DREAM-C secondary and tertiary structure as evident
from the increase in the α-helical structure. Importantly, the structural changes induced by
Mg2+ association to ApoDREAM-C are reversed by addition of Ca2+ suggesting that
DREAM-C can populate three distinct structures ApoDREAM-C, Mg2+DREAM-C and
Ca2+DREAM-C. These results also suggest that the inter-domain interactions between the
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C-terminal domain and N-terminal domain is modulated by the metal binding properties of
the EF-hand 3 in DREAM.
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6. MOLECULAR INSIGHTS INTO DREAM AND PRESENILIN 1 C-TERMINAL
FRAGMENT INTERACTIONS
(The work described in this chapter was published in K., Pham and J., Miksovska (2016),
FEBS letters, 590(8):1114-1122)
6.1 Background and significance
Downstream regulatory element antagonist modulator (DREAM), also known as
calsenilin or KChIP3, belongs to the neuronal calcium sensor (NCS) family (Burgoyne et
al., 2004). DREAM carries four EF-hand Ca2+ binding motifs (EF-hand) of which EFhands 3 and 4 functionally bind to Ca2+ with high affinity (Kd ~ 1 – 10 µM), whereas EFhand 2 preferentially interacts with Mg2+ (Kd ~ 13 µM) and EF-hand 1 is inactive (Osawa
et al., 2005). The NMR structure of Ca2+ bound mouse DREAM (PDB code: 2JUL, Figure
6.1) reveals that its amino- and carboxy-terminal domains are arranged in tandem and
stabilized by a cluster of hydrophobic residues F114, F135, W169, F171, F218, and F235
(Lusin et al., 2008). A dynamic loop connecting EF-hands 3 and 4 in DREAM was
suggested to be involved in the binding and recognition of target proteins (Yu et al., 2007).
Several physiological functions of DREAM have been reported including prodynorphin
gene transcriptional repression (Carrion et al., 1999; Osawa et al., 2001), potassium
channel activity modulation (An et al., 2000), and enhancement of calcineurin activation
by binding to calmodulin (Ramachandran et al., 2012). Interactions between DREAM and
the carboxy-terminal fragment (CTF) of presenilin (PS) 1 and PS2 were proposed to be
involved in many biological functions including amyloid precursor protein processing, beta
amyloid peptide generation, neuronal apoptosis, calcium signaling in the endoplasmic
recticulum, and regulation of N-cadherin processing (Buxbaum et al., 1998; Leissring et
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al., 2000; Jo et al., 2001; Lilliehook et al., 2002; Jo et al., 2004; Jo et al., 2005; Fedrizzi et
al., 2008; Jang et al., 2011).
PS1 is a catalyst component of the γ-secretase complex which mediates cleavage
of amyloid precursor protein to produce Aβ peptides. In order to activate γ-secretase
complex, PS1 undergoes endoproteolysis within the hydrophobic sequence T291-A299
forming the amino-terminal fragment (NTF) and CTF (Podlisny et al., 1997; Li et al.,
2014). Initially, it was suggested that PS1 consists of 6 transmembrane helices at NTF and
one to three transmembrane helices at CTF (Lehmann et al., 1997; Dewji and Singer, 1997;
Nakai et al., 1999; Li and Greenwald, 1998; Spasic et al., 2006). The NMR structure of
human PS1-CTF (PDB entry: 2KR6, Figure 6.1) reveals that PS1-CTF consists of a long
unstructured loop (residues 300 – 354, not shown in Figure 6.1) and a soluble helix β (HLβ,
residues 355 - 369) at the amino-terminus. The core of PS1-CTF contains two
transmembrane helices HL7 (residues 384 - 398) and HL8 (residues 407 - 428). The
carboxyl HL9 (residues 441- 462) is an intramembranous helix, which is divided into two
perpendicular helices due to the presence of proline 455. The last four residues (463 – 467)
in PS1 are unstructured (Sobhanifar et al., 2010). NMR studies and molecular dynamic
simulations of PS1-CTF incorporated in lipid environments demonstrated that residues in
HL9 are exposed to the surrounding aqueous environment and experience greater dynamics
(Sobhanifar et al., 2010). Recently, the cryo-electron microscopy structure of PS1 in human
γ-secretase complex revealed that PS1 is comprised of nine helices, which are loosely
organized and exhibit considerable flexibility (Bai et al., 2015).
A thorough understanding of the molecular mechanism of DREAM and PS1
interactions requires the identification of binding sites between DREAM and PS1-CTF as
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well as characterization of the role of Ca2+ and/or Mg2+ on DREAM and PS1-CTF complex
formation. In this report, binding interfaces between DREAM and PS1-CTF were
identified by determining the binding affinity for DREAM, DREAM with non-functional
EF hand 3 or 4, and chimeric forms of DREAM association to synthetic peptides derived
from residues 445 - 467 (HL9) and residues 355 - 369 (HLβ) of PS1. The residues
comprising HL9 were chosen because previous studies demonstrated that they interact with
DREAM and a homologous protein KChIP4 in a yeast two-hybrid system (Buxbaum et al.,
1998; Morohashi et al., 2002). In addition, the residues composing HLβ are in the region
(residues 263 - 407) previously shown to interact with catenin, but have not been tested
with DREAM (Zhou et al., 1997; Buxbaum et al., 1998). Since transmembrane helices 7
and 8 are composed of highly hydrophobic natural amino acid residues and were shown to
be stably integrated in a lipid bilayer (Sobhanifar et al., 2010; Bai et al., 2015), these
structural elements were not included in this study.
6.2 Results
6.2.1 Computational protein-protein docking of DREAM and PS1-CTF
Docking complex of Ca2+DREAM:PS1-CTF, as shown in Figure 6.1, reveals that
the assembly of Ca2+DREAM and PS1-CTF involves π-π interactions in which the
aromatic ring of F252 in DREAM stacks against the aromatic rings of F462 and F465 from
HL9. The complex is further stabilized by a cation-π interaction in which the planar
guanidinium group of R200 interacts with the aromatic ring of F465 from HL9. Moreover,
F462 and F465 from HL9 insert into a cavity formed by hydrophobic residues M191, I194,
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M197, M198, M249, F252, V255, and I256 in α-helices 7 and 10 of DREAM (grey solid
surface in Fig 6.1).

Figure 6.1: Left: Protein-protein docking complex of Ca2+DREAM (PDB: 2JUL, molecule
1) and PS1-CTF (PDB: 2KR6, molecule 1). DREAM (residues 76 - 256) contains 10 αhelices respectively labeled α1 - α10, and four EF-hands: EF-1, EF-2, EF-3, and EF-4. Two
Ca2+ ions (yellow sphere) are bound at EF-3 and EF-4 loops in DREAM. PS1-CTF
comprises two trans-membrane helices: HL7 and HL8, a solvent exposed helix HLβ, and
an intramembranous HL9 which is divided into two perpendicular helices. Right: Detailed
presentation of the binding interfaces between Ca2+DREAM and PS1-CTF. Amino acid
residues from DREAM and PS1 are colored in green and red, respectively. Yellow dot
lines represent for hydrogen bond interactions.
The residue F465 in PS1 plays an important role not only for interaction with
DREAM, but also for interaction with anterior pharynx defective-1 (APH1) in the γsecretase complex (Bai et al., 2015). Furthermore, assembly of DREAM and PS-CTF
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involves formation of salt bridges between R207 in DREAM and D450 and D458 from
HL9. An additional salt bridge is found between R217 in DREAM and residue D458 from
HL9. In addition, hydrogen bond interactions are found between the side chains of four
pairs of residues: D450-R207, D458-R217, Q459-R217, and H463-D209, where D450,
D458, Q459, and H463 are residues from PS1 and R207, R209, and R217 are residues from
DREAM (Figure 6.1). Additional hydrogen bond is found between the carbonyl oxygen of
Y466 from PS1 and side chain of R200 from DREAM. This hydrogen bond likely stabilizes
side chain of R200 in order to direct its guanidinium group to the aromatic ring of F465
from PS1.
6.2.2 Region of PS1-CTF in contact with DREAM
In order to determine which regions of PS1-CTF are in contact with DREAM and
investigate the impact of Mg2+/Ca2+ on DREAM and PS1-CTF complex formation,
titrations of DREAM, DREAM with inactivated EF-hand 3 or 4, DREAM-C, and DREAM
chimeric constructs into PS1 derived peptides were conducted in the presence of 1 mM
Ca2+ and/or 5 mM Mg2+. The titration curve for DREAM binding to HL9 is shown in Figure
6.2 and the dissociation constants are summarized in Table 6.1.
Table 6.1: Dissociation constant (Kd) of DREAM binding to HLβ and HL9 in PS1-CTF
Kd (µM)

DREAM

HL9

2+

Ca DREAM
Ca2+/Mg2+DREAM
Mg2+DREAM

0.6 ± 0.1
0.7 ± 0.1
29 ± 2

ApoDREAM

183 ± 12
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HLβ

No binding

Figure 6.2: Titration curves for DREAM binding to HL9 (a) and HLβ (b) of PS1-CTF.
Solid lines correspond to the best fit using equation 3.63 in section 3.5.2.
HL9 binds to Ca2+DREAM and Mg2+Ca2+DREAM with a similar Kd of 0.6 µM. In
the absence of Ca2+, a weak interaction was determined for binding of HL9 to ApoDREAM
(Kd = 183 ± 12 µM), whereas the Kd value for HL9 association with Mg2+DREAM was
found to be 29 ± 2 µM. Unlike HL9, the HLβ does not form a complex with DREAM.
6.2.3 HL9 associates with DREAM at the carboxy-terminal domain
Since our titration data indicate that HL9 associates with DREAM in the presence
of Ca2+ and the Ca2+ binding sites are located at DREAM carboxy-terminal domain, I tested
whether DREAM-C provides a binding site for HL9. Titration data of HL9 binding to
DREAM-C (Figure 6.3) demonstrate that HL9 binds to Ca2+DREAM-C with a Kd of 11 ±
1 µM and a similar Kd was determined for association of HL9 with Ca2+Mg2+DREAM-C.
On the other hand, a weaker affinity was obtained for HL9 binding to Mg2+DREAM-C (Kd
~146 ± 12 µM) and no interaction was observed in the Apo form (Table 6.2).
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Figure 6.3: Titration curves for DREAM-C binding to HL9 of PS1-CTF in the presence
and absence of Ca2+. Solid lines correspond to the best fit using equation 3.63 in section
3.5.2.
Table 6.2: Dissociation constant (Kd) of DREAM-C binding to HL9 in PS1-CTF
Kd (µM)

Protein
Ca2+DREAM-C

11 ± 1

Ca2+/Mg2+DREAM-C

9±1

Mg2+DREAM-C

146 ± 12

ApoDREAM-C

No binding

6.2.4 Residues 200-207 in the DREAM flexible loop mediate HL9 association
Bioinformatics analysis of the carboxy-terminal domain of presenilin-interacting
proteins (DREAM and KChIP4) and a non-presenilin-interacting protein, such as NCS1
(Braunewell, 2005) suggests that the basic amino acid residues 200RHTYPILR207 in the
flexible loop connecting α7 and α8 (α7/α8 loop) of DREAM may play a role in regulating
the association of HL9 (Figure 6.4).

139

Figure 6.4: Sequence alignment of 66 amino acid residues in the carboxyl-terminus of
mouse DREAM with various members of KChIPs subfamily and NCS1 protein using
Clustal Omega program. The conserved hydrophobic residues at the binding interface with
HL9 are highlighted in green. The conserved basic residues at positions 200 and 207 in the
flexible loop of various members in KChIP subfamily are highlighted in blue. The neutral
residue and the acidic residue of NCS1 corresponding to positions 200 and 207 in flexible
loop are highlighted in grey and red, respectively. Aromatic residues corresponding to ππ stacking interaction with PS1 are in orange.
To test whether these residues functionally mediate interaction with HL9, titrations
of DREAM fused with NCS1 flexible loop (residues 200NTVELPEE207) were conducted.
The titration curve for HL9 binding to Ca2+DREAM-NCS1 (Figure 6.5a) demonstrates a
lower affinity (Kd = 38 ± 4 µM) and a negligible interaction was, observed for binding of
HL9 to ApoDREAM-NCS1.

Figure 6.5: Titration curves for HL9 binding to Ca2+DREAM-NCS1 (a) and Ca2+DREAMKChIP1 (b). Solid lines correspond to the best fit using equation 3.63 in section 3.5.2.
Since residues in the 7/8 loop are conserved among various members of KChIP
subfamily, I have also fused KChIP1 loop (200KYTYPVLK207) into 7/8 loop of
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DREAM and determined dissociation constant for binding to HL9 (Figure 6.5b).
Interestingly, the HL9 binds to DREAM-KChIP1 with a lower affinity compared to that of
DREAM (Kd = 3.9 ± 0.7 µM).
6.2.5 Binding of Ca2+ at EF-hand 3 functionally modulates the interaction of
DREAM with HL9
To investigate the mechanism by which Ca2+ binding to EF-hands 3 and 4 in
DREAM mediates DREAM and HL9 interactions, binding of HL9 to DREAM-E234Q and
DREAM-E186Q were studied. Titration data demonstrate that HL9 binds to DREAME234Q in the presence of Ca2+ and Ca2+/Mg2+ with a Kd of 8 µM (Figure 6.6a), whereas a
weaker binding (Kd = 32 µM) was observed for DREAM-E186Q mutant (Figure 6.6b).

Figure 6.6: Titration curves for HL9 binding to Ca2+DREAM-E234Q (a) and
Ca2+DREAM-E186Q (b). Solid lines correspond to the best fit using 3.63 in section 3.5.2.
These results also show that weak interaction was determined for HL9 binding to
Mg2+DREAM-E234Q and Mg2+DREAM-E186Q. In addition, the HL9 exhibits very weak
interaction with the Apo form of these DREAM mutants (Table 6.3).
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Table 6.3: Dissociation constant (Kd) for HL9 binding to DREAM EF-hand mutants
Kd (µM)
DREAM-E234Q
(active EF-hand 3 )
8±1

DREAM-E186Q
(active EF-hand 4)
32 ± 1

7±1

30 ± 2

Mg2+

68 ± 5

55 ± 2

Apo

146 ± 14

149 ± 22

Ca2+
Ca2+Mg2+

6.2.6 Oligomerization states of DREAM in complex with HL9
Since alternative oligomerization states of DREAM directly mediate the
interactions with intracellular proteins and DNA and this process depends on Ca2+/Mg2+
occupancy at EF-hands (Osawa et al., 2001; Osawa et al., 2005; Lusin et al. 2008; Gonzalez
and Miksovska, 2014), the oligomeric states of DREAM in complex with HL9 were
characterized. The anisotropy decay traces for HL9 (circles) and Ca2+DREAM:HL9
complex (squares) are shown in Figure 6.7a.
The data were fit into a two rotational correlation-time model where the fast
rotational correlation time (θ2) corresponds to the local rotation of FITC and the slow
rotational correlation time (θ1) reflects global rotation of HL9 or DREAM bound HL9
(Table 6.4). The values of local rotation of FITC probe in HL9 and in the complex of
DREAM and HL9 are almost identical (θ2 ~1 ns), whereas the global rotation values
increase from 2 ns in the case of HL9 in buffer solution to 12 ns and 20 ns when HL9 is
bound to Mg2+DREAM and Ca2+DREAM/Ca2+Mg2+DREAM, respectively. With the
known molecular weight of HL9 and DREAM, the values of θ1 for DREAM monomer
binding to one HL9 and DREAM dimer binding to two HL9 are estimated to be 11.4 ns
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and 22.7 ns, respectively, using a degree of hydration of 0.43 ml g-1 for a spherical protein
at 20 °C (Weber, 1953; Fischer et al., 2004). The experimentally determined θ1 value for
Mg2+DREAM and HL9 complex is 11.8 ns which matches well with the expected value of
DREAM monomer bound to one HL9. However, the experimental θ1 value for HL9 in
complex with Ca2+DREAM/Ca2+Mg2+DREAM was determined to be 20 ns, which is about
2 ns faster than the expected correlation time of a dimeric DREAM bound to two HL9.
These results suggest that the structure of DREAM is more rigid when Ca2+ is bound to
EF-hands 3 and 4.

Figure 6.7: Panel (a) is time-resolved anisotropy of HL9 in buffer solution (circles) and
HL9 bound Ca2+DREAM (square). Differential phase angle and modulation ratio are
shown as solid and empty symbols, respectively. Panel (b) is a Job plot curve represents a
1:1 stoichiometry for molecular association of HL9 with Ca2+DREAM.
Furthermore, the Job plot (Figure 6.7b) shows a maximum at HL9 mole fraction
(XHL9) of 0.5, what is consistent with a 1:1 stoichiometry for molecular association of
HL9 with Ca2+DREAM (Olson and Bühlmann, 2011; Furlong et al., 2013). These results
further suggest that a dimeric DREAM binds to two HL9 in the presence of Ca2+ or
Ca2+Mg2+.
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Table 6.4: Time-resolved anisotropy parameters for DREAM and HL9 complex
θ1
(ns)

r1a

θ2 a
(ns)

r2a

χ2

HL9 in buffer

1.7 ± 0.2

0.12

0.4

0.24

0.6

Mg2+DREAM:HL9

11.8 ± 2.0

0.05

0.8

0.26

0.7

Ca2+DREAM:HL9

20.4 ± 0.8

0.25

0.8

0.14

0.3

Ca2+Mg2+DREAM:HL9

19.3 ± 0.7

0.26

0.7

0.13

0.3

experimental error ≤ 4 %; θ1 and θ2 is a slow and fast rotational correlation
times, respectively; r1 and r2 are fluorescence anisotropy amplitudes
corresponding to θ1 and θ2, respectively.
a

6.2.7 Kinetics of HL9 association with DREAM
Binding of HL9 to DREAM leads to an increase in emission intensity at 520 nm
due to the fluorescence resonance energy transfer (FRET) between W169 in DREAM and
FITC label on HL9 (inset in Figure 6.8).

Figure 6.8: Titration curves for HL9 binding to Ca2+DREAM by monitoring FITC
fluorescence emission change at 520 nm (inset figure). Solid lines correspond to the best
fit using equation 3.63 in section 3.5.2. The dissociation constant was determined to be 0.6
μM.
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By monitoring emission intensity change at 520 nm as a function of DREAM
concentration, dissociation constant of HL9 association with Ca2+DREAM was determined
to be 0.6 ± 0.1 µM (Figure 6.8). The determined Kd in this titration is comparable with the
Kd previously obtained in steady-state anisotropy measurements. The results suggest an
increase in the emission intensity of fluorescein probe can be used to probe kinetics of HL9
interactions with DREAM.
A representative kinetics trace for HL9 binding to Ca2+DREAM is shown in Figure
6.9a. The dissociation rate constant (koff) of HL9 from ApoDREAM was determined by
addition of EDTA to Ca2+DREAM:HL9 solution and a decrease of emission intensity at
520 nm was monitored (Figure 6.9b). The equilibrium dissociation constant calculated
from the ratio of the dissociation rate constant (koff = 1.0 s-1) to association rate constant
(kon = 0.6 x 106 M-1s-1) is in excellent agreement with the Kd determined from titration
experiments (Table 6.5).

Figure 6.9: Kinetics trace for association of HL9 to Ca2+DREAM (a) and dissociation of
HL9 from ApoDREAM (b) monitored by change in the fluorescence intensity at 520 nm.
The solid line represents single exponential fitting curve.
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Table 6.5: Kinetic parameters for HL9 association with Ca2+DREAM
Activation energy (Ea)(a)

15.9 ± 3.1 kcal mol-1

Association rate constant (kon)

0.6 x 106 M-1s-1

Dissociation rate constant (koff)

1.0 s-1

(a)

Ea and error were determined from the mean and standard
deviations of three independent measurements, respectively.
Our kinetics data showed that the rate constant for the formation of Ca2+DREAMHL9 complex is temperature and concentration dependent. The kinetics experiment was
carried out at different temperatures, from 281 to 297 ºK, and at various Ca2+DREAM
concentrations, from 1 to 7.5 µM. The apparent first order rate constants (kobs) for
association of HL9 to each Ca2+DREAM concentration and at each temperature was
recovered and analyzed by using the first order exponential decay model. The activation
energy (Ea) was calculated from the slope (-Ea/R) of the Arrhenius plot (Figure 6.10).

Figure 6.10: The Arrhenius plot of HL9 association with Ca2+DREAM. Ea and
experimental error were determined from the mean and standard deviations of three
independent measurements, respectively.
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The activation barrier for HL9 association to Ca2+DREAM was found to be 15.9 ±
3.1 kcal/mol (Table 6.5) suggesting for a large conformational change on the HL9 docking
site on Ca2+DREAM protein upon the complex formation. The high activation energy can
be attributed to the structural changes, which results in a decrease of flexibility of long loop
connecting α7 in EF-hand 3 and α8 in EF-hand 4 of DREAM protein (Figure 6.1).
To examine if the kinetics curves of HL9 association to Ca2+DREAM include any
diffusional components, I performed kinetics experiment with increasing in Ca2+DREAM
concentration (1 to 7.5 µM). Apparent association rate constants (kobs) were plotted against
varied Ca2+DREAM concentrations (Figure 6.11) showed that the association rate constant
(kon) is 0.6 x 106 M-1s-1 and the dissociation rate constant (koff) is 1.0 s-1 (Table 6.5).

Figure 6.11: Apparent association rate constants (kon(obs)) were plotted against
Ca2+DREAM concentrations. The association rate constant (kon) and the dissociation rate
constant (koff) were determined to be is about 0.6 x 106 M-1s-1 and 1.0 s-1, respectively.
The association rate constant (0.6 x 106 M-1s-1) occurs within the range for
bimolecular rate constants on the order of 106 M-1s-1, which is about three-order in
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magnitude slower than the diffusion-limited association rate constant for a typical small
spherical protein of 18Å radius (7 x 109 M-1s-1) (Northrup and Erickson, 1992). These
results suggest that the association of HL9 with Ca2+DREAM excludes diffusional
components.
6.2.8 Residue F252 plays an important role in regulating the interaction of
DREAM with presenilin 1
To test whether residue F252 in DREAM plays a crucial role in regulating the
interaction of DREAM with PS1-HL9, titrations of 20 μM DREAM with F252 replaced by
A (herein named DREAM-F252A) into 0.5 μM of PS1-HL9 in the presence and absence
of 1 mM Ca2+ were conducted (Figure 6.12).

Figure 6.12: The bar plot represents titrations of 20 μM of Ca2+DREAM, ApoDREAM,
Ca2+DREAM-F252A, and ApoDREAM-F252A into 0.5μM PS1-HL9.
The results show that replacement of residue F252 in DREAM by alanine
significantly reduces anisotropy changes observed for PS1-HL9 association to either Ca2+
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bound or free form of DREAM. These results confirm that F252 in DREAM plays an
important role in regulating the interaction DREAM with PS-HL9.
Furthermore, the computational docking data reveal that the Ca2+DREAM-PS1CTF complex is also stabilized by salt bridge interactions between residues R200 and R207
from the loop connecting 7 and 8 in DREAM and the residues D450 and D458 from
HL9 of presenilin 1 (Figure 6.1). To test whether these salt bridge play an important role
in modulating the interaction of DREAM with presenilin 1, titration of Ca2+DREAM into
PS1-HL9 was conducted in buffer solution containing high concentration of salt (0.3 M
NaCl) (Figure 6.13). The titration data show that binding of Ca2+DREAM to HL9 is salt
independent with a Kd similar to that observed in the absence of salt (0.6 μM).

Figure 6.13: Titration curves for HL9 binding to Ca2+DREAM in the presence of 0.3 M
NaCl. The Solid line corresponds to the best fit using equation 3.63 in section 3.5.2.
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6.2.9 Binding of PS1-CTF to DREAM inhibits the interaction of NS5806 drug
compound with DREAM
Previous studies in our laboratory demonstrated that binding of the drug compound
NS5806 at the hydrophobic site on the C-terminus of DREAM increases the binding
affinity between DREAM and the N-terminus of K+ channel Kv4.3 (Gonzalez, Pham et al.,
2014). The dissociation constant of NS5806 for Ca2+DREAM was previously determined
to be 2.5 μM (Gonzalez, Pham et al., 2014). Interestingly, the residues Y174, F218, and
F252 in DREAM (Figure 6.1) are responsible not only for the NS5806 drug binding but
also for interaction with the HL9 in presenilin 1. Therefore, I speculated that the determined
DREAM–presenilin interface hot spots (Figure 6.1) are druggable pockets for NS5806
compound that binds to DREAM and inhibits the interaction between DREAM and
presenilin 1.

Figure 6.14: Titration of NS5806 into the Ca2+DREAM-HL9 complex. The dissociation
constant was determined by fitting the data using a single binding site displacement
equation 3.64 in section 3.5.2.
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To test that hypothesis, the titration of NS5806 into the Ca2+DREAM and HL9
complex was conducted (Figure 6.14). Titration data show that binding affinity of NS5806
to Ca2+DREAM significantly decreases (Kd = 97 μM) in the presence of PS1-HL9. The
binding affinity of NS5806 for Ca2+DREAM in the presence of PS1-HL9 significantly
decreases compared to that determined in the absence of PS1-HL9 suggesting that binding
of PS1-HL9 to DREAM blocks the docking site of NS5806 drug compound for DREAM
at the hydrophobic residues Y174, F218, and F252 in DREAM.
6.3 Discussion
Previous studies have shown that DREAM and KChIP4 bind to the CTF of PS1
and PS2, however, the role of Ca2+/Mg2+ in regulating protein-protein interactions remains
unclear. By using co-immunoprecipitation, Choi et al. have reported that the interaction of
DREAM and PS2 is calcium independent (Choi, Zaidi et al. 2001), whereas Jo et al. have
reported that DREAM association with PS1-CTF stimulates the activity of γ-secretase and
facilitates production of Aβ42 plaques in Alzheimer’s disease in the presence of Ca2+ (Jo,
Jang et al. 2005b). Titration data show that Ca2+DREAM binds to HL9 with high affinity
(Kd = 0.6 µM), whereas negligible binding was observed in the Apo form (Kd = 183 µM).
In addition, identical dissociation constants were determined for HL9 association HL9 with
Ca2+DREAM and Ca2+Mg2+DREAM suggesting that Ca2+ but not Mg2+ functionally
regulates interactions between DREAM and HL9. The titration data also demonstrate that
DREAM does not interact with HLβ suggesting that the region in PS1 interfacing with
DREAM comprises amino acid residues from HL9 (residues 445 - 467). These
observations are consistent with previous studies demonstrating that the carboxy-terminal
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region in PS1 (residues 425 - 467) binds to DREAM and the homologous protein KChIP4
(Buxbaum, Choi et al. 1998, Morohashi, Hatano et al. 2002).
These results are in agreement with the model structure of Ca2+DREAM:PS1-CTF
determined by protein-protein docking. The assembly of Ca2+DREAM and PS1-CTF
involves two interaction interfaces on DREAM protein. The first binding interface is
formed by residues from the dynamic loop connecting α7 and α8 in DREAM, namely R207
which forms salt bridges with D450 and D458 from PS1 and R200 in DREAM which is
involved in cation- interactions with F465 in PS1. The second interface is provided by
hydrophobic residues located in the cavity between α7 and α10 of the DREAM carboxyterminal domain (Figure 6.1), namely residues M191, I194, M197, M198, M249, F252,
V255, and I256 in DREAM which forms an aromatic cluster with F462 and F465 from
PS1. The location of the binding sites in DREAM carboxy-terminal domain is confirmed
by titration data between HL9 and DREAM-C. HL9 binds to DREAM-C with a Kd that is
10 times lower than that determined for the full length DREAM. Since the NMR structure
of the isolated DREAM-C in the presence of Ca2+ is nearly identical to the structure of the
Ca2+ bound carboxy-terminal domain of the full length protein, the observed decrease in
the DREAM-C affinity for HL9 reflects a distinct organization of individual monomers
within the DREAM-C dimer due to the lack of amino-terminal domain in DREAM-C
compared to DREAM (Yu et al., 2007; Lusin et al., 2008).
To understand the mechanism of how Ca2+ regulates DREAM and PS1-CTF
interactions, the structure of Ca2+DREAM was superposed with the model structure of
ApoDREAM (Pham et al., 2015) as shown in Figure 6.15. In the ApoDREAM structure,
the aromatic ring of F252 rotates ~90 degrees preventing π-π stacking with aromatic rings
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of F462 and F465 from PS1 and destabilizing the aromatic cluster between phenylalanine
residues from DREAM and PS1-CTF. In addition, the guanidinium group of R200 points
away from the center of aromatic ring of F465 in PS1, weakening the interactions between
7/8 loop and PS1. Also in the Ca2+ bound DREAM, α10 moves away from α7,
enhancing the accessibility of the hydrophobic cavity between α7 and α10 in Ca2+DREAM.
A high activation energy observed for HL9 association with Ca2+DREAM, likely
reflects a conformational changes in the DREAM carboxyl domain during HL9 binding.
This structural rearrangement at the binding interfaces may include the repositioning of
α10 away from α7 as well as a reduction in the flexibility of 7/8 loop of DREAM.
Increased accessibility of the carboxyl cavity in the Ca2+ bound DREAM was previously
observed using hydrophobic fluorescent probes and associated with the increased DREAM
affinity for arachidonic acid and site one of KV channel (Gonzalez, Pham et al., 2014).

Figure 6.15: Left: Superposed structures of Ca2+DREAM (PDB code: 2JUL, molecule 1,
cyan) and molecular dynamics simulation structure of ApoDREAM (yellow). Alpha
helices 1 – 10 in DREAM are labeled by α1 – α10, respectively. The movement of α10
away from α7 is indicated by black arrows. Right: aromatic ring of F252 in ApoDREAM
rotates ~90 degrees with respect to aromatic ring of F252 in Ca2+ bound DREAM. The
guanidinium group of R200 in ApoDREAM points 180 degrees away with respect to that
of Ca2+DREAM.
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The relevance of the flexible loop in DREAM to association of HL9 is further
highlighted by titration of HL9 with Ca2+DREAM-NCS1 chimera construct. These results
show that binding affinity for HL9 to Ca2+DREAM-NCS1 is decreased (Kd = 38 µM, ΔG
= - 5.9 kcal mol-1) compared to that of DREAM (Kd = 0.6 µM, ΔG = - 8.3 kcal mol-1). The
difference in binding affinity is expressed in terms of difference in the free energy (ΔΔG)
of - 2.4 kcal mol-1 which is comparable to the formation energy of a salt bridge. The binding
affinity of HL9 to Ca2+DREAM-KChIP1 chimera is only partially reduced (Kd = 3.9 µM,
G = -7.2 kcal mol-1). Amino acid sequence alignment of mouse DREAM with various
KChIP members and NCS1 protein shows that the hydrophobic residues in the DREAM
carboxyl terminus are well conserved and thus selectivity for PS1/PS2 is modulated by
residues located in the 7/8 loop (Figure 6.4). For instance, the substitution of basic
residues R200 and R207 in DREAM by a neutral residue N200 and an acidic residue E207
from NCS1 is likely responsible for reducing the binding affinity of DREAM-NCS1
chimera and HL9. Also, a replacement of R200 in DREAM by K200 from KChIP1 may
contribute to the lower binding affinity of DREAM-KChIP1 chimera and HL9 due to a
weaker cation-pi interaction between Phe and Lys compared to that of Phe and Arg
(Andrew et al., 2002). However, addition of 300 mM NaCl does not affect binding affinity
of HL9 and Ca2+DREAM (Figure 6.13) suggesting that interactions between Ca2+DREAM
and HL9 comprise predominantly van der Waals contacts among hydrophobic residues
exemplified by interactions of F462 and F465 residues from HL9 with F252 in α10 in
DREAM as well as the residues at the hydrophobic crevice near α10.
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Moreover, binding of PS1-CTF to DREAM inhibits interaction of the NS5806 drug
compound with DREAM. Furthermore, the highly conserved amino acid residues at the
region of HL9 in both PS1 and PS2 suggest that DREAM may also interact with PS2 with
similar binding interfaces as determined in the DREAM and PS1 complex.
6.4 Summary
The results presented here provide insight into the nature of binding interfaces
between DREAM and HL9 peptide and demonstrate the role of Ca2+/Mg2+ in
DREAM:HL9 complex formation. The hydrophobic cavity in the DREAM carboxyterminal domain provide the binding site for HL-9 from presenilin and the complex is
stabilized through interactions between the dynamic loop between helix 7 and 8 in DREAM
and HL9 residues. The identified DREAM-presenilin interface hot spots provide druggable
pockets for structure-based development of a novel drug compound that binds to DREAM
and inhibits the interaction of DREAM with presenilin as an efficient treatment of
Alzheimer’s disease.
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7. THE ROLE OF INDIVIDUAL EF-HANDS IN MODULATING DREAM
CONFORMATIONAL DYNAMICS AND INTERACTION WITH DNA
(The results in this chapter were described in a manuscript that will be submitted to the
Biochemistry journal by Pham and Miksovska)
7.1 Background and significance
Downstream regulatory element antagonist modulator, also known as K+ channel
interacting protein 3 (KChIP3) or calsenilin, is a neuronal calcium sensor (NCS) protein
that acts as a transcriptional repressor of prodynorphin/c-fos gene to modulate pain
signaling in the spinal cord (Buxbaum et al., 1998; Carrion et al., 1999; An et al., 2000;
Cheng et al., 2002). Structurally, DREAM contains four EF-hand Ca2+ binding motifs, of
which EF-hand 1 does not bind Ca2+/Mg2+ due to the presence of conserved residues C104
and P105 on the first EF-hand (Flaherty et al., 1993). In addition, EF-hand 2 selectively
binds Mg2+ with a high affinity (Kd ~ 13 µM), whereas EF-hands 3 and 4 exclusively bind
to Ca2+ with a relatively high affinity (Kd ~ 1 µM) (Osawa et al., 2005). Functionally,
interactions of DREAM with intracellular target proteins and DNA are either Ca2+
dependent or independent. These interactions are involved in numerous physiological
functions, including prodynorphin/c-fos gene transcriptional repression (Carrion et al.,
1999; Osawa et al., 2001), potassium channel activity modulation (An et al., 2000),
enhancement of calcineurin activation by binding to calmodulin (Ramachandran et al.,
2012), modulation of presenilins enzymatic activity (Buxbaum et al., 1998; Buxbaum,
2004, Pham and Miksovska 2016), neuronal apoptosis, and Ca2+ signaling in the
endoplasmic recticulum (Buxbaum et al., 1998; Leissring et al., 2000; Jo et al., 2001;
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Lilliehook et al., 2002; Jo et al., 2004; Jo et al., 2005; Fedrizzi et al., 2008; Jang et al.,
2011). The mechanism of pain processing by transcriptional repression of prodynorphin/cfos gene has gained much attention in recent decades (Carrion et al., 1999; Osawa et al.,
2001; Cheng et al., 2002, Costigan and Woolf, 2002; Osawa et al., 2005; Lusin et al, 2008).
However, a detailed insight into the molecular mechanism of DREAM interaction with
downstream regulatory elements (herein named DNA) of prodynorphin/c-fos gene, the
functional role of individual EF-hands in regulating the DREAM conformational dynamics
and oligomerization of the DREAM-DNA complex formation remain unclear.
The critical barrier for envisioning the molecular mechanism of interaction between
DREAM and DNA lies in unknown structures of the Apo and Mg2+DREAM. The primary
goal of this study was to delineate the structure-dynamics-function relationship of DREAM
in modulating the interaction with DNA. To accomplish this goal, the impact of Mg2+
and/or Ca2+ on the conformational dynamics of DREAM and functional EF-hands 2, 3, and
4 were characterized in order to highlight the role of individual EF-hands. The interaction
between DREAM and DNA in the Ca2+ and/or Mg2+ dependent was also identified by
characterizing the association of DNA with DREAM and DREAM EF-hand mutants. The
binding interface of the ApoDREAM-DNA complex, as well as the conformational
dynamics of ApoDREAM upon DNA association, were also examined using
computational approaches. Recently, advances in computational chemistry, including
computational docking (Comeau et al. 2004; Comeau et al., 2004; van Dijk et al., 2006; de
Vries et al., 2010; Lyskov and Gray, 2008; van Dijk and Bonvin, 2009), molecular
dynamics simulations (Brooks et al., 1983), and protein dynamical network analysis (Sethi
et al., 2009), have opened the opportunity not only to visualize the binding interface
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between DREAM and DNA, but also to observe the dynamic structures of DREAM in the
Apo, Mg2+, and Ca2+ bound forms at the level of individual amino acid residue. In addition,
distinct signaling pathways, propagated by Ca2+ and Mg2+ from their binding sites to the
DNA binding interface. The results of computational studies were integrated with
experimental information to elucidate the structure-function relationship of DREAM in
modulating the interaction with DNA.
I employed isothermal titration calorimetry (ITC) to investigate the association of
DNA to DREAM and DREAM EF-hand mutants in terms of binding affinity (Kd), binding
stoichiometry (n), and binding energy (ΔH). Additionally, the oligomeric states of
DREAM in complex with DNA were characterized using fluorescence anisotropy decays.
In parallel, the roles of individual EF-hands 2, 3, and 4 in DREAM were also investigated
by analyzing fluorescence emission and lifetimes of the intrinsic tryptophan residue
(W169) in DREAM EF-hand mutants. Lastly, the binding interfaces between ApoDREAM
and DNA were determined using a combination of computational docking (de Vries et al.,
2010), molecular dynamics (MD) simulation (Phillips et al., 2005), and dynamical network
analysis (Sethi et al., 2009; Alexander et al., 2010).
7.2 Results
7.2.1 Steady-state emission spectra of tryptophan.
The single tryptophan residue (W169) in DREAM, located at the interface between
the N- and C-terminal domains, is an ideal fluorescence probe for investigation of the
protein conformational dynamics of DREAM EF-hand mutants upon binding to Ca2+
and/or Mg2+ (Pham et al., 2015). The approach enables us to elucidate the functional role
of each EF-hands in DREAM. The emission spectra of DREAM EF-hand 2 mutant
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(DREAM-D150N) are almost identical in the Apo and Mg2+ forms, with the emission
maximum centered at 340 nm (Figure 7.1, left panel). Ca2+ association at EF-hands 3 and
4 in DREAM-D150N mutant leads to a decrease in emission intensity along with 5 nm
blue-shift of emission maximum in the Ca2+DREAM emission spectrum compared to that
obtained in the Apo or Mg2+ form (Figure 7.1, left panel).

Figure 7.1: Tryptophan (W169) emission spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ bound
DREAM-D150N (left panel) and DREAM-E186Q (right panel) upon excitation at 295 nm.
Conditions: 40 µM DREAM in 20 mM Tris pH 7.4, 10 mM LDAO, and 1 mM DTT.
These results suggest that Ca2+ association to DREAM-D150N propagates
structural rearrangement, by which W169 residue becomes more buried in a hydrophobic
environment in a similar way as observed previously for DREAM wild-type (DREAMWT) described in chapter 4 (Pham et al., 2015). However, a small but reproducible
deviation was observed in the emission spectra of DREAM-D150N relative to that of
DREAM-WT. Upon Ca2+ association, emission intensity of Ca2+DREAM decreases about
18% relative to that of ApoDREAM as previously described in section 4.2.1 (Pham et al.,
2015). On the other hand, the emission intensity of Ca2+DREAM-D150N decreases about
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11% compared to that of ApoDREAM-D150N. These results suggest a small structural
difference in either the Apo or Ca2+ bound form of DREAM-D150N compared to DREAM,
but overall the mutation D150  N at EF-hand 2 in DREAM does not affect the
conformational transition triggered by Ca2+ in the protein.
The association of Ca2+ to DREAM EF-hand 3 mutant (DREAM-E186Q) leads to
a small but reproducible decrease in emission intensity (~ 2%) along with a 2 nm blue-shift
of emission maximum in Ca2+DREAM-E186Q emission spectrum relative to that observed
in the ApoDREAM-E186Q (Figure 7.1, right panel). These results illustrate that Ca2+
association to EF-hand 4 in DREAM-E186Q does not trigger a significant change in the
protein tertiary structure, suggesting that the side chain of W169 residue remains solvent
exposed in the Ca2+ bound form.
On the other hand, Ca2+ association to DREAM EF-hand 4 mutant (DREAME234Q) results in about 11% decrease in the emission intensity along with 5 nm blue-shift
of emission maximum on Ca2+DREAM-E234Q emission spectrum relative to that
ApoDREAM-E234Q (Figure 7.2). These changes in emission intensity and hypsochromic
shift are similar to that obtained in DREAM-D150N mutant and DREAM wild-type. These
results indicate that binding of Ca2+ at EF-hand 3 induces structural transition in DREAME234Q mutant. In contrast, association of Mg2+ to ApoDREAM-E234Q does not lead to
changes in W169 surrounding as evident from the emission spectrum of ApoDREAME234Q is similar to that of Mg2+DREAM-E234Q. Interestingly, emission intensity of
Ca2+Mg2+DREAM-E234Q is increased about 5% relative to that of the Ca2+DREAME234Q.
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Figure 7.2: W196 emission spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ bound DREAME234Q. Conditions: 40 µM DREAM in 20 mM Tris pH 7.4, 10 mM LDAO, and 1 mM
DTT.
These results suggest that the replacement of E234 by Q leads an increase the
binding affinity for Mg2+ at EF-hand 4 with Mg2+ binding to EF-hand 4 impacts the
emission of W169. Also, we cannot exclude the mutation of EF-hand 4 impacts the
emission properties of W169 in the Mg2+ bound DREAM.
7.2.2 Association of Ca2+ triggers changes in hydrophobicity at the surface of
DREAM-EF hand mutants
Previous work in our lab demonstrated that a large hydrophobic pocket exists on
the surface of DREAM wild-type (Gonzalez and Miksovska, 2014). As the apolar cavity
may provide a binding site for small hydrophobic molecules, surface hydrophobicity of
DREAM was further explored. DREAM EF-hand mutants and their Ca2+ and/or Mg2+
bound forms were studied using steady-state fluorescence spectroscopy. Extrinsic
fluorophores 8-anilino 1-naphathalene sulfonate (1,8-ANS) and 6-anilino 2-naphthalene
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sulfonate (2,6-ANS) were employed to probe the surface hydrophobicity due to their high
sensitivity to their local environment.
The increase in emission intensity of 1,8-ANS in the presence of DREAM-D150N
indicates that ANS association to the protein is independent of deactivated EF-hand 2.
Significant increase in emission intensity was observed upon Ca2+ association to both Apo
and Mg2+DREAM-D150N (Figure 7.3, left panel). Interestingly, the emission spectra of
1,8-ANS bound to Ca2+- and Ca2+Mg2+DREAM-D150N are similar suggesting that the
change in surface hydrophobicity is dependent solely on Ca2+ association. Moreover,
previous studies have shown that Mg2+ binding to DREAM wild-type leads to a small but
reproducible increase in the 1,8–ANS emission compared to that of Apo form (Gonzalez
and Miksovska, 2014). In contrast, association of Mg2+ to ApoDREAM-D150N does not
change in 1,8–ANS emission intensity relative to that of Apo form suggesting that the
replacement of D150 by N abolishes the association of Mg2+ at EF-hand 2.

Figure 7.3: Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS (right
panel) bound to DREAM-D150N (40 µM). The excitation wavelength was 350 nm and
319 nm for 1,8-ANS and 2,6-ANS, respectively.
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The results for 2,6-ANS bound to DREAM-D150N are consistent with those
obtained using 1,8-ANS probe (Figure 7.4, right panel). A significant increase in the
emission intensity of 2,6-ANS upon Ca2+ association to both Apo and Mg2+DREAMD150N was observed. Likewise, the emission intensity of 2,6-ANS is remained unchanged
in both Apo and Mg2+ forms.
Furthermore, the same fluorescence emission pattern was observed in EF-hand 3
mutant. Emission intensity change obtained for either 1,8-ANS or 2,6-ANS bound to
DREAM-E186Q upon Ca2+ association to both the Apo and Mg2+ forms was comparable
to the aforementioned results for DREAM-D150N (Figure 7.4, left and right panels,
respectively). Likewise, identical change in emission intensity was also observed for either
1,8- or 2,6-ANS bound to the Apo and Mg2+ forms of DREAM-E186Q.

Figure 7.4: Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS (right
panel) bound to DREAM-E186Q (40 µM). The excitation wavelength was 350 nm and
319 nm for 1,8-ANS and 2,6-ANS, respectively.
Furthermore, the identical results were also observed in the emission intensity of
both 1,8- and 2,6-ANS in the presence of Apo and Mg2+DREAM-E234Q (Figure 7.5 left
and right panels). A further increase in intensity was obtained upon Ca2+ association to

163

both the Apo and Mg2+ forms. However, association of Mg2+ to ApoDREAM-E234Q leads
to a small but reproducible increase in the 1,8- and 2,6-ANS emission intensity relative to
that of the Apo form. These results suggest that Mg2+ binding to EF-hand 4 may impact the
emission of ANS, or the mutation of EF-hand 4 may affect the emission properties of ANS
in the Mg2+ bound form.

Figure 7.5: Fluorescence emission spectra of 1,8-ANS (left panel) and 2,6-ANS (right
panel) bound to DREAM-E234Q (40 µM). The excitation wavelength was 350 nm and
319 nm for 1,8-ANS and 2,6-ANS, respectively.
7.2.3 Fluorescence intensity decay of tryptophan
Since the tryptophan fluorescence lifetime is highly sensitive to small variations in
the fluorophore environment, probing the lifetime of W169 in DREAM provides further
insight into Ca2+ and/or Mg2+ induced changes in protein dynamics. The W169 lifetime
data of DREAM mutants were best fit using a combination of Gaussian distribution and
discrete exponential model. Goodness of the fits was judged based on residuals and the 2
value of the non-linear least square fitting curve. The W169 lifetime parameters of
DREAM EF-hand mutants are summarized in Table 7.1.
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The DREAM-D150N (Figure 7.6, left panel) exhibits two distinct lifetimes, of
which the discrete lifetime component (2) of 7.4 ns is Ca2+ independent, whereas Gaussian
distribution lifetime component (1) varies upon Ca2+ binding to the Apo or Mg2+ forms.
In the Apo form, the components 1 is centered at 2.9 ns with a distribution width (w1) of
1.3 ns. Upon Ca2+ association, these values of 1 and w1 decrease to 1.9 ns and 0.7 ns,
respectively. In addition, the fractional contribution of the Gaussian distribution (f1) also
decreases from 39% in the Apo to 16% for the Ca2+ bound form. These results are similar
to the results determined for DREAM-WT (see Chapter 4).

Figure 7.6: Frequency domain W169 intensity decay of Apo, Mg2+, Ca2+, and Ca2+Mg2+
bound DREAM-D150N (left panel) and DREAM-E186 (right panel). The solid lines
represent the data fitting using a combination of Gaussian distribution and discrete
exponential decay model. The recovered parameters are shown Table 7.1.
In contrast, Ca2+ association at EF-hand 4 in DREAM-E186Q (Figure 7.6, right
panel) does not induce a structural change in the protein as evident from constant lifetime
components 1 of 2.1 ns and 2 of 5.9 ns in both Apo and Ca2+ and/or Mg2+ bound forms.
In addition, the Gaussian distribution width (w1) and the fractional contribution (f1)
parameters are almost identical in the Ca2+ free and Ca2+ bound forms of the protein.
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On the other hand, Ca2+ association at EF-hand 3 in DREAM-E234Q (Figure 7.7)
induces similar change in protein dynamics as observed for DREAM-WT and DREAMD150N mutant. Namely, Ca2+ association leads to a decrease in W169 lifetime component
1 from 2.5 ns in the Apo to 1.8 ns for the Ca2+ bound form.

Figure 7.7: Frequency domain intensity decay of Apo, Mg2+, Ca2+, and Ca2+Mg2+ bound
DREAM-E234Q (40 μM). The solid lines represent the data fitting using a combination
of Gaussian distribution and discrete exponential decay model
Moreover, the Gaussian distribution width (w1) becomes narrower in the Ca2+
bound form (0.76 ns) compared to that obtained for the Apo or Mg2+ form (1.1 ns). Similar
to other DREAM constructs, the W169 lifetime component 2 of DREAM-E234Q (6.3 ns)
is independent of Ca2+ association. Our fluorescence lifetime results suggest that Ca2+
association at EF-hand 3 but not EF-hand 4 triggers significant alteration in the tertiary
structure and/or modulates conformational flexibility of DREAM protein. These results are
in accordance with that obtained in the steady-state emission study.
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Table 7.1: Emission decay parameters of W169 in DREAM EF-hand mutants using a
continuous Gaussian distribution and a discrete component.
1

w1

f1

2

f2

(ns)

(ns)

(%)

(ns)

(%)

Apo

2.9

1.29 ± 0.04

39.2

0.62 ± 0.02

7.4

60.8

0.38 ± 0.02

5.6

0.9

Mg2+

2.8

1.20 ± 0.08

34.6

0.58 ± 0.05

7.4

65.4

0.42 ± 0.05

5.8

0.6

1.9

0.72 ± 0.07

16.2

0.45 ± 0.02

7.4

83.8

0.55 ± 0.02

6.5

0.9

1.8

0.70 ± 0.04

16.0

0.43 ± 0.04

7.4

84.0

0.57 ± 0.04

6.5

1.1

Apo

2.1

0.82 ± 0.08

22.1

0.44 ± 0.01

5.9

77.9

0.56 ± 0.01

5.0

1.0

Mg2+

2.1

0.82 ± 0.04

23.5

0.46 ± 0.01

5.9

76.5

0.54 ± 0.01

5.0

1.4

2.2

0.88 ± 0.03

24.8

0.47 ± 0.01

5.9

75.2

0.53 ± 0.01

5.0

1.1

2.1

0.85 ± 0.07

22.8

0.44 ± 0.05

5.8

77.2

0.56 ± 0.05

5.0

3.4

2.5

1.11 ± 0.01

33.1

0.54 ± 0.01

6.3

66.9

0.46 ± 0.01

5.0

0.7

2.4

1.00 ± 0.01

31.3

0.55 ± 0.01

6.3

68.7

0.45 ± 0.01

5.0

0.8

1.8

0.76 ± 0.02

18.7

0.45 ± 0.01

6.3

81.3

0.55 ± 0.01

5.4

0.9

1.8

0.74 ± 0.04

18.8

0.45 ± 0.02

6.3

81.2

0.55 ± 0.02

5.4

0.9

DREAM-D150N

Ca

2+

Ca2+Mg2+

1

α2

<>
(ns)

2

DREAM-E186Q

Ca

2+

Ca2+Mg2+
DREAM-E234Q
Apo
Mg

2+

Ca2+
2+

Ca Mg

2+

A constant standard error of 0.2 for the phase angle and 0.004 for modulation ratio was used. 1 is the
mean decay time of the Gaussian distribution with a width of distribution w1. 2 is the lifetime of the discrete
single exponential term. Values of 1 and 2 were determined from the fitting curve of an average intensity
decay trace of five measurements. Values of w, , and experimental errors were calculated from the means
and standard deviations of an average intensity decay trace of five measurements in at least two independent
protein preparations while 1 and 2 parameters were linked across.

7.2.4 Fluorescence intensity decay of 1,8-ANS binding to DREAM mutants
The fluorescence decay parameters of 1,8-ANS are sensitive to structural changes
associated with Ca2+ or Ca2+Mg2+ binding to DREAM EF-hand mutants. The decay
parameters for 1,8-ANS binding to DREAM EF-hand mutants are summarized in Table
7.2. In 20 mM Tris pH 7.4 buffer, 1,8-ANS exhibits a fast lifetime, 1 of 0.27 ns and a
minor fraction (~ 2%) of 4 ns lifetime due to the non-planar excited state decay (Upadhyay
et al. 1995, Someya, Yui 2010). In the presence of DREAM protein, two additional
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lifetimes, 2 and 3 were obtained suggesting that 1,8-ANS binds to DREAM at two distinct
binding sites with different polarity (Gonzalez and Miksovska, 2014).
The long lifetime, 3, was associated to 1,8-ANS bound to a nonpolar solvent
restricted binding site on DREAM’s surface that promotes the decay of the excited state by
populating the long lived non-planar conformation of 1,8-ANS (Gonzalez and Miksovska,
2014). The fast lifetime, 2, was attributed to the 1,8-ANS probe bound to a partially solvent
exposed binding surface (Gonzalez and Miksovska, 2014).
Intensity decay of 1,8-ANS bound to DREAM EF-hand 2 mutant (DREAMD150N) is shown in Figure 7.8.

Figure 7.8: Frequency domain intensity decay of 1,8-ANS bound to DREAM-D150N.
Phase delay and modulation ratio are shown as solid symbols and empty symbols,
respectively. Recovered intensity decay parameters are shown Table 7.2.
Binding of 1,8-ANS to Ca2+ or Ca2+Mg2+ DREAM-D150N exhibits an increase in
its long lifetime (3 ~ 18 ns) and pre-exponential value (α3 ~ 44%) relative to that of
ApoDREAM-D150N (3 ~ 17 ns, α3 ~ 27 %). The similar values of 3 and α3 were obtained
for 1,8-ANS binding to both Ca2+ and Ca2+Mg2+DREAM-D150N suggest that 1,8-ANS
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binding to the identical binding sites in both Ca2+ and Ca2+Mg2+ forms. The results also
suggest that 1,8-ANS association to the DREAM-D150N is independent of deactivated EFhand 2. Interestingly, an increase in the value of 3 and α3 components (18 ns and 37 %,
respectively) is also obtained for Mg2+ association to ApoDREAM-D150N suggesting that
association of Mg2+ at EF-hands 3 and/or 4 in DREAM leads to a change in hydrophobicity
similar to that obtained in Ca2+ bound form. These results suggest that change in surface
hydrophobicity of DREAM-D150N is dependent on Ca2+ and/or Mg2+ association to EFhands 3 and 4.
Intensity decay of 1,8-ANS bound to DREAM EF-hand 3 mutant (DREAME186Q) and DREAM EF-hand 4 mutant (DREAM-E234Q) are shown in Figure 7.9 (left
and right, respectively).

Figure 7.9: Frequency domain intensity decay of 1,8-ANS bound to DREAM-E186Q (left)
and DREAM-E234Q (right). Phase delay and modulation ratio are shown as solid symbols
and empty symbols, respectively. Recovered intensity decay parameters are shown Table
7.2.
Binding of 1,8-ANS to DREAM-E186Q and DREAM-E234Q exhibits the same
fluorescence intensity decay pattern (Figure 7.9). An increase in the values of 3 and α3
components (~ 16 ns and ~ 24 %, respectively) is obtained for Ca2+ association to Apo and
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Mg2+DREAM-E186Q. The results suggest that Ca2+ association solely at EF-hand 3 is able
to induce change in DREAM’s surface hydrophobicity. Furthermore, Ca2+ association to
ApoDREAM-E234Q leads a decrease of 2 component (4.3 ns) and a small increase in the
values α3 component (14 %) compared to that of Apo form (2 = 5.3 ns and α3 = 11%).
These results suggest that binding of Ca2+ at EF-hand 4 results in change in DREAM’s
surface hydrophobicity, however, the surface hydrophobicity change induced by Ca2+
association at EF-hand 4 differs from that of Ca2+ association at EF-hand 3.
Table 7.2: Decay parameters for 1,8-ANS and DREAM EF-hand mutant complexes
DREAM-D150N

1 (*)
(ns)
0.27
0.27
0.27
0.27

α1
(%)
48
28
25
24

2
(ns)
5.2
6.6
6.6
6.6

α2
(%)
26
37
32
32

3
(ns)
16.6
17.6
17.8
17.9

α3
(%)
26
35
43
44

2

Apo
1.4
2+
Mg
1.7
2+
Ca
1.6
2+
2+
Ca Mg
1.5
DREAM-E186Q
Apo
0.27
60
5.5
22
15.2
18
1.4
Mg2+
0.27
62
5.6
21
15.7
17
1.3
2+
Ca
0.27
55
5.9
21
16.4
24
1.4
2+
2+
Ca Mg
0.27
55
6.0
22
15.9
23
0.8
DREAM-E234Q
Apo
0.27
67
5.3
22
14.3
11
0.3
2+
Mg
0.27
65
5.0
22
13.5
13
1.2
Ca2+
0.27
66
4.3
20
13.1
14
1.9
2+
2+
Ca Mg
0.27
62
4.8
23
13.6
15
2.7
(*)
: fixed value of 0.27 ns for the lifetime of free 1,8 ANS in 20 mM Tris pH 7.4
buffer (Upadhyay et al. 1995, Someya, Yui 2010).
7.2.5 Circular dichroism spectra
Circular dichroism (CD) is an excellent method for characterization of the
secondary structural change in DREAM upon Ca2+ and/or Mg2+ association. In this study,
the functional role of each EF-hand induces the secondary structure changes that were
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characterized in DREAM EF-hand mutants. Similar to DREAM, the CD spectra of
DREAM EF-hand mutants exhibit the strong negative CD signal at the region between 208
nm and 222 nm on the spectrum, indicating a high alpha-helical content of the protein.
Upon Ca2+ association to ApoDREAM-D150N (Figure 7.10, left panel), a significant
decrease in ellipticity between 208 nm and 222 nm was observed, which indicates an
increase in alpha helical content and/or rearrangement of the alpha helices. On the other
hand, Mg2+ association to ApoDREAM-D150N leads to a minor decrease in CD signal
suggesting that when EF-hand 2 is inactive, Mg2+ binds to EF-hand 3 and 4, inducing a
local rearrangement in alpha helices at its binding site. However, association of Mg2+ to
these sites does not significantly alter the secondary structure of DREAM.

Figure 7.10: Circular dichroism spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ DREAMD150N (left panel) and DREAM-E186Q (right panel). Conditions: 40 μM DREAM in 20
mM Tris pH 7.4, 10 mM LDAO, and 1 mM DTT.
On the other hand, Ca2+ association DREAM-E186Q (Figure 7.10, right panel)
induces significant secondary structural change similar to that obtained in DREAM and
DREAM-D150N. Association of Mg2+ to DREAM-E186Q results in an intermediate CD
signal compared to that measured for the Apo and Ca2+DREAM-E186Q. Thus, the CD data
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indicate that Mg2+ is able to induce a structural change distinct from those observed for
metal free and Ca2+ bound DREAM-E186Q.
Moreover, Ca2+ association to DREAM-E234Q (Figure 7.11) leads to a decrease of
ellipticity compared to that observed for the Apo or Mg2+DREAM-E234Q. Our CD data
demonstrate that binding of Ca2+ at either EF-hands 3 or 4 induces significant secondary
structural change in DREAM, whereas binding of Mg2+ at EF-hand 2 leads to a local
rearrangement in the secondary structure near its binding site.

Figure 7.11: Circular dichroism spectra of Apo, Mg2+, Ca2+, and Ca2+Mg2+ DREAME234Q. Conditions: 40 μM DREAM-E234Q in 20 mM Tris pH 7.4, 10 mM LDAO, and
1 mM DTT.
7.2.6 Thermodynamics of DREAM and DNA interaction
Characterization of the thermodynamics of interactions is important for
understanding the biomolecular recognition between DREAM and DNA, as well as the
functional role of individual EF-hands in DREAM. The energetics of DREAM and
DREAM EF-hand mutants binding to the duplex DNA oligonucleotides corresponding to
the DRE sequence of prodynorphin (namely DNA) were carried out using isothermal
titration calorimetry (ITC) technique. The isotherms for DNA binding to both ApoDREAM
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and ApoDREAM EF-hand mutants were best fit into a two-sets of sites model, which
represents two independent sets of binding affinity between ApoDREAM and DNA. The
recovered isotherm parameters are summarized in Table 7.3.
Table 7.3: ITC parameters recovered for DNA binding to DREAM and DREAM EF-hand
mutants using a two sets of sites model
Kd1

ΔH1

Kd2

ΔH2

(µM)

(kcal/mol)

(µM)

(kcal/mol)

1.4 ± 0.1

0.8 ± 0.1

35 ± 2

3.3 ± 0.3

8.5 ± 0.1

8.8 ± 2.8

Mg DREAM

0.6 ± 0.1

0.3 ± 0.1

-18 ± 1

6.8 ± 0.8

10 ± 0.5

0.7 ± 0.1

ApoDREAM-D150N

1.1 ± 0.1

2.8 ± 0.8

12 ± 1

3.4 ± 1.8

74 ±30

15 ± 11

ApoDREAM-E186Q

0.9 ± 0.1

1.4 ± 0.5

21 ± 1

3.5 ± 1.5

98 ± 4

39 ± 28

ApoDREAM-E234Q

0.7 ± 0.1

2.7 ± 0.2

43 ± 1

2.8 ± 0.4

67 ± 6

50 ± 9

1

222 ± 5

330 ± 5

-

-

-

*Ca DREAM-D150N

1

264 ± 6

360 ± 6

-

-

-

*Ca2+DREAM-E186Q

1

174 ± 2

79 ± 1

-

-

-

1

164 ± 3

86 ± 1

-

-

-

DREAM and DNA
ApoDREAM
2+

*Ca2+DREAM
2+

2+

*Ca DREAM-E234Q

n1

n2

(*) Isothermal data were fit using a sequential binding sites model with n1 = 1.
All experiments were conducted at 25 °C

ApoDREAM association to DNA (Figure 7.12, panel A) exhibits an endothermic
interaction evidenced by positive binding enthalpy (+ΔH). The first binding site has higher
binding affinity (Kd1 = 0.8 μM) and larger binding enthalpy (ΔH1 = + 35 kcal/mol)
compared to that of the second binding site (Kd1 = 8.5 μM, ΔH1 = + 8.8 kcal/mol). In
addition, the stoichiometry at the high (n1) and low (n2) binding affinity sites are 1.4 ± 0.1
and 3.3 ± 0.3 mole of protein per mole of DNA, respectively. These results suggest an anticooperative mechanism, in which one ApoDREAM molecule binds to DNA with higher
affinity that decreases the binding affinity of the other three ApoDREAM molecules for
the same DNA. Our isothermal profile for ApoDREAM (residues 65-256) binding to DNA
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(duplex DNA corresponding to the DRE sequence of prodynorphin gene) is similar to that
obtained for ApoDREAM mut65-256 (identical amino acid sequence with the
ApoDREAM construct in this study) binding to the same DNA (duplex DNA
corresponding to the DRE sequence of prodynorphin gene) reported previously (Osawa et
al., 2001). The lower binding affinity observed at the first binding site for ApoDREAM
binding to DNA (Kd = 0.8 μM) in our experiment compared to that obtained in the previous
study (Kd = 0.2 μM) (Osawa et al., 2001) can be explained by the different temperatures
between our experiment (25˚C) and in the previous study (37 ˚C) (Osawa et al., 2001). The
similar tendency for temperature dependence of binding affinity has been observed for
binding of polymerase to primed-template DNA (Datta et al., 2006; Datta and LiCata
2003). Nevertheless, the isotherm of ApoDREAM binding to DNA in our study denotes a
good reference to investigate the functional roles of individual EF-hand in DREAM in
modulating the interaction with DNA.
Mg2+DREAM exothermically interacts with DNA (Figure 7.12, panel B) with
higher binding affinity (Kd1 = 0.3 μM) and negative binding enthalpy (ΔH1 = -18
kcal/mole) at the first binding site compared to that of ApoDREAM. In addition, a high
stoichiometry value (n2 = 7), low binding affinity (Kd2 = 10 μM), and small binding
enthalpy (ΔH2 = 0.7 kcal/mol) at the second binding site between Mg2+DREAM and DNA
suggest a non-specific interaction at this binding site. Our ITC results indicate that DNA
specifically binds to both Apo and Mg2+ DREAM; however, binding affinity is higher in
the Mg2+ form. In addition, different binding thermodynamics of DNA association with
Apo and Mg2+DREAM suggest the different binding mechanisms of interaction between
these forms (Holdgate, 2001; Freiburger et al., 2009).
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Figure 7.12: ITC isotherms for ApoDREAM (A) and Mg2+DREAM (B) binding to DNA. The upper panels of each profile reflects the
thermal power expressed in units of µcal/s. The lower panel shows integrated reaction heats (ΔH) expressed in units of kcal/mol. The
solid lines present the best fitting curve using a two-set of sites model with deletion of the first titration point. The experiment was
carried out by titration of 500 μM of DREAM protein (in syringe) into 15 μM DNA (in sample chamber) at 25 ˚C.

175

To understand the functional properties of each EF-hand of DREAM in modulating
the interaction with DNA, ITC experiments were carried out for the association of DNA
with DREAM EF-hand mutants. The isotherm profiles for DNA binding to ApoDREAM
mutants D150N, E186Q, and E234Q (Figure 7.13 panels: A, B, and C, respectively) are
similar to that obtained for ApoDREAM binding to DNA. However, the binding affinity is
slightly smaller at the first binding site (Kd1 ~ 1.4 to 2.8 μM) and that is much higher (Kd2
~ 67 to 98 μM) at the second binding site compared to that of ApoDREAM. These results
suggest a small structural deviation between ApoDREAM wild-type and mutants (see
explanation in discussion). In contrast, the isotherms of DNA association to Ca2+ bound
DREAM and DREAM EF-hand mutants can be best modeled using a sequential binding
sites model with binding stoichiometry, n = 1. No significant binding was observed for
DNA association with Ca2+DREAM wild-type and Ca2+DREAM-D150N (Kd ~ 225 to 265
μM) (Figure 7.14, panel A and B, respectively), whereas a higher binding affinity was
observed for association of DNA to Ca2+DREAM-E186Q and Ca2+DREAM-E234Q (Kd ~
164 to 174 μM) (Figure 7.14, panels C and D, respectively). These results suggest that
binding of Ca2+ at either EF-hand 3 or 4 in DREAM is able to modulate interaction with
DNA, but binding of Ca2+ at both EF-hands 3 and 4 in DREAM fully inhibits the interaction
between DREAM and DNA.
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Figure 7.13: ITC isotherms for ApoDREAM-D150N (A) and ApoDREAM-E186Q (B), and ApoDREAM-E234Q (C) binding to DNA.
The upper panels of each profile reflects the thermal power expressed in units of µcal/s. The lower panel shows integrated reaction heats
(ΔH) expressed in units of kcal/mol. The solid lines present the best fitting curve using a two-set of sites model with deletion of the first
titration point. The recovered isothermal parameters are shown in Table 7.3.
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Figure 7.14: ITC isotherms for Ca2+DREAM (A), Ca2+DREAM-D150N (B), Ca2+DREAM-E186Q (C), and Ca2+DREAM-E234Q (D)
binding to DNA. The upper panels of each profile reflects the thermal power expressed in units of µcal/s. The lower panel shows
integrated reaction heats (ΔH) expressed in units of kcal/mol. The solid lines present the best fitting curve using a sequential binding
sites model with deletion of the first titration point. The recovered isothermal parameters are shown in Table 7.3.
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7.2.7 Oligomeric states of DREAM in complex with DNA
Because Ca2+/Mg2+ occupancy at EF-hands directly changes oligomerization of
DREAM, which in turn mediates the interactions with DNA (Osawa et al., 2001; Osawa et
al., 2005; Lusin et al., 2008; Gonzalez and Miksovska 2014), the oligomerization states of
DNA in complex with ApoDREAM and Mg2+DREAM were characterized using timeresolved anisotropy. The anisotropy decay traces of DNA in buffer, and DNA in complex
with ApoDREAM, Mg2+DREAM, and Ca2+DREAM are shown in Figure 7.15, panel A.
The anisotropy decay parameters are shown in Table 7.4. The anisotropy decay of DNA in
buffer solution and Ca2+DREAM-DNA complex were fit into a single correlation time
model with rotational correlation time (θ1) of 10.7 ns and 8.1 ns, respectively. Anisotropy
decay of ApoDREAM-DNA complex was fit into a two rotational correlation time model,
in which the fast rotational correlation time (θ1) of 8.1 ns represents the rotation of DNA
free in buffer solution and the slow rotational correlation time (θ2) of 54.5 ns reflects global
rotation of ApoDREAM-DNA complex (Table 7.4).
To investigate the interaction of Mg2+DREAM with DNA, anisotropy decay
experiments were carried out in the presence of 100 μM. The anisotropy decay of DNA in
buffer solution containing Mg2+ and the Mg2+DREAM-DNA complex (Figure 7.15, panel
B) complex were fit using a two correlation time model with the fast rotational correlation
time (θ1) of 2.7 ns reflecting the local motion of the fluorophore (ethidium bromide) and
the slow rotational correlation time (θ2) of 21.9 ns representing the global motion of the
Mg2+DREAM-DNA complex (Table 7.4).
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Figure 7.15: A: Time-resolved anisotropy of DNA in buffer solution (triangle), Ca2+DREAM-DNA complex (square), and ApoDREAMDNA complex (circle). B: Time-resolved anisotropy of DNA in buffer solution containing 100 μM MgCl2 (pentagon) and
Mg2+DREAM-DNA complex (hexagon). Differential phase angle and modulation ratio are shown as solid and empty symbols,
respectively. Solid lines represent the non-linear least square fit and recovered parameters are shown in Table 7.4.
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Table 7.4: Time-resolved anisotropy decay parameters of DREAM and DNA interaction
r2

2

-

1.1

θ1 (ns)

θ2 (ns)

r1

DNA in buffer

10.7 ± 0.2

-

0.30

ApoDREAM-DNA

8.1 ± 0.2

54.5 ± 6.0

0.22

0.11

0.9

Ca2+DREAM-DNA

8.1 ± 0.1

-

0.28

-

2.7

DNA in Mg2+ buffer

2.8 ± 0.2

14.2 ± 0.6

0.12

0.16

1.0

Mg2+DREAM-DNA

2.7 ± 0.2

21.9 ± 0.9

0.13

0.16

1.2

All experiments were conducted at 20 °C
With the known molecular weight of DNA and DREAM, the rotational correlation
time is estimated to be 8 ns for DNA, 18.5 ns for monomeric DREAM bound to one DNA
molecule, and 50 ns for tetramer DREAM bound to one DNA molecule, using a degree of
hydration of 0.98 ml g-1 for a spherical complex at 20 °C (Weber, 1953; Fischer et al.,
2004). The experimentally determined value of θ1 for unbound DNA in the ApoDREAM
and Ca2+DREAM samples matches well with the estimated θ1 value. However, the θ1 value
of DNA in buffer is about 2 ns slower, reflecting rotation of a non-spherical shape of DNA.
The determined θ2 value for ApoDREAM-DNA complex (54.5 ± 6.0 ns) matches the
estimated θ2 value for tetramer DREAM bound one DNA molecule (50 ns), within
experimental error. In addition, the determined θ2 value for Mg2+DREAM-DNA (21.9 ns)
is about 2 ns slower compared to the calculated value, suggesting a non-spherical shape of
the Mg2+DREAM-DNA complex.
7.2.8 Molecular dynamics simulation of DREAM and DREAM EF-hand
mutants
To get insight into the functional roles of individual EF-hands in modulating the
conformational dynamics, the three dimensional (3D) structures of the Apo and Mg2+ and
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Ca2+ bound DREAM are required. Since the structure of the Ca2+ free form exhibits high
flexibility and heterogeneity in solution, the 3D structure of Apo or Mg2+ bound DREAM
has not been experimentally determined (Lusin et al., 2008). Alternatively, advances of
molecular dynamics (MD) simulations provide a comprehensive approach to model the
structures of proteins (Hospital et al., 2015).

Figure 7.16: The backbone root-mean-square deviations (RMSD) of Apo, Mg2+, and Ca2+
DREAM during a 100 ns simulation time.
The MD simulations of Apo and Mg2+DREAM were constructed using the NMR
structure of Ca2+DREAM as an initial structure. The time evolution of the backbone rootmean-square deviations (RMSD) profile (Figure 7.16) shows that the RMSD of
Ca2+DREAM increased quickly within the first 10 ns, then changed gradually, and reached
equilibrium around 4.5 and 5.5 Å after 15 ns simulation time. The backbone RMSD of
Mg2+DREAM shows more flexibility compared to that of Ca2+DREAM, but changed
gradually and remained around 4.5 and 5.0 Å after 60 ns. The RMSD of ApoDREAM
exhibits the highest flexibility compared to that of the Mg2+ and Ca2+ bound forms.
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However, the ApoDREAM also reached equilibrium around 5.5 and 6.0 Å after 85 ns
simulation time.
The root-mean-square fluctuation (RMSF) plot of C atoms was used to calculate
the fluctuations of individual residues with respect to the average structure in Apo, Mg2+,
and Ca2+ bound forms of DREAM protein. The RMSF profile (Figure 7.17) shows that
binding of Ca2+ at EF- hands 3 and 4 in DREAM reduces the fluctuation of the Ca2+ binding
loop of EF hands 3 (residues 170 - 186) and 4 (residue 215 - 234), whereas the long flexible
loop connecting α7 and α8 (residues 200 - 210) in DREAM remains highly flexible when
Ca2+ is bound.

Figure 7.17: The root-mean-square fluctuation (RMSF) plot of C atoms represents the
fluctuations of individual residues with respect to the average structure in the structures of
Apo, Mg2+, and Ca2+ bound forms of DREAM from 20 to 100 ns simulation time.
These results are in agreement with that observed from the previous MD simulation
study in our group (Pham, Dhulipala et al. 2015) and the NMR study reported by Lusin et
al. (Lusin et al., 2008), indicating that the force field (CHARMM27) and the MD
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simulation approach in this study are suitable for constructing a 3D model of
Mg2+DREAM. Indeed, the RMSF profile of Mg2+DREAM shows that when Mg2+ is bound
at EF-hand 2, the region containing α1, α2, and α5 in the N-terminus of DREAM exhibit
decrease in fluctuation compare to that of Apo and Ca2+ bound forms. Interestingly, the
loop connecting α3 and α4 (residues 121 – 128) exhibits increased fluctuation, whereas the
long loop connecting α7 and α8 (residues 197 – 211) and C-terminal regions (residues 216
to 256) are more stable in Mg2+DREAM.
7.2.9 Dynamical network analysis of DREAM molecular dynamics simulations
To better illustrate the dynamic organization of DREAM, I carried out analysis of
the MD simulations using dynamic network analysis. This approach allows me to build
three dimensional networks which represent the cluster of amino acids whose motions are
highly correlated. The resulting networks of Apo, Ca2+ bound at EF-hands 3 and 4, Ca2+
bound at EF-hand 3 (DREAM-E234Q mutant), and Ca2+ bound at EF-hand 4 (DREAM186Q mutant) (Figure 7.18).
Dynamical network analysis of ApoDREAM and Ca2+DREAM simulations
(Figure 7.18, top left and right panels, respectively) shows that communities in
ApoDREAM remain connected, however, the correlation between communities,
represented by thinner edges connecting the nodes, is much weaker compared to that of
Ca2+DREAM. In addition, communities containing α-helices 1, 2, 3, 4, and 5 in the Nterminus (red, yellow, and orange) are rearranged upon calcium binding to either or both
EF-hands. The red community, which contains only α2 in the Apo form, is correlated to
α3, α5, and partially with α4 in Ca2+ bound form, creating a compact domain in the Nterminus. Interestingly, in the absence of Ca2+, the α10 helix is coupled to the N-terminal
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domain of DREAM through weak interactions with α3 and α4, whereas

it strongly

interacts with α7 and α8 in the Ca2+ bound form creating a highly correlated domain in the
C-terminus. Analysis of DREAM-E186Q shows that binding of Ca2+ at EF-hand 4
rearranges the purple community, in which α8 becomes connected with α6 and α7. In
addition, organization of the red, yellow, and orange communities in the N-terminus
remains similar with that of the ApoDREAM.

Figure 7.18: Graphic representation of the monomer structures averaged over 100 ns of
MD simulations of Apo (green), Ca2+ bound at EF-hands 3 and 4 (blue), Ca2+ bound at EFhand 4 in DREAM-E186Q mutant (light blue), and Ca2+ bound at EF-hand 3 in DREAME234Q mutant (pink). All nodes and edges of the communities are colored and shown as
ball and stick, respectively.
On the other hand, analysis of DREAM-E234Q mutant (Ca2+ bound EF-hand 3)
shows that the gray community, which contains only α9 and/or partial α6 in ApoDREAM,
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Ca2+DREAM, and Ca2+DREAM-E186, is significantly spatially reorganized and includes
a new connection to a part of α5. Furthermore, the organization of the red, yellow, and
orange community in Ca2+DREAM-E234Q is structurally similar to that of Ca2+DREAM
wild-type, lacking the strong correlation within residues of α1. These results suggest that
EF-hand 3 may play an important role in Ca2+ signaling transduction from the C- to Nterminal domains of DREAM.
7.2.10 Dynamical paths connecting residues R98 and E186 in DREAM
Following the results from dynamical network analysis, which suggested that Ca2+
association to EF-hand 3 may play a crucial role in tertiary structure reorganization and
propagation of Ca2+ signal transduction from C- to N-terminal domains in DREAM
dynamic pathway was determined between E186, the catalytic residue in EF-hand 3
(Osawa et al., 2005), and R98, located in N-terminal. The residue R98 was chosen for
analysis because it was proposed to be critical for DREAM interaction with DNA (Lusin
et al., 2008). Therefore, the paths connecting R98 and EF-hand 3 may reflect the paths for
Ca2+ signal transduction from EF-hands 3 from the C-terminus to the N-terminus in order
to allosterically regulate the interactions with DNA. Experimentally, W169 was employed
as an intrinsic fluorophore due to its sensitivity to changes in hydrophobicity of the
surrounding environment upon Ca2+ association. Steady-state fluorescence emission and
change in fluorescence lifetimes of W169 were monitored and combined with
computational results elucidate the functional role of each EF-hand in DREAM. Analysis
of ApoDREAM shows a single path connecting residues R98 and E186 (Figure 7.19, top
left panel). In addition, the thinner edges connecting the communities in this path represent
weak connection. Furthermore, residue W169 is not included in the path connecting R98
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and E186 in ApoDREAM. In contrast, two strongly coupled paths connecting residue R98
and E186 were obtained in Ca2+DREAM wild-type (Figure 7.19, bottom panel). Further
analysis of the paths connecting R98 and E186 in Ca2+DREAM reveals that they contain
the major hydrophobic residues F88, L155, I157, L158, L159, W169, L173, F121, L155,
Y118, F114, L134, F135, F133, Y130, and A137 (Figure 1.19, bottom panel), which are
strongly coupled and create a large hydrophobic cluster in the center of DREAM,
connecting the N- and C-terminal domains and surrounding the W169 residue.

Figure 7.19: Top: The path connecting residues E186 and R98 in ApoDREAM (left),
Ca2+DREAM-E234Q mutant (right), and Ca2+DREAM wild-type (bottom). The nodes in
communities are shown as balls. Communities are colored using the same color codes as
shown in Figure 7.18. The hydrophobic residues in the path connecting from R98 to E186
in Ca2+DREAM wild-type are shown in stick (bottom).
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Furthermore, analysis of DREAM-E234Q (Ca2+ bound at EF-hand 3) reveals a
single path connecting residues R98 and E186 (Figure 7.19, top right panel). Interestingly,
the path contains hydrophobic residues F88, L155, I157, L158, L159, W169, and L173
which are also observed in Ca2+DREAM wild-type.
Computational results show structural reorganization in DREAM when Ca2+ is
bound at EF-hands 3 and 4. This conformational change is accompanied by rearrangement
of α-helices 4, 5, 7, 8, and 10, which allow residues L155, I157, L158, L159, L134, Y130,
Y118, and L173 to form a hydrophobic pocket around W169 in the Ca2+ bound form.
Indeed, the fluorescence steady-state emission and lifetime data show a decrease in
emission intensity as well as a 5 nm hypsochromic shift, along with decrease in
fluorescence lifetime of W169 which indicates that the residue W169 is buried in a less
polar environment compared to their Apo forms (section 7.2.1). These results highlight the
role of EF-hand 3 in Ca2+ signal transduction in DREAM.
7.2.11 Dynamical paths connecting residues R98 and E234 in DREAM
In parallel, dynamical network analysis was performed to determine contribution
of EF-hand 4 in Ca2+ signaling. The computational results show a single path connecting
residues R98 and E234Q in ApoDREAM, Ca2+DREAM wild-type, Ca2+DREAM-E186Q
mutant (Figure 7.20).
The path between R98 and E234 in ApoDREAM is weakly coupled, which is
represented by the thin edges connecting the nodes between communities. On the other
hand, a strongly coupled path between R98 and E234 was observed in Ca2+DREAM wildtype and is comprised of hydrophobic residues F88, V152, L159, I157, W169, F235, L236,
I232, L167, and F171 (Figure 7.20, bottom panel).
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Figure 7.20: The path connecting residues R98 and E234 in ApoDREAM (green),
Ca2+DREAM (blue). The nodes in communities are shown as balls. Communities are
colored using the same color scheme as shown in Figure 7.18. The hydrophobic residues
within paths connecting from R98 to E234 in Ca2+DREAM are shown in stick. Note that
only two hydrophobic residues I157 and L167 surrounding W169 were observed in the
path.
Interestingly, only two hydrophobic residues I157 and L167 surrounding the
residue W169 were observed in this path, suggesting that binding of Ca2+ at EF-hand 4
may not significantly alter the hydrophobic environment surrounding W169. Moreover,
the path connecting residues R98 and E234 in Ca2+DREAM-E186Q mutant shares some
common residues with that of Ca2+DREAM wild-type. However, a strongly coupled
hydrophobic cluster formed by residues L167, F171, I232, F235, and L236 was obtained
in Ca2+DREAM wild-type (Figure 7.20, bottom panel).
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7.2.12 Mg2+ association to EF-hand 2 stabilizes the N-terminal domain
Previous studies have shown that binding of Mg2+ at EF-hand 2 in DREAM
stabilizes the monomeric form of the protein, whereas ApoDREAM mainly forms a
tetramer (Osawa et al., 2005; Gonzalez and Miksovska, 2014). However, the absence of
Mg2+DREAM structure prevents us from understanding how Mg2+ binding to EF-hand
stabilizes the DREAM monomer, as well as the influence of Mg2+ on the interaction with
DNA. In this study, MD simulation and dynamical network analysis were employed to
provide insight into structural changes initiated upon Mg2+ association. Then, the
functional role of EF-hand 2 in the modulating DREAM-DNA interaction was elucidated.

Figure 7.21: The MD simulation model of Mg2+DREAM: Association of Mg2+ at EF-hand
2 forms a new hydrophobic cluster (shown as pink solid surface), that has not been
observed in either Apo or Ca2+DREAM. The other two aromatic clusters identified in the
C-terminus and N-terminus are conserved in the NMR structure of Ca2+DREAM and
shown as grey solid surface and blue solid surface.
The MD simulation of Mg2+DREAM reveals that binding of Mg2+ at EF-hand 2
results in the formation of a new hydrophobic cluster formed by hydrophobic residues L93,
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L96, F100, F148, F151, V151, L155, and L159 (shown as pink surface cluster in Figure
7.21 which has not been observed in the NMR structure of Ca2+DREAM (Lusin et al.,
2008).
The presence of a hydrophobic cluster is consistent with the dynamical network
analysis that reveals a large network reorganization at the N-terminus upon Mg2+ binding.
Specifically, α1, α2 and α5 (the exiting α-helix of EF-hand 2) form a strongly coupled
community that is shown in Figure 7.22, left panel.
It is important to note that binding of Mg2+ at EF-hand 2 changes the orientation of
DNA-interacting helix α2 so that the hydrophobic residues L93, L96, and F100 on the inner
side of α2 are in contact with the hydrophobic residues F121 (from α3), F148, F151, V151,
L155, and L159 from α5 (exiting helix of EF-hand 2), creating a strongly coupled network.
Binding of Mg2+ triggers reorganization of the N-terminus domain which results in an
increased exposure of basic and polar residues K90, K91, Q94, S95, R98, K101 on the
solvent exposed side of α2 (Figure 7.22, right panel). A salt bridge between residues E92
from α2 and R160 from α5 is observed in the structure of Apo (Figure 7.23, left panel) and
Mg2+DREAM (Figure 7.22, left panel), absent in the average MD structure of
Ca2+DREAM, may contribute to the stabilization of α2 and could lead to the increased
stability of ApoDREAM and Mg2+DREAM-DNA complex (see ITC experimental results).
The orientation of α2 in ApoDREAM and Mg2+DREAM is somewhat similar to
that of the basic helix-loop-helix DNA binding motif, in which exposed residues on the
basic helix form sequence-specific contacts with the DNA backbone (Ma et al., 1994; Lusin
et al., 2008). Interestingly, residues L155 and L159 from α5, which are proposed to interact
with L251 on the second Ca2+DREAM molecule to form a Ca2+DREAM dimer (Lusin et
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al., 2008), are inserted into the N-terminal hydrophobic cluster surrounded by F87, F100,
F121, F148, and F151 in Mg2+DREAM. The structure of the ApoDREAM tetramer is
unknown, however it is possible that L155, L159 and L251 are involved in the stabilization
of ApoDREAM tetramer suggesting that Mg2+ association at EF-hand 2 precludes the
protein from forming a tetramer in the absence of Ca2+. These observations are in
accordance with the experimental results, showing that Mg2+ stabilizes DREAM as a
monomer, previously reported by our group (Gonzalez and Miksovska, 2014) and Osawa
et al. (Osawa et al., 2005).

Figure 7.22: Left: Dynamical network analysis of the 100ns MD simulation of the first 6
α-helices in Mg2+DREAM N-terminus displayed in communities (each community has
different color). Right: The dynamical network Hydrophobic cluster L93, L96, and F100
on the inner side of α2 contact with the hydrophobic residues F121 (from α3), F148, F151,
V151, L155, and L159 from α5 (exiting helix of EF-hand 2) that is stabilized upon Mg2+
association to DREAM. The basic and polar residues K90, K91, Q94, S95, R98, and K101
interfacing with DNA are shown on the outer site of α2. The leucine residues L155 and
L159 at the dimeric interface of DREAM are in red, whereas the basic residues forming a
salt bridge between α2 and α5 are shown in light blue.
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On the other hand, dynamical network analysis of the MD simulation structure of
ApoDREAM reveals that α2 is not involved in an extended community, suggesting a
decrease in stability of the N-terminus domain (Figure 7.23, right panel).

Figure 7.23: Left: Dynamical network analysis of the 100ns MD simulation of the first 6
α-helices in ApoDREAM N-terminus displayed in communities (each community colored
differently). Right: In the absence of Mg2+, the α2 is not involved in an extended
community formed by α1, α5, and α6, suggesting a decrease in stability of the N-terminus
domain despite of the salt bridge formation between residues E92 and R160 (in light blue,
bottom).
In contrast to Mg2+DREAM, dynamical network analysis of the MD simulation
structure of Ca2+DREAM reveals that binding of Ca2+ at EF-hand 3 and 4 leads to the
breakage of salt bridge between residue E92 and R160 as well as the absence of the of the
extended community formed by α1, α2, and α5. Indeed, in the structure of Ca2+ DREAM,
α1 is repositioned in such way that partially blocks the DNA binding site on α2, resulting
in the decrease of DREAM affinity for DNA (Figure 7.24).
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Figure 7.24: Dynamical network analysis of the 100ns MD simulation of the first 6 αhelices in Ca2+DREAM N-terminus displayed in communities (each community colored
differently). Rearrangement of α1 partially blocks the DNA binding site on α2.
7.2.14 Computational docking of ApoDREAM and DNA
The computational docking complex of ApoDREAM and DNA is shown in Figure
7.25. The docking complex of ApoDREAM-DNA reveals that the assembly of
ApoDREAM and DNA involves two major types of interaction. Electrostatic interactions
are found between the negatively charged phosphate oxygens from nucleotides C43, A13,
and C41 from DNA and the positively charged side chain of residues K90, K91, and K101
from α2 in DREAM, respectively.
The complex is further stabilized by hydrogen bonds between residue R98 and
nucleotides T11, C12, and C41 with the total energy of 14.3 kcal/mol, determined using
YASARA Structure program version 13.1.25 (Krieger et al., 2002), in which the planar
guanidinium group of residue R98 from DREAM inserts into the minor groove at the target
DRE site formed by 5’-10GTCA13-3’ and ‘3-41CAGT38-5’ (Carrion, 1999; Ledo et al., 2000)
(Figure 7.23). Moreover, the cation- interactions was also obtained between residue R98
from DREAM and nucleotides T11, C12, A40, and C41 from DNA with the total
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interaction strength of 10.6 kcal/mol. Hydrogen bond interactions were also found between
pairs of amino acid residue-nucleotide: K90-C43 (5.8 kcal/mol), K91-A13 (5.2 kcal/mol),
K101-A41 (5.1 kcal/mol), Q94-T42 (3.4 kcal/mol), S95-A13 (5.7 kcal/mol), and Q120G15 (4.5 kcal/mol) (Figure 7.23). Furthermore, the residues and nucleotides at interface
hot spots determined in the ApoDREAM-DNA docking complex are consistent with the
basic residues proposed in other studies (Carrion et al., 1999; Lusin et al., 2008).

Figure 7.25: (a): The MD simulation of docking complex between ApoDREAM (residues
75-256) and 25 oligomers corresponding to the DRE sequence of prodynorphin gene
(namely DNA). (b): A closer view at the interaction interface between ApoDREAM and
DNA. Yellow dot lines represent hydrogen bond interactions. (c): the sequence of 25
oligonucleotides corresponding to the DRE. (d): the sequence alignment of 45 amino acid
residues in the N-terminus of DREAM (residues: 75-120, top) and that of the non-DNA
binding recoverin (residues: 12-57) to highlight the positively charged residues in DREAM
participating to the interaction with DNA.
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7.3 Discussion
7.3.1 Conformational dynamics associated with Ca2+ binding at EF-hand 3
and/or 4 modulates DREAM and DNA interaction
In this report, I have studied functional properties of individual EF-hands of
DREAM in regulating the protein conformational dynamics and interaction with DNA. In
the previous study, I have shown that Ca2+ association to the EF-hands 3 and 4 in the Cterminal domain of DREAM leads to the changes in conformational dynamics of residue
W169. In the Ca2+ bound DREAM, W169 is located in a less polar environment, as
demonstrated by a decrease in the emission intensity (-18 %) along with a concomitant
hypsochromic shift of 5 nm of the emission spectra relative to that of Ca2+ free forms (Pham
et al., 2015). In addition, the Gaussian distribution component of W169 lifetime (1) in
ApoDREAM decreases from 3.5 ns to 1.7 ns in the Ca2+ bound form suggesting lower
heterogeneity of the Ca2+ bound protein Furthermore, the exponential decay fraction of
ApoDREAM (f1 = 77%) significantly decreases when Ca2+ is bound (f1 = 44%) (Pham et
al., 2015).
The overall emission properties of Ca2+ free and Ca2+ bound DREAM-D150N are
very similar to those determined for DREAM wild-type. However, closer inspection of the
results reveals a small deviation in fluorescence properties of W169 in this mutant, namely,
quenching of W169 emission intensity in this mutant is less efficient than in the DREAM
wild-type and the Gaussian component of the W169 lifetime is shorter (2.9 ns) in the Ca2+
free form of the protein. In the Ca2+ bound form of protein, residue D150 is located ~ 14.5
Å from W169, indicating that the charge distribution in the EF-hand 2 impacts the
conformation of residues located at the interface of the C- and N- terminus domains.
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Furthermore, our ITC data show that the binding affinity of ApoDREAM-D150N
with the duplex DNA at the high affinity site is weaker (Kd1 = 2.8 μM) and the change of
enthalpy (ΔH1 = + 12 kcal/mol) is smaller compared to that of ApoDREAM (Kd1 = 0.8 μM
and ΔH1 = + 35 kcal/mol) suggesting a small deviation in the conformational dynamics
between the structures of ApoDREAM-D150N and ApoDREAM impact DREAM
interactions with DNA.
In order to explain the deviation between the Apo forms of DREAM wild-type and
DREAM-D150N mutant, the MD simulation structure of ApoDREAM was superposed
with the MD simulation structure of ApoDREAM-D150N (Figure 7.26, left panel).

Figure 7.26: Left: Residue W169 is buried in a more hydrophobic environment observed
in ApoDREAM (yellow) compared to that obtained in ApoDREAM-D150N mutant
(green). Right: The superposition of five α-helices in the N-terminal domain of
ApoDREAM (yellow) and ApoDREAM-D150N (green).
Interestingly, the indole ring of W169 in ApoDREAM-D150N (green in Figure
7.26, right panel) becomes more buried in the hydrophobic cavity formed by residues
Y130, L134, F138, I157, L158, L173, and F252 (Figure 7.26, left panel) compared to that
observed in ApoDREAM wild-type. The subtle structural rearrangement of the α1 in the
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N-terminal domain of ApoDREAM-D150 (Figure 7.26, right panel) relative to
ApoDREAM explaining the weaker interaction of duplex DNA with ApoDREAM-D150N.
The Ca2+ association at EF-hands 3 and 4 in DREAM-D150N completely
eliminates the interaction with duplex DNA with a Kd of 225 μM, similar to that of
Ca2+DREAM wild-type (Table 7.3).
The fluorescence properties of W169 are differently modulated by Ca2+ binding to
EF-hands 3 and 4. The fluorescence properties of DREAM-E186Q with Ca2+ bound to
EF-hand 4 are similar to the fluorescence properties of ApoDREAM, whereas the
fluorescence properties of DREAM-E234Q with Ca2+ bound to EF-hand 3 are analogous
to emission properties of calcium saturated DREAM wild-type. These data strongly
indicate that Ca2+ association to the EF-hand 3 is necessary for structural transition between
the ApoDREAM and Ca2+ bound DREAM conformation. Interestingly, the emission data
of 1,8-ANS indicate that the accessibility of the C- terminal hydrophobic cavity increases
upon Ca2+ binding to EF-hand 3 or EF hand 4. On the other hand, the Ca2+ association to
either EF-hand 3 or 4 is able to diminish the DREAM affinity for DNA. However, binding
of Ca2+ at both EF-hands 3 and 4 is necessary for the regulation of DREAM association to
DNA. Also, Ca2+ binding to EF-hand 3 may triggers structural changes that are localized
in the vicinity of EF-hand 3 and Ca2+ association to both EF-hands may be necessary for
global structural transition in DREAM that is required for inhibition of DREAM
interactions with DNA. These data also indicate that fluorescence emission and lifetime of
W169 may not be an ideal probe to monitor the global transition in DREAM protein and
thus there is a need for additional fluorescence probe to be placed in the N- terminal domain
that would be sensitive to conformational changes in this domain. There are two tyrosine
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residues located in the N- terminal domain of DREAM, but their emission is efficiently
quenched by W169 and they cannot be used for probing conformational changes in the Nterminus domain.
The ITC data show several DNA binding sites on DREAM molecules with one high
affinity site and additional three lower affinity site. Ca2+ association to DREAM inhibits
DNA binding to both the high and low affinity sites. To understand how Ca2+ binding to
DREAM antagonistically modulates the interaction with duplex DNA, the structure of
Ca2+DREAM was superposed with the MD simulation structure of ApoDREAM (Figure
7.27, top panel).

Figure 7.27: Top: Amino acid sequence alignment of residues (K90 – N102) in α2 of
ApoDREAM (green) and Ca2+DREAM (blue). Bottom: The dimer Ca2+DREAM was
constructed according to the model proposed by Lusin et at. (Lusin et al., 2008).
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The amino acid alignment of residues (K90 – N102) from α2 of ApoDREAM and
Ca2+DREAM (Figure 7.27, top panel) reveals that the side chains of residues in α2 (Q94,
R98, K101) in Ca2+DREAM rotate about 180 degrees, preventing formation of DREAMDNA complex. In addition, the structure of head-to-tail homodimer of Ca2+DREAM
(Figure 7.27, bottom panel), constructed using the dimeric model proposed by Lusin et al
(Lusin et al., 2008), reveals the loop connecting α7 and α8 from the second Ca2+DREAM
molecule blocks the DNA binding interface (α2) in the first Ca2+DREAM molecule which
prevents interaction of DNA.
7.3.2 Association of Mg2+ at EF-hand 2 structurally facilitates the interaction
between DREAM and DNA
Because the concentration of free Mg2+ is maintained at nearly constant level of 1
μM in cells, Mg2+ is not likely to directly regulate cell signaling (Romani, Scarpa 1992).
However, DREAM possesses a highly Mg2+ sensitive EF-hand 2 (Kd ~ 13 μM) that raises
a question about the physiologically relevance of Mg2+DREAM in the resting state of the
cell, as well as its role in modulating the interaction with DNA. The functional role of Mg2+
bound to EF-hand 2 in DREAM in modulating DNA interaction was demonstrated by
experimental data. Dynamical network analysis illustrates that Mg2+ binding at EF-hand 2
alters the orientation of α2 in such way that the residues L93, L96, and F100 on the inner
side of α2 are coupled with the hydrophobic residues F121 (from α3), F148, F151, V151,
L155, and L159 from α5 (exiting helix of EF-hand 2), while side chain of the basic and
polar residues K90, K91, Q94, S95, R98, K101 at DNA binding interface are extruded to
the solvent (Figure 7.20). Our ITC data show that affinity for DNA specifically binding to
Mg2+DREAM (Kd1 = 0.3 μM) is somewhat higher compared to that of ApoDREAM (Kd1
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= 0.8 μM). In addition, association of DNA to Mg2+DREAM is an exothermic reaction
with favorable enthalpy (ΔH) of -18 kcal/mol, whereas binding of DNA to ApoDREAM is
an endothermic reaction with ΔH of + 35 kcal/mol. These results suggest that the binding
mechanisms are different for association of DNA to Apo and Mg2+ forms of DREAM. To
further examine the different mechanisms of DNA association with ApoDREAM and
Mg2+DREAM, time-resolved anisotropy experiments were carried out. Our anisotropy
decay data illustrate that DNA binds to tetrameric ApoDREAM and monomeric
Mg2+DREAM. The binding interface between ApoDREAM and the duplex DNA was
determined using experimental restraints from previous studies (Carrion, Link et al. 1999a,
Ledo, Link et al. 2000, Lusin, Vanarotti et al. 2008) for the input in protein-DNA
computational docking. The model of Mg2+DREAM-DNA complex was not investigated
in this study due to the lack of experimental information for docking input. These results
demonstrate that assembly of ApoDREAM and DNA involves two major types of
interaction: electrostatic interactions between the negatively charged phosphate oxygens
from nucleotides C43, A13, and C41 from DNA and the positively charged residues K90,
K91, and K101 from α2 in DREAM. The complex is further stabilized by hydrogen bond
interactions between pairs of amino acid residue-nucleotide: K90-C43, K91-A13, K101A41, Q94-T42, S95-A13, and Q120-G15 (Figure 7.25). Furthermore, the complex is
further stabilized by hydrogen bonds and cation- interactions between the side chain of
residue R98 from DREAM with the nucleotides at the minor groove of the target DRE site
formed by 5’-10GTCA13-3’ and ‘3-41CAGT38-5’. The residue R98 in DREAM plays a role
in the interaction not only with DNA (Lusin et al., 2008), but also with K+ channel Kv4.3

201

(Gonzalez, Pham et al. 2014), highlighting its biological relevance in modulating
interactions with DNA and target proteins.
7. 4 Summary
In this report, we show comprehensive evidence demonstrating the impact of
Mg2+/Ca2+ on conformational dynamics of DREAM as well as the functional properties of
individual EF-hands in DREAM upon interaction with duplex DNA. We demonstrate that
Mg2+ binding at EF-hand 2 structurally stabilizes the DREAM N-terminal domain, which
facilitates interaction with duplex DNA. The binding of Ca2+ at either EF-hand 4 is able to
modulate the interaction of DNA. However, binding of Ca2+ at both EF-hands 3 and 4 is
necessary to abolish interaction between DREAM and DNA. These findings provide
insight into the roles of individual EF-hands in DREAM under physiological and
pathological conditions, which can be used as a model to uncover the functional properties
of EF-hands in other neuronal calcium sensor proteins and to characterize the effects of
Mg2+ on various Ca2+ signaling pathways in cells.
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8. CHARACTERIZE KINETICS AND THERMODYNAMICS ASSOCIATED
WITH CARBON MONOXIDE BINDING OR RELEASING FROM HORSE
HEART MYOGLOBIN AND MICROPEROXIDASE-11 IN SODIUM BIS-(2ETHYLHEXYL) SULFOSUCCINATE ENCAPSULATION: A MODEL SYSTEM
TO STUDY CONFORMATIONAL DYNAMICS OF DREAM FULL LENGTH IN
MEMBRANE ANCHORED STATE.
(The work described in this chapter was partially published in (Larsen, Vetromile et al.
2011))
8.1 Background and significance
Reverse (inverted) micelles (RM) are nanoscale droplets of water surrounded by
amphiphilic surfactants in nonpolar solvent with surfactant molecules oriented in such way
that the nonpolar tails are in contact with the organic phase and the polar heads enclose a
water pool inside the micellar cavity (Figure 8.1).

Figure 8.1: The schematic presentation of AOT molecule (left) and a reverse micelle
particle containing an Mb molecule encapsulated within internal water pool (right).
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Reverse micelles have attracted considerable attention as micromedia for chemical
and biochemical reactions due to their ability to solubilize hydrophilic reactants in organic
solvents. Reverse micelles based upon sodium bis-(2-ethylhexyl) sulfosuccinate (AOT)
have been extensively studied using various physical techniques since these micelles are
thermodynamically stable, optically transparent and the size of the internal water pool can
be varied from 10 Å (≈30 water molecules) to 140 Å (≈400,000 water molecules) through
varying the molar water to surfactant ratio (wo = [water]/[surfactant]) (Kotlarchyk et al.,
1985; Moilanen et al., 2007; Fenn et al., 2009). The properties of encapsulated water
molecules are traditionally described using a two-state model as originally proposed by
Zinsli (Zinsli, 1979). Interfacial water molecules that solubilize charged surfactant head
groups as well as counter cations exhibit increased viscosity and slow relaxation rates
whereas the water molecules located within the core of the water pool show properties
similar to bulk water. Reverse micelles have been extensively used to probe the effect of
confinement and hydration on protein structure, dynamics, and folding. The structural
properties of encapsulated proteins depend on the water pool size, surfactant charge and
interactions between protein and surfactant (Van Horn et al., 2005; Van Horn et al., 2009;
Naoe et al., 2004). For example, it has been shown that encapsulation of cytochrome c in
AOT RM is associated with a structural destabilization, opening of the heme crevice and
dissociation of the Met-80 heme axial ligand (Abel et al., 2010; Brochette et al., 1988). To
investigate the conformational dynamics in restricted environment of RM, I have used PAC
and transient absorption to characterize the kinetics and thermodynamics associated with
CO binding/releasing from horse heart Mb and from microperoxidase-11 (MP-11). Protein
MP-11 is an 11 residue polypeptide fragment obtained by proteolytic cleavage of
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cytochrome c. The heme group in MP-11 is covalently attached to the peptide chain
through two thioether linkages and retains axial histidine ligand (Verbaro et al., 2009).
8.2 Results
8.2.1 UV/Vis absorption spectra
The absorption spectra of ferric, ferrous and CO bound Mb encapsulated in AOT
RM of wo = 40 are displayed in Figure 8.2. The optical spectrum of Fe3+Mb exhibits a
maximum of the Soret band at 414 nm and a broader absorption band with maximum at
534 nm with an additional shoulder at 564 nm (Table 8.1). These values are very similar
to the absorption spectrum of a hemichrome Mb intermediate with bis-histidine heme iron
coordination (Miksovksa et al., 2006). Formation of the hemichrome Mb was previously
reported for metMb exposed to low concentration of GuHCl (Culbertson and Olson, 2010)
or to Fe3+Mb complexed with negatively charged surfactants such as sodium dodecyl
sulfate (Miksovksa et al., 2006) or AOT (Murakami et al., 2011).

Figure 8.2: Optical absorption spectra of Mb (left) and MP-11 (right) encapsulated within
RM w=40. The traces for Fe3+Mb/Fe3+Mp-11 are shown as solid thick lines, for
Fe2+Mb/Fe2+MP-11 as dashed lines and for CO-Mb and CO-MP11 as solid thin lines.
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Reduction of Mb in AOT micelles is associated with a hypsochromic shift of the
Soret band to 411 nm and the appearance of a broad band in the visible region, max = 626
nm. Such a large blue shift in the Soret band absorption maxima relative to Fe2+Mb in
aqueous solutions (max = 434 nm) indicates pronounced changes in the heme binding
pocket.
Table 8.1: The position of the Soret band and Q bands for Mb, and MP-11 encapsulated
within the AOT reverse micelles, wo = 40. The numbers is parenthesis corresponds to the
max for Mb and MP-11 in aqueous solutions, pH = 7.0.

Fe3+Mb
Fe2+Mb
CO-Mb

Soret band
max (nm)
414
(406)
411
(435)
420
(424)

Q bands
max (nm)
534, 565
(508. 630)
531
(560)
537, 567
(540, 579)

Fe3+MP-11
Fe2+MP-11
CO-MP-11

Soret band
max (nm)
410
(400)
419
(416)
415
(412)

Q bands
max (nm)
521
(532)
523, 551
(520, 550)
528, 562
(525)

The absorption spectra of MP-11 in RM are shown in Figure 8.2 (right). The Soret
band of Fe3+MP-11 is centered at 410 nm and upon heme iron reduction, shifts to 419 nm
with two Q bands appearing at 523 nm and 551 nm that are characteristic of a low-spin sixcoordinated heme c species. The formation of six-coordinate species was previously
observed for MP-11 solubilized in aqueous solutions and was attributed to intermolecular
coordination between the heme iron and -NH2 group of Val11 or ε-NH2 group of Lys 13
(Wang, Van Wart 1989)(144). The optical absorption results suggest that the
intermolecular coordination of MP-11 is retained upon peptide encapsulation within the
reverse micelles. Saturation of Fe2+MP-11 within RM with CO leads to the formation of
the six-coordinated low-spin heme iron. Interestingly, the Soret band maxima of MP-11
adducts are red-shifted relative to the optical spectra of MP-11 in aqueous solutions
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suggesting strong interactions between MP-11 and the negatively charged sulfate groups
of the AOT molecules.
8.2.2 Photoacoustic calorimetry results
The PAC trace for CO photo-dissociation from Mb in RM is displayed in Figure
8.2 together with the PAC trace for Fe3+Mb (used as the calorimetric reference). The
sample acoustic wave is shifted in phase relative to the reference indicating the presence
of volume/enthalpy changes occurring on timescales from ~ 50 ns to ~ 15µs. These data
indicate that CO escape from Fe2+Mb in RM can be described as a two-step process with
the prompt step (prompt < 50 ns) corresponding to Fe-CO bond cleavage and the subsequent
step reflecting CO escape from the protein matrix to the surrounding solvent.

Figure 8.3: PAC traces for CO photo-dissociation from Fe2+Mb in AOT RM of wo = 40
(thick black line), for the reference compound (Fe3+Mb in AOT RM of wo = 40) and the fit
(gray line).

207

The PAC sample and reference traces were measured over the temperature range
from 20 to 35 C and deconvolution of the PAC traces provided the rate constant for CO
escape from Fe2+Mb encapsulated within AOT RM to be ~ 8.3 x106 s-1 at 20 C with an
associated activation energy, Ea = 24 ± 13 kJ mol-1. The observed rate constant is
approximately six times faster relative to the rate constant for CO escape from Fe2+Mb in
aqueous solutions at pH 7.0 (kesc = 1.4 x 106 s-1 and Ea = 43 ± 3 kJ mol-1) (Belogortseva et
al., 2007). Based upon spectroscopic data and molecular dynamics approaches, a
comprehensive molecular mechanism for ligand migration in Mb was proposed including
the initial diffusion of the photo-dissociated ligand into the internal network of
hydrophobic cavities and subsequent ligand return into the distal heme binding pocket
(Small et al., 1992; Mouawad et al., 2005). The escape of CO from the protein matrix
requires opening of a transient channel between the heme propionates through an outward
rotation of the distal histidine side chain and the rate for closing/opening of histidine gate
was estimated to occur on timescale of 1 -10 µs, which is comparable to the 700 ns time
constant determined in previous PAC measurements (Larsen et al., 2011). The faster
ligand escape observed for Mb within RM indicates that either Mb confinement within RM
and/or electrostatic interactions between the encapsulated Mb and negatively charged
micellar interface accelerates the transition between the closed and open conformations of
the histidine gate resulting in the faster CO exit from protein matrix. Alternatively,
perturbations to the Mb tertiary structure may trigger the opening of new ligand migration
pathway(s) with lower activation barriers that are not populated under native conditions.
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8.2.3 Transient absorption results
To further investigate the interactions between CO and Fe2+Mb/Fe2+MP-11 in
reverse micelles, the rate constants for CO rebinding were determined using transient
absorption spectroscopy (Figure 8.4). Rebinding of CO to the heme iron in the Fe2+MbAOT system is a biphasic process with the faster process occurring with the time constant
of 41 µs (A1 ~ 0.7) and the second phase having a lifetime of 176 µs (A2~ 0.3) at 20 C. A
similar biphasic process was observed for CO rebinding to MP-11 with 1 = 23 µs and 2
= 57 µs with equal amplitudes for both phases (data not shown). The rate constants for CO
rebinding to Fe2+Mb were probed over the temperature range from 15 C and 30 C to
determine the activation barrier for ligand rebinding (Figure 8.4, Inset).

Figure 8.4: Transient absorption trace for CO rebinding to Fe2+Mb encapsulated within
RM, wo = 40. Inset: Arrhenius plot of the rate constants for the fast (circles) and slow
(squares) phase of the CO rebinding to Mb.
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The fast phase shows an activation barrier of 15 ± 6 kJ mol-1 and similar activation
barrier was determined for the slow phase, Ea = 19 ± 9 kJ mol-1. These values are
comparable to the activation energies determined for CO rebinding to Fe2+Mb in aqueous
solutions, Ea ~ 19 kJ mol-1 (Hasinoff, 1974).
Overall, these data are in agreement with the photoacoustic results confirming that
Mb encapsulation within RM leads to the opening of the protein structure facilitating ligand
access to the heme binding pocket. The presence of bi-exponential CO rebinding kinetics
to both Fe2+Mb and Fe2+MP-11 is somewhat surprising. Analysis of the CO rebinding data
in RM is complicated as the CO concentration within the micellar water pool and surfactant
interface is unknown. However, the presence of the multi-exponential CO rebinding
kinetics points out that Fe2+MP-11 and Fe2+Mb may be located at least in two distinct
environments, such as water pool and surfactant interface, with different CO concentration
or that the CO rebinds from both the interior water cavities as well as diffusion from the
bulk organic solvent.
8.3 Summary and Outlook
The ability to probe thermodynamics associated with physiological processes in
biomolecules on sub-millisecond time scales remains a significant challenge in molecular
biophysics. Nonetheless, as demonstrated in the sections above, time resolved
photothermal methods offer a unique opportunity to access enthalpy and molar volume
changes associated with photo-initiated processes on time scales ranging from tens of
milliseconds down to tens of nanoseconds. Photoacoustic calorimetry has now been widely
applied to a vast array of biological molecules with photo-triggerable physiological
processes and thermodynamic profiles have been revealed on very fast time scales. I have
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now demonstrated the utility of the PAC method for proteins encapsulated within reverse
micelles and are currently employing these methods to investigate the conformational
dynamics of DREAM full length (residues 1 -256) in membrane-anchored state as well as
the interaction of presenilins with DREAM full-length encapsulated in reverse micelles
upon photolysis of caged Ca2+ compound.
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9. CONCLUSIONS
The conformational dynamics and stability associated with Mg2+ and/or Ca2+
binding to DREAM in the regulation of interactions between DREAM and DNA or
presenilins have been successfully delineated throughout this dissertation.
The impact of Ca2+ and/or Mg2+ on conformational dynamics and stability of
DREAM have been described in Chapters 4 and 5. The binding of Ca2+ to DREAM triggers
the reorganization of the interface between EF-hand 2 and EF-hand 3 with the W169 side
chain being located in a less polar environment. In addition, association of Ca2+ reduces
solvent accessibility to the W169 residue due to tertiary structure alterations and/or
decreased conformational flexibility. In addition, a transition from the t to g+ rotamer of
W169 side chain was observed during molecular dynamic simulations supporting the idea
that the bimodal distribution could arise from two rotameric orientations of W169 with the
side chain of the g+ rotamer being more solvent exposed than that of the t rotamer. The
W169 lifetime data indicates that DREAM can adopt an additional conformation with a
long W169 lifetime of 7.5 ns that may reflect conformations of DREAM populated in the
presence of lipid membranes and vesicles.
In addition, I have also shown that association of Mg2+ and/or Ca2+ to DREAM EFhands increases the stability of the protein, although to different extents. Despite the low
impact of Mg2+ association with EF-hand 2 on the DREAM tertiary structure, the presence
of Mg2+ stabilizes the native state with respect to a partially unfolded state. The results
show that DREAM unfolding is a complex process that occurs through a partially unfolded,
intermediate state. The Ca2+ association to EF-hands 3 and 4 stabilizes the partially
unfolded state with respect to the unfolded state whereas the association of Mg2+ increases
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the stability of the native state only in the presence of Ca2+. These results suggest that the
intracellular fluctuations in Ca2+ and Mg2+ concentrations control the global conformation
and stability of DREAM and likely regulate its interactions with intracellular partners.
In Chapter 6, I have presented that association of presenilin-1 carboxyl α-helix 9
(HL9) with DREAM is Ca2+ dependent. The assembly of DREAM and HL9 is primarily
dominated by hydrophobic interactions between residues F462 and F465 from HL9 and
residues M191, I194, M197, M198, M249, F252, V255, and I256 at the C-terminal
hydrophobic cavity in DREAM. I have also illustrated that residue F252 as well as EFhand 3 in DREAM play crucial roles in the regulation of the interaction of DREAM with
HL9. These results provide an insight into the conformational dynamics of DREAM
associated with Ca2+ and/or Mg2+ binding to DREAM in regulation of DREAM and
presenilins interactions. Our findings also provide the crucial hot spots at the binding
interface between DREAM and presenilin 1, which provides the potential druggable
pockets for structure-based development of a novel drug compounds to treat Alzheimer’s
disease.
The functional roles of individual EF-hands in DREAM in modulating the
conformational dynamics of DREAM protein and upon interactions with DNA have been
delineated in Chapter 7. I have shown that Mg2+ association at EF-hand 2 structurally
stabilizes the N-terminal alpha-helices 1, 2, and 5, thereby assisting the interaction with
DNA. The binding of Ca2+ at EF-hand 3 induces significant structural changes in DREAM,
represented by the critical paths comprised of hydrophobic residues F88, F121, Y130,
F133, L134, A137, V152, L155, I157, L159, W169, and L173. These findings illustrate

213

the critical role of EF-hand 3 for Ca2+ signal transduction from the carboxy- to aminoterminus in DREAM. Interestingly, Ca2+ association at EF-hand 4 stabilizes the carboxyterminus by forming a strong coupled network consisting of hydrophobic residues L167,
F171, I232, F235, and L236 in DREAM.
Lastly, in Chapter 8, I successfully characterize kinetics and thermodynamics
associated with carbon monoxide binding or releasing from horse heart myoglobin and
microperoxidase-11 in sodium bis-(2-ethylhexyl) sulfosuccinate encapsulation for the
development of a novel model system to study conformational dynamics of DREAM full
length in membrane anchored state. I have demonstrated that transient absorption and
photoacoustic calorimetry methods for proteins encapsulated within reverse micelles are
novel and reliable approaches to investigate the conformational dynamics of DREAM full
length (residues 1 -256) in membrane-anchored state as well as the interaction of
presenilins with DREAM full-length encapsulated in reverse micelles. The study also
reveals novel insights into the protein conformation, physiological function, and proteinmembrane interactions. Such information is critical to understanding NCS proteins
function within the confined space of the cell as well as to develop a more reliable method
to study myristoylation or palmitoylation switch of NCS proteins.
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